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Fetal germ cell development is a key stage of female reproductive life. The DAZ 
family proteins (DAZ, DAZL and BOLL) are RNA-binding proteins with critical 
roles in murine germ cell development but their expression and potential targets in 
the human are largely unknown. The studies in this Thesis investigated the 
expression and function of DAZL and BOLL in human fetal ovary.  
Both DAZL and BOLL mRNA are increased dramatically at the time of entry into 
meiosis. Immunohistochemical analysis with specific meiotic markers suggested that 
DAZL and BOLL have distinct spatial-temporal expression patterns, with minimal 
co-expression – BOLL expression was transient prior to follicle formation. This 
pattern was shown not to be present in the mouse fetal ovary, where Dazl and Boll 
are co-expressed, indicating a limitation of the mouse for exploring the function of 
Boll.  
Two human cell lines, embryonic kidney derived HEK293 cells and germ cell 
tumour derived TCam-2 cells were used as models to identify the mRNA targets of 
DAZL and BOLL after transfection of DAZL or BOLL vectors. In HEK293 cells, 
TEX19 and TEX14 were confirmed as potential targets of both DAZL and BOLL, 
and CDC25A as a potential DAZL target. Further experiments indicated that DAZL 
and BOLL did not increase target mRNA transcription but increased stabilisation. A 
DAZL/GFP co-transfection-FACS system for TCam-2 cells was established as this 
cell line has very low transfection efficiency. TEX14 and SYCP3 significantly 
increased in GFP+ve-DAZL+ve cells when compare to the GFP-ve-DAZL-ve cells, 
whilst SOX17 and DNMT3L significantly decreased in the GFP+ve-DAZL+ve cells. A 
3'-UTR luciferase assay confirmed regulation of TEX14 and SOX17 by DAZL 
through their 3'-UTR. RNA immunoprecipitation further demonstrated direct binding 
between human TEX14, TEX19, SYCP3, SOX17 mRNA and DAZL protein, and that 
TEX14 binding is through its 3'-UTR. Dual fluorescence immunohistochemistry 
showed that SOX17 and DMNT3L are expressed in early germ cells with DAZL, and 
are later down-regulated co-incident with that of DAZL, consistent with the novel 




These studies indicate that DAZL and BOLL are associated with different key 
meiotic stages of germ cell development in human fetal ovary. Several potential 
mRNA targets of DAZL and BOLL, and a novel repression function of human DAZL 
on its mRNA targets were identified giving further insight into the role of these 
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Investigating the Expression and Function of DAZL and 
BOLL during Human Oogenesis 
 
Sperm, eggs and their precursors are called germ cells. During the germ cell development, a 
critical process called meiosis happens, which allows the genetic materials to be reduced to half 
in the mature sperm and egg. Therefore, once fertilisation happens the offspring will have normal 
amount of genetic materials and the abnormal of meiosis leads to reproductive diseases.  
 
In this study, we investigated the functions of two proteins called DAZL and BOLL which are 
important for meiosis in human fetal ovary. DAZL and BOLL bind to and regulate RNA targets, 
however, none of their definitive targets have been identified in humans. So this study aimed to 
find out whether DAZL and BOLL are expressed in human fetal ovary, and what their targets are. 
 
We first looked at their expression in human fetal ovary by staining DAZL and BOLL proteins in 
ovary sections. We found that they were expressed in different cell types. DAZL was mostly 
distributed in less mature germ cells before and just after meiosis started, while BOLL was in 
more mature ones. Furthermore, BOLL was only expressed in a very short period and DAZL was 
then re-expressed. 
 
We identified from previous studies some potential Dazl/Boll targets that had been identified in 
mouse, and investigated them further in human samples. DAZL or BOLL were over-expressed in 
human cells to see whether the expression of these targets had been changed. Indeed we found 
that the levels of 3 genes called TEX14, TEX19, and SYCP3 were increased by DAZL. 
Surprisingly, other genes (SOX17 and DNMT3L) decreased, indicating a possible novel 
repression function of human DAZL. We also did experiments that showed that DAZL could 
directly bind to these targets. 
 
After identified the potential targets, we tested whether DAZL could regulate them in human fetal 
ovary. These studies showed that DAZL and DNMT3L/SOX17 were present in the same germ 
cells in the ovary. In addition, most more mature DAZL+ve germ cells did not express DNMT3L or 
SOX17, implying that the expression of these two targets could be repressed by DAZL, which 
was consistent with our previous results. 
 
In conclusion, the expression pattern of DAZL and BOLL suggested that DAZL might be 
important before and at meiosis initiation, in contrast BOLL was potentially necessary for later 
stage of meiosis. The putative human DAZL targets we identified, namely TEX14, TEX19, 
SOX17 and DNMT3L are all involved with different aspects of the germ cell development. 
Therefore this study sheds light on the understanding how DAZL/BOLL regulates the production 
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Chapter 1. Literature Review 
1.1 Introduction 
Germ cells are gametes and their precursors. In mammals, the primordial germ cells 
are induced from epiblast cells (Tam and Zhou, 1996), migrate through hindgut and 
proliferate at the same time, and finally reach the genital ridge to form the fetal 
gonad (Chiquoine, 1954, Witschi, 1948). Once the primordial germ cells are settled, 
they will undergo a process called meiosis, during which they will duplicate their 
DNA once and divide twice to form haploid gametes. In mammalian testis, the germ 
cells will not enter meiosis until puberty, whilst in female, the meiosis starts during 
fetal life but will arrest at a specific stage called diplotene before birth, and it will 
resume at puberty in developing follicles. Disruption of meiosis, for example through 
knockout of meiosis-specific genes (e.g. Synaptonemal complex protein 3 (Sycp3)) 
can cause severe phenotypes such as aneuploidy and lead to infertility (Yuan et al. , 
2002). Therefore, germ cell development during fetal life, especially in the fetal 
ovary is very important for future reproductive capacity. 
The highly conserved Deleted in Azoospermia (DAZ) family proteins (DAZ, DAZL 
and BOLL) are RNA binding proteins, which bind to and regulate target mRNAs at 
the post-transcriptional level during germ cell development (Eberhart et al. , 1996, 
Reijo et al. , 1995, Reijo et al. , 1996). DAZ is located on the Y chromosome and 
thus only expressed in males (Reijo et al., 1995). DAZL and BOLL are autosomal, 
and therefore, only DAZL and BOLL may be involved in female germ cell 
development. Loss of Dazl in mice causes complete loss of germ cells (Ruggiu et al. , 
1997), and male Boll-/- mice are also sterile (VanGompel and Xu, 2010). In humans, 
mutations of DAZL and BOLL have been found to be associated with subfertility 
phenotypes such as azoospermia, early menopause or premature ovarian failure 
(Tung et al. , 2006b, Tung et al. , 2006c), however the effect of DAZL and BOLL 
function at molecular level remains unclear. Previous studies have already revealed 
the expression pattern of human DAZL and BOLL in human testis, and suggested 
that DAZL and BOLL proteins are distributed in different groups of germ cells 
(Luetjens et al. , 2004), but their expression patterns are poorly detailed in the fetal 
ovary. Several Dazl or Boll mRNA targets have been identified in model animals 
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(Reynolds et al. , 2007, Reynolds et al. , 2005, Zeng et al. , 2008, Zeng et al. , 2009), 
and some potential human mRNA targets have been proposed to be bound by DAZL 
or BOLL (Fox et al. , 2005, Kee et al. , 2009), however none of these have been 
definitely proven in humans as yet.  
Therefore, to understand how DAZL and BOLL regulate germ cell development in 
the human fetal ovary, it is necessary to find out their expression pattern and also 
identify the potential target mRNAs they regulate. This chapter will review germ cell 
development, especially the meiotic stages during fetal life of human and mouse, and 
will also discuss previous research on DAZL and BOLL. 
 
1.2 Fetal ovarian development 
1.2.1 Introduction 
Reviews in this section will be mainly based on both human and mouse data, as 
human fetal tissue is difficult to obtain, and therefore it has limited the exploration on 
human; in contrast, mouse tissue is easier to obtain and handle, and most relevant 
previous research was performed in mice.  
In general, both human and mouse germ cells migrate to the genital ridge, 
proliferating as they migrate. In females, they then form germ cell nests and enter 
into meiosis, but later arrest as the nests breakdown to form primordial follicles. 
Many oocytes will undergo apoptosis, during which up to over 90% germ cells could 
be lost (Baker, 1963).  
However, although the general process is similar, the timing of human and mouse 
ovarian development is very different. This review will talk about human fetal ovary 
development using the scale of trimesters and gestational ages, i.e. the pregnancy 
period will be calculated from the date of last menstrual period, which is about 2 
weeks prior to the actual week post fertilisation (wpf). Using this scale, the 
pregnancy period of human is 40 weeks. Human pregnancy is further divided into 
three trimesters, which can be subdivided further into first (before 13 week), early 
second (13-16 week) and late second trimester (17 - 28 week), which are coincident 
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with some key stages of ovarian germ cell development (Stoop et al. , 2005). In mice, 
pregnancy lasts about 20 days. Moreover, the germ cells in mouse fetal ovary are 
synchronised, which means they are all at approximate the same stage during 
development (Borum, 1961); (Pepling and Spradling, 1998), whilst in human fetal 
ovary, the germ cells are not completely synchronised even in the same nest, and 
more mature cells are distributed toward the central area of the ovary (Gondos, 1987). 
Also, in humans, follicle formation and most oocyte apoptosis happens during fetal 
life (De Pol et al. , 1997), but follicle formation happens at or immediately after birth 
in the mouse (Borum, 1961). The key differences of human and mouse early ovarian 
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Figure 1. 1 Comparison of key time points of human and mouse fetal ovarian development 
A) In human, the primordial germ cells differentiate at ~3 week gestation, then migrate to and settle 
in the fetal gonad at 6 – 7 week gestation, further differentiating into oogonia. They proliferate 
during migration and afterwards, and more mature germ cell enter the meiosis at 10 – 12 week 
gestation (at the beginning of the early second trimester). Meiosis begins to arrest at late second 
trimester, from 18 week gestation, accompanied by primordial follicle formation and oocyte 
apoptosis. 
B) In mouse, germ cells differentiate from embryonic day (e) 5.5 and are detectable from e7.0; they 
then migrate, and have mostly settled in fetal gonads by e11.5, proliferating at same time. The 
mitotic proliferation will arrest at e13.5 and meiosis starts at this time point. Meiosis will begin to 
arrest, with the follicle formation and oocyte apoptosis around the time of birth. 
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1.2.2 Germ cell differentiation and migration 
Although it is now known that germ cells originate from the proximal epiblast, for a 
long time it had been believed that primordial germ cells (PGCs) arose at the base of 
yolk sac. Their extraembryonic appearance in human had been observed as early as 
in 1910s (Felix, 1912). However, the first detailed description of human germ cell 
origination and migration is credited to Witschi (1948), whom examined 23 early 
human embryos from 13 somite stage (3-4 wpf) to 8mm (5-6 wpf), and suggested 
that the PGCs appear at the base of yolk sac, near the developing allantois and then 
migrate through the hind gut, enter the mesentery and finally reach the genital ridges. 
During migration, germ cells proliferate by mitosis, and it seems that those germ 
cells are guided by some chemicals from gonadal region (Witschi, 1948). However, 
Witschi mistakenly assumed that these PGCs were originated from common 
endoderm or early “endoderm” (prospective yolk sac or hind gut) based on his 
observation that those germ cells seemed to first appear at the base of yolk sac. In 
1954, Chiquoine developed the technique of staining PGCs with alkaline 
phosphatase (ALP) in mouse embryos, and also for the first time demonstrated that 
mouse germ cells occur as early as E8.5 around the yolk sac, and migrate through a 
similar pathway as in human to the genital ridge. Using the same technique, 
Ginsburg et al. (1990) demonstrated that the PGCs originate from the proximal 
epiblast at e7.25 in mouse embryos. Later research suggested that these cells may 
occur at e7.0 (Saitou et al. , 2002) and their precursors are from distal epiblast cells 
at e6.5 (Tam and Zhou, 1996). In 1999, Lawson et al. reported that the epiblast cells 
may be induced to form germ cells by Bmp4 (bone morphogenetic protein 4) as early 
as e5.5 in mouse embryo. 
BMP signalling is essential for the induction of PGCs. Bmp2, Bmp4 and Bmp8b are 
all key factors for the germ cell differentiation (Lawson et al., 1999, Ying et al. , 
2000, Ying and Zhao, 2001). The Bmp4-null phenotype is lethal and completely 
lacking germ cells, whilst heterozygotes survive but have reduced germ cell number. 
The lower germ cell number is due to the reduced number of precursor cells formed 
at e7.25 (Lawson et al., 1999). The phenotype of Bmp8b mutations in C75BL/6 mice 
is similar to these of Bmp4 (Ying et al., 2000). Bmp4 and Bmp8b are produced by 
the extraembryonic ectoderm (Ying et al., 2000). Bmp2, is secreted by proximal 
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anterior visceral endoderm and its null mutation leads to reduced but not complete 
loss of germ cells on C75BL/6 mice (Madabhushi and Lacy, 2011, Ying and Zhao, 
2001).  
The BMPs bind to and stimulate the interaction of its type I and II receptors, and 
these receptors again send the signals to downstream to regulate transcription 
(Wieser et al. , 1995), by phosphorylating the Small/mothers against decapentaplegic 
(Smad) family proteins, which are important transducers of this signalling pathway 
(reviewed by Kretzschmar et al., 1997). Among this family, Smad1 and Smad5, 
which mainly mediate the signals from BMP2 and 4, are directly phosphorylated and 
thus activated by the BMP receptor I, migrate to the nucleus and regulate the 
transcription (Kretzschmar et al., 1997). Loss of Smad1 in mouse causes impaired 
development of extraembryonic tissues and reduced number of PGCs, but the overall 
embryo development is relatively normal when compared to BMP-deficient 
phenotypes (Tremblay et al. , 2001). Smad5, which is a very similar homologue of 
Smad1 and involved in Bmp4 signalling together with Smad4 (Pellegrini et al. , 
2003), is also necessary for the PGC differentiation, and Smad5 mutation causes a 
phenotype of reduced germ cell number (Chang and Matzuk, 2001). B 
lymphocyte-induced maturation protein (Blimp1, or Positive regulatory domain 
containing 1, Prdm1), which is regulated by Bmp signalling, is also necessary for the 
germ cell differentiation (Ohinata et al. , 2005). The Blimp1+ve cells in the epiblast 
will develop into PGCs and deficiency of this gene will cause both loss and abnormal 
behaviour of germ cells (Ohinata et al., 2005).  
After formation, germ cells migrate to the fetal gonads (Witschi, 1948). The initiation 
of germ cell migration starts in mouse at e7.5, moving from the streak to the 
definitive endoderm (Anderson et al. , 2000), just after these cells could first be 
detected using the ALP staining at e7.25 (Ginsburg et al., 1990). Molyneaux et al. 
(2001) extended the research to e9.0 - e12.5, suggested that the part of the endoderm 
(hindgut pocket) which contains germ cells will later develop into the hindgut by 
e9.0, and although germ cells are already motile before this stage, they will only 
move out of the hindgut and invade into the dorsal body wall between e9.0 and e9.5. 
By e9.5, the movement appears quite random and not toward genital ridge, however 
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the germ cells will soon find their target by e10.5 and most are settled into the fetal 
gonad at e11.5. 
The mechanism of germ cell migration is still largely unknown. Most research has 
focused on two main aspects: how do the germ cells gain their motile ability, and 
how do they home to the genital ridge? The movement of germ cells is 
amoeboid-style (Blandau et al. , 1963), and stimulation of this ability is thought to 
associate with the somatic steel/c-kit expression (Runyan et al. , 2006) (Gu et al. , 
2009). c-kit is the tyrosine-kinase receptor for the Steel ligand, whilst Steel is a 
glycoprotein with two isoforms (reviewed by Loveland and Schlatt, 1997)  . Both 
the ligand and receptor are expressed during the germ cell migration in pre-hindgut 
(Motro et al. , 1991) and also on the route of later migration (Keshet et al. , 1991). 
Expression of We, a mutation of c-Kit caused delayed germ cell migration but the 
cells still localised into genital ridge successfully (Buehr et al. , 1993), and the Steel-/- 
phenotype suggested that this gene is necessary for germ cell motility from early on 
when the germ cells were still in the allantois, until after their entry into the hindgut 
(Gu et al., 2009).  
It has been thought for a long time that germ cells are at least partly attracted by 
some factors released by the genital ridge, and some strong evidence was provided 
by Rogulska et al. in 1971, who found mouse germ cells could travel toward the 
chick gonad in transplantation. Later studies suggested that Stromal cell-derived 
factor 1 (Sdf1) and its receptor Cxcr4 are expressed by the dorsal body wall and 
PGCs respectively, and are involved in chemotaxis (Molyneaux et al. , 2003), as in 
vitro studies demonstrated that germ cell migration was disrupted when culture 
media contained Sdf1 and that germ cells could also be attracted by Sdf1-coated 
beads. Furthermore, loss of Cxcr4 in germ cells decreases the number of germ cells 
that colonise the genital ridges, but this activity is only necessary for the migration 
after they moved into hindgut. Beside Sdf1/Cxcr4, Wingless-type MMTV integration 
site family member 5a (Wnt5a) and Transforming growth factor-β1 (TGFβ1) are also 
thought to be associated with the signals sent from genital ridge (Chawengsaksophak 
et al. , 2012, Godin and Wylie, 1991). Notably, germ cells form a network after 
leaving the hindgut (Gomperts et al. , 1994) and disruption of this network by 
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blocking E-Cadherin function leads to failed colonisation of germ cells in the genital 
ridge (Bendel-Stenzel et al. , 2000).  
 
1.2.3 Germ cell colonization and formation of nests  
Upon their arrival at the genital ridge, germ cells quickly lose motility and their 
shape becomes rounded (Donovan et al. , 1986), although a few germ cells in mouse 
ovary still maintain motility even after entry of meiosis whilst all the germ cells in 
testis are quiescent as soon as the seminiferous tubules form (Blandau et al., 1963). 
Germ cells still undergo mitosis and apoptosis in the fetal ovary as they did during 
migration (Blandau et al., 1963), however their gene expression pattern begins to 
change, with the re-activation of the silenced X chromosome (Monk and McLaren, 
1981) and the loss of some early PGC markers like Nanos3 (Tsuda et al. , 2003). 
However, the expression of pluripotency markers Nanog and Octamer-binding 
transcription factor (Oct)4 is maintained (Anderson et al. , 2007, Pesce et al. , 1998, 
Yamaguchi et al. , 2005) until the germ cells enter meiosis. Some later germ cell 
specific markers, such as DAZL and VASA (also known as Ddx4, DEAD box 
polypeptide 4) begin to be expressed in these germ cells as well (Anderson et al., 
2007). The differentiated germ cells in ovary are now called oogonia, which could be 
visually distinguished from PGCs by their shape (Gondos, 1987). Oogonia further 
differentiate and enter meiosis during the second trimester, whereupon they become 
oocytes (Gondos, 1987, Gondos et al. , 1986). Meiosis in the fetal ovary will be 
discussed in detail in Section 1.3. 
Another significant change during the transition from PGCs to oogonia is the 
formation of intercellular bridges. The existence of intercellular bridges in mammals 
was first found in cat testis, and then was described in the ovary of many species 
(reviewed by Ruby et al., 1969). As mentioned in Section 1.2.1, the PGCs are 
connected and form a network during migration, however this connection is lost after 
reaching the genital ridge by e11.5 (Gomperts et al., 1994) and instead germ cells are 
connected between each other by intercellular bridges from this stage on (Pepling 
and Spradling, 1998). In humans, the intercellular bridges were also only found 
during oogonial stages but not in PGCs, and persisted during meiosis until follicle 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
Chapter 1. Literature Review 
9 
 
formation occurs (Gondos, 1987). The clusters of germ cells connected by these 
bridges are termed germ cell cysts or nests (Pepling and Spradling, 1998).  
The formation of intercellular bridges between germ cells is believed to be due to 
incomplete cytokinesis during mitotic proliferation (Zamboni and Gondos, 1968). 
This phenomenon was first described by LaValette St. George in 19th Century as 
connected testicular germ cells after division in vitro (reviewed by Dym & Fawcett, 
1971), and was finally confirmed by Weber and Russell (1987)’s work on rat 
spermatogenesis. The process of cytokinesis is quite complicated, including site 
selection, furrow ingression, and midbody abscission; the midbody is a temporal 
structure formed at late cytokinesis, connecting two daughter cells and similar to 
inter cellular bridges; the proper germ cell intercellular bridges are formed after the 
breakdown of midbody and therefore it is the late cytokinesis which is most 
important for this process (reviewed by Greenbaum et al., 2011). One of the key 
factors involved in the formation of intercellular bridge is Tex14 (Testis-expressed 
gene 14; Greenbaum et al., 2007). This study showed that during late cytokinesis, the 
Tex14 protein localised to the inner side of the dividing site, forms a ring and later 
expands and merges with an outside centralspindlin ring (a protein complex, the 
division remnants of spindle with a ring-like structure) (Mishima et al. , 2002) and 
the size of the mature ring canal increases during development. The intercellular 
bridge cannot form without Tex14, and beside its structural function, other factors 
recruited by Tex14 also seem to be necessary to prevent the complete abscission of 
midbody and to stabilise the intercellular bridges (Greenbaum et al. , 2007).  
Ultrastructural studies suggest that intercellular bridges contain microtubules and 
organelles (Gondos, 1987, Pepling and Spradling, 1998, Ruby et al., 1969). 
Therefore, it is believed that these bridges are involved in the synchronized 
development of germ cells and also the nursing behaviour between oocytes in 
mammals (Ruby et al., 1969, Zamboni and Gondos, 1968). As Tex14 is necessary for 
the formation of intercellular bridges, loss of Tex14 could partly reveal their 
functions. Tex14-/- mice have no intercellular bridges and display infertility 
phenotypes, including decreased testes weight and meiosis defects, i.e. lacking of 
germ cells from late pachytene stage (Greenbaum et al. , 2006). However, it seems 
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that the development of PGCs and spermatogonia/oogonia is not affected, and 
infertility phenotype of Tex14-/- is restricted to male mice (Greenbaum et al. , 2009). 
Although loss of intercellular bridges also occurs in Tex14-/- females and they have 
fewer oocytes at birth, these mice are still fertile and their folliculogenesis is 
unaffected in relatively long-term (Greenbaum et al., 2009). Interestingly, the 
existence of intercellular bridges is conserved from insects to human, but these 
bridges are required for the Drosophila gametogenesis in both male and female, and 
mutations of several key factors could disrupt oogenesis (reviewed by Greenbaum et 
al., 2011), which implies some non-conserved functions of intercellular bridge 
between species and sexes. 
 
1.2.4 Primordial follicle formation and germ cell apoptosis 
At later stages of ovarian germ cell development, the pregranulosa cells will invade 
the germ cell nest and surround single germ cells to form primordial follicles 
(Gondos, 1987). In mouse, this happens at or just after birth (Borum, 1961) whilst in 
human, it begins during fetal life, from 18 weeks gestation onwards (De Pol et al., 
1997, reviewed by Mahishwari and Fowler, 2008). Not all the germ cells in the ovary 
form primordial follicles; some early research indicated that total germ cell loss 
could exceed 90% by birth (Baker, 1963), but recent studies showed that through 
primordial follicle assembly and nest breakdown, up to one third to two thirds germ 
cells are lost (reviewed by Tingen et al., 2009). 
The arrest of meiosis at diplotene (see Section 1.3) seems to be required for the 
breakdown of germ cell nests. Studies in rats suggested that meiotic arrest occurs 
before primordial follicle formation (Beaumont and Mandl, 1962) and loss of 
synaptonemal complex protein 1 (Sycp1), an important factor for recombination 
during meiosis, leads to both earlier meiotic arrest and nest breakdown (Paredes et al. 
, 2005).  
A lot of other factors associated with this process have been identified as well. Factor 
in the germline alpha (Figα, subsequently termed Figla) is a transcription factor 
expressed from meiosis initiation in females (Soyal et al., 2000). Mutation of Figα 
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causes female-specific infertility, due to the absence of primordial follicles without 
disruption of meiosis, and these mice suffer complete germ cell loss after birth 
(Soyal et al. , 2000). Another gene called Nobox is also necessary for follicle 
formation, as loss of this gene will cause delayed nest breakdown and fewer 
primordial follicles at postnatal day 7; even these very rare follicles will all undergo 
degeneration and lead to sterility whilst males are still fertile (Rajkovic et al. , 2004). 
The members of the TGFβ superfamily of genes such as Growth differentiation 
factor 9 (GDF9) also join this process. In vitro studies suggest that Gdf9 is necessary 
for primordial follicle formation in hamster, as the formation of pregranulosa cells 
seems to be blocked by silencing Gdf9 with siRNA in cultured hamster ovary (Wang 
and Roy, 2006), which might also represent its function during human 
folliculogenesis as it is also expressed in human fetal ovary before follicle formation 
(data generated by our lab).  
Soon after primordial follicle formation, it is believed that the process of continuous 
follicle activation and growth (initial recruitment) begins; the follicles will grow 
through primary, secondary and early antral stages; these follicles will all undergo 
atresia until ovulation occurs from the time of puberty (McGee and Hsueh, 2000). At 
puberty, under the stimulation of circulating FSH, some of the activated antral 
follicles will be able to grow further and escape from the fate of atresia during each 
menstrual cycle (called cyclic recruitment) (McGee and Hsueh, 2000). Follicle 
activation includes the growth of oocyte, as well as the differentiation and 
proliferation of granulosa cells – the flattened pregranulosa cells will become 
cuboidal-shaped and steroidogenic (reviewed by Wandji et al. , 1996). Factors which 
are known to be involved in the maintenance of arrest and activation of primordial 
follicles including Phosphatase and tensin homolog deleted on chromosome Ten 
(PTEN), Kit ligand and its receptor c-Kit, GDF9, Anti-Müllerian hormone (AMH) 
and more (reviewed by Adhikari and Liu, 2009). The Phosphatidylinositol 3 kinase 
(PI3K) pathway is crucial for the activation of primordial follicles before they are 
able to response to FSH directly (Liu et al. , 2006). This pathway can be supressed 
by PTEN, as deletion of this gene in oocytes causes global premature follicle 
activation (Reddy et al. , 2008). AMH is also a suppression factor of initial 
recruitment but it is undetectable in primordial follicles; it can be produced by 
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primary or later follicles and therefore repress the activation of their adjacent 
follicles, acting as a paracrine factor (reviewed by Adhikari and Liu, 2009). In 
contrast, GDF9 is not only important for the formation of primary follicles but also 
play a role in promoting their activation in human, as more primordial follicles 
started growth when cultured with GDF9 (Hreinsson et al. , 2002).  
Germ cell loss is due to programmed apoptosis (De Pol et al., 1997). Several 
hypotheses were developed to explain the significance of germ cell apoptosis during 
follicle formation. For example, it might due to the quality control mechanism, such 
that germ cells with chromosome aneuploidy (e.g. Tuner’s Syndrome) show much 
higher apoptosis ratio (Modi et al. , 2003). In addition, it seems that the germ cells 
“nursing” others through the intercellular bridges also will undergo apoptosis; the 
intercellular bridge is sufficient for the transfer of mitochondria (see Section 1.2.2) 
and injection of mitochondria into mouse oocyte could significantly rescue the germ 
cells from apoptosis (Perez et al. , 2000). This phenomenon is similar to the case in 
Drosophila, as during its oogenesis only one oocyte out of 16 connected ones in a 
cyst will survive, and mitochondria, proteins and mRNAs are all enriched in this 
particular oocyte (reviewed by Huynh and St Johnston, 2004). 
The molecular basis of germ cell apoptosis remains largely unknown, but it is 
associated with several different protein families, such as B-cell 
leukemia/lymphoma-2 (Bcl-2) and TGFβ. The most important factors of general 
programmed cell apoptosis might be the Bcl-2 family of proteins, which contain pro- 
and anti-apoptosis members (reviewed by Morita & Tilly, 1999). Bcl-2 itself belongs 
to the anti-apoptotic group and therefore is a negative regulator of apoptosis; in 
contrast, another member of this family, the Bcl-2 associated X protein (Bax) 
belongs to pro-apoptotic group and can suppress the Bcl-2 function by directly 
interacting with it, subsequently promoting cell death (Oltvai et al., 1993; reviewed 
by Tilly, 2001). Bax-/- female mice have more primordial follicles than the WT, and 
this effect is maintained during their adulthood (Perez et al. , 1999). In addition, two 
other members of this family, Myeloid cell leukemia 1 (Mcl-1) and BCL2-associated 
agonist of cell death (Bad) play similar roles to Bcl-2 and Bax respectively; like 
Bcl-2, Mcl-1 could also maintain the viability of cells (Kozopas et al. , 1993). 
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Although Bad can also interact with Bcl-2, its binding to Bcl-xL, another 
anti-apoptosis member of Bcl-2 family is stronger, and also promotes cell death 
(Yang et al. , 1995). In the human fetal ovary, BCL-2 and BAD expression is 
restricted to somatic cells through first to late second trimester, whilst MCL-1 is only 
expressed in germ cells (Hartley et al. , 2002). The pro-apoptosis protein BAX is 
widely expressed in both germ and somatic cells, and it seems that its protein is more 
concentrated in germ cells around the edge of the ovary between 14-17 weeks 
gestation, prior to primordial follicle formation (Hartley et al., 2002).  
A TGFβ family member, activin is also associated with germ cell survival. Both in 
vivo studies in mouse and in vitro studies in human suggested that treating neonatal 
female mouse or human fetal ovary fragments (second trimester) with recombination 
human Activin A could increase number of primordial follicles (Bristol-Gould et al. , 
2006, Martins da Silva et al. , 2004). Activin is expressed in germ cells and might act 
as a suppressor of kit ligand expression in somatic cells (Childs and Anderson, 2009), 
as its subunit activin βA is mainly expressed in the oocytes before follicle formation 
and its expression pattern is inversely coincident with the dynamic changes of c-kit 
during fetal ovary development (Coutts et al. , 2008).  
Although it was believed for over fifty years that the number of oocytes does not 
increase after birth and therefore the female reproductive capacity cannot be restored 
(reviewed by Kuo and Yang, 2008), the effort of looking for germ stem cells in the 
adult ovary has never ceased. Over the recent decade, the aforementioned theory has 
been challenged. One of the most remarkable finding is the proposed existence of 
new-formed germ cells which express early meiotic markers in adult mouse ovary, as 
well ongoing folliculogenesis (Yuan et al. , 1998). Work by another research group 
isolated female germline stem cells (FGSCs) from adult mouse ovary using flow 
cytometry (with germ cell marker Mvh) and demonstrated their self-renewal ability, 
with the further potential of producing offspring (Moses, 1958). Similar putative 
germ stem cells have also found in human ovary (White et al. , 2012). While these 
are undoubtedly important findings, much further work will be required to 
investigate their potential contribution to ovarian physiology. 
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1.3 Meiosis in fetal ovary 
1.3.1 Introduction 
Meiosis, which was historically named “reduction division” by A. Weismann and 
firstly termed as “maiosis” (Farmer and Moore, 1905), is what its obsolete name 
indicates; the process by which diploid germ cells replicate their DNA once and 
divide twice to form haploid gametes. The general process of meiosis includes two 
stages, i.e. meiosis I and meiosis II, and each stage is further divided to four phases, 
namely prophase, metaphase, anaphase and telophase. In meiosis I, the DNA 
replicates, then homologous chromosomes pair allowing crossover between them and 
the exchange of genetic material (i.e. recombination). Homologous chromosomes 
then separate when the germ cell divides into two daughter cells, leaving each cell 
with half a set of chromosomes, but each chromosome has a pair of chromatids. 
During meiosis II the daughter cells divide again to separate the sister chromatids 
and form the haploid gametes. The pairing of homologous chromosomes during 
meiosis I is termed synapsis by Moore (1895); the special structure formed by paired 
chromosomes during meiosis is called bivalent or tetrad. 
The prophase of meiosis I can be further divided into four stages, i.e. leptotene, 
zygotene, pachytene and diplotene. Leptotene, pachytene and diplotene were defined 
and termed by H. von Winiwarter (1900) and zygotene by V. Gregoire (1907) 
(reviewed by Agar, 1911, Manton, 1939). During leptotene, the chromosomes are 
long and thin; during zygotene, the homologue chromosomes begin to pair, they then 
become shorter, condensed, and entirely pair at pachytene; synapsis and crossover 
also happen at this stage. During diplotene, the chromosomes further thicken and 
show a very clear structures of crossover and recombination called chiasmata, a 
morphology very unique to meiosis.  
Early at the end of 19th Century, the core of meiosis theory, i.e. the halving of 
chromosome number in germ cells by two divisions during gametogenesis was 
already established. Scientists (T. Boveri and O. Hertwig) began to realise that the 
general process of meiosis is strikingly similar between two sexes, and they also 
found that one primary spermatocyte will first divide into two secondary 
spermatocytes and finally form four sperms, whilst in female the primary oocyte will 
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first divide into a secondary oocyte and a first polar body. The first polar body 
usually degenerates before the second meiotic division in mammals, but can persist, 
in which case the first polar body and secondary oocyte together will finally form 
one egg and three second polar bodies (reviewed by Baxter & Farley, 1979). 
In mammals, meiosis initiates in the ovary during fetal life, whilst in male it only 
begins at puberty. During oocyte development in the fetal ovary, meiosis arrests at 
diplotene of prophase I, and resumes when ovulation occurs (i.e. from puberty 
(reviewed by Baillet & Mandon-Pepin, 2012)) as it is triggered by the mid-cycle LH 
surge. Despite all stages of meiosis being important for the adult reproductive 
capacity, this review will only focus on the meiosis prophase I which occurs during 
fetal ovary development. 
 
1.3.2 Entry of meiosis 
Meiosis initiates in the mouse fetal ovary at e13.5 (Borum, 1961, Monk and 
McLaren, 1981), and in human at 10-12 weeks gestation (Gondos et al., 1986). In the 
mouse fetal ovary, the germ cells are roughly synchronised and entering meiosis in 
an anterior-to-posterior wave (Menke et al. , 2003). In the human fetal ovary, germ 
cell development is very asynchronous – the germ cells toward the periphery are still 
in mitosis, whilst those in central area are more mature and entering meiosis 
(Gondos, 1987). Therefore, germ cells of different maturation stages, from oogonia 
to primordial follicles can all exist in the same human fetal ovary. 
In mouse, the different timing of meiosis entry between male and female is very 
likely due to the action of retinoic acid (RA) in the ovary, and the expression of the 
retinoic acid metabolising enzyme Cyp26b1 in the testis (Bowles et al. , 2006, 
Koubova et al. , 2006). 
CYP26B1 is a cytochrome P450 enzyme expressed in gonadal somatic cells of both 
sexes (Bowles et al., 2006). It was firstly identified and termed as “P450RAI-2” by 
White et al. (2000) in human brain; this study also showed that CYP26B1 is 
specifically involved in the metabolism of all-trans-RA, one of the retinoids, and acts 
to metabolise this molecule. In mouse fetal gonads, Cyp26b1 is expressed in both 
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males and females at e11.5 when germ cells settle in the genital ridge, but is only 
detectable in males after e13.5 (Bowles et al., 2006), which is coincident with the 
timing of meiosis initiation in the fetal mouse ovary. Adding the P450 enzyme 
inhibitor ketoconazole to cultured gonads at e11.5 led to increased expression of 
meiosis markers in male gonad, and meiotic cells were found as well (Bowles et al., 
2006), demonstrating that a P450 enzyme must be involved in inhibiting meiosis in 
the fetal testis. A similar effect was shown in Cyp26b1-null testes, and germ cells in 
the ovaries of Cyp26b1-null mice enter meiosis slightly earlier than in those in wild 
type mice (Bowles et al., 2006). Further examination of their testes indicated that 
meiosis occurs prematurely at e13.5 of fetal life but only reaches pachytene stage, 
accompanied by increased germ cell apoptosis, whilst germ cells in the ovary are 
normal (MacLean et al. , 2007). The high expression of Cyp26b1 at e12.5-e13.5 in 
male gonad and prior to meiosis initiation in female gonad (Bowles et al., 2006), 
indicates that this gene may act as the proposed meiosis inhibiting factor in the fetal 
testis (McLaren and Southee, 1997), and also prevents premature meiosis initiation in 
the fetal ovary (Bowles et al., 2006). 
Adding Cyp26-resistant synthetic retinoid to cultured Cyp26b1-deficient male gonad 
also induces meiosis, further providing evidence about the role of direct regulation 
on meiosis by RA itself, rather than its metabolites generated by Cyp26b1 (MacLean 
et al., 2007). There is extensive expression of RA signalling pathways during fetal 
development. This molecule acts through RA receptors (RAR), including RARα, β 
and γ, which can form heterodimers with retinoid reporters (RXR) α, β and γ, then 
the heterodimers bind to the RA-regulatory elements (RARE) of their target genes to 
modulate their expression (reviewed by Bowles and Koopman, 2007). Both RARs 
and RXRs are expressed in germ cells (Koubova et al., 2006), and they are 
responsive to RA at e12.5-14.5 as shown by studies using a LacZ-reporter gene 
controlled by a RARE that is expressed during this period in mesonephros of both 
sexes and ovary (Bowles et al., 2006). The possible source of RA in mouse is the 
mesonephros, because Aldehyde dehydrogenase 1 family member A (Aldh1a)2 (also 
known as Raldh2), the main gene relating to RA synthesis, is strictly expressed in the 
fetal mouse mesonephros but not in fetal mouse gonads (Bowles et al., 2006).  
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RA was first found to accelerate entry of oogonia into meiosis whilst reducing the 
number of oogonia in cultured rat ovary, and this effect is similar to that induced by 
RARα agonist in culture (Livera et al. , 2000). Several subsequent studies in mice 
proved this role of RA, as adding this molecule in culture could increase the 
expression of meiosis markers and decrease the level of pluripotency markers at the 
same time; an effect that could be masked by adding RA receptor antagonist (Bowles 
et al., 2006). Interestingly, RA treatment could prematurely promote meiosis in e11.5 
mouse fetal testis, but after e13.5 it seems lose this capacity and instead prevents the 
mitotic arrest of germ cells in those specimens (Trautmann et al. , 2008). 
The effect of RA on initiating meiosis is believed to be through Stimulated by 
Retinoic Acid 8 (Stra8). Mouse Stra8 was first identified by Bouillet et al. (1995) 
with 11 other novel Stra genes, as their expression is promoted by treating mouse 
embryonic carcinoma cells with RA, and it was further characterised by 
Oulad-Abdelghani et al. (1996), showing that it was not only induced but also 
phosphorylated by RA signalling. They also found that in adult mouse testis, both 
Stra8 mRNA and protein expression only occurred in pre-meiotic germ cells, so the 
authors assumed that it may associate with pre-meiotic phase of spermatogenesis. 
This prediction was proved correct and expanded to oogenesis by further 
investigations (Anderson et al. , 2008, Baltus et al. , 2006, Menke et al., 2003). In the 
mouse embryo, Stra8 has been proven to be an early meiosis marker, expressed 
specifically in germ cells of female from e12.5 to e14.5, in an anterior-to-posterior 
wave (Menke et al., 2003). The germ cells of Stra8-/- outbred (C57BL/6×129) mice 
display multiple abnormalities at the entry of meiosis in mouse ovary including 
defects in DNA replication, chromosome thickening and synapsis/recombination 
(Baltus et al., 2006). The male mouse of the same strain has meiosis initiation 
problems as well – their germ cells barely develop beyond the leptotene stage and 
end up in apoptosis (Baltus et al., 2006). The inbred mouse strain (C57BL/6), 
derived from the aforementioned outbred mice by backcrossing, also show similar 
meiotic defects in males when they lose Stra8, but their germ cells could successfully 
replicate their DNA and enter the pre-leptotene stage (Anderson et al., 2008).  
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It is clear that Stra8 expression in germ cells is induced by RA signalling. When RA 
signalling is blocked by a pan-antagonist of Retinoic acid receptor (RAR) receptors, 
no Stra8 is expressed in mouse fetal ovary (Koubova et al., 2006). After injection 
with vitamin A, adult mice previously fed with vitamin A-deficient diet show 
dramatically increased Stra8 expression in their testes (Koubova et al., 2006). It 
seems that all three kinds of RAR receptors (α, β and γ) can induce Stra8 expression, 
as adding the specific agonist of any of the receptors could induce Stra8 in the fetal 
gonads of both sexes (Koubova et al., 2006). RA signalling directly functions on 
germ cells rather than through somatic cells, because RA could promote the 
expression of Stra8 from isolated germ cells from neonatal testes (Zhou et al. , 
2008).  
Cyp26b1, which metabolises and degrades RA as described before, negatively 
regulates Stra8 expression by disrupting the RA signalling. Nonspecific inhibition of 
CYP family members, results in expression of Stra8 in cultured mouse fetal testes 
(Koubova et al., 2006). Blocking RAR receptors in Cyp26b1-/- adult male mouse can 
repress Stra8 expression (Saba et al. , 2014). In Cyp26b1/Stra8 double-knockout 
mice, although Cyp26b1 is absent and therefore cannot block RA signalling, the 
expression of meiosis markers is still almost completely absent without the presence 
of Stra8 (Saba et al., 2014). Together with the evidence provided by Bowles et al. 
(2006), who found that Cyp26b1 is selectively expressed in mouse fetal testis after 
e13.5, and also demonstrated that inhibiting Cyp26b1 activity promotes the 
expression of meiosis markers in mouse, it is possible to conclude that 
Cyp26b1→RA→Stra8 is an important, if not the only pathway to regulate the entry 
of meiosis in mouse. 
However, this theory, although based on and supported by abundant observation and 
evidence, is challenged. Mark et al. (2008), who also established Stra8-null mutant 
mice on an outbred background (C57BL/6×129/sv), found that in this strain, the 
germ cells of male mice could successfully enter meiosis and express some meiotic 
markers, but synapsis is abnormal and they cannot reach the stages beyond 
pachytene. Therefore, the induction of meiosis might not be completely dependent on 
Stra8. Another study (Kumar et al. , 2011) questioned the Stra8 model further. In 
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Raldh2-null mice, or even Raldh2/Raldh3 double-knockout mice (which are 
expressed in mesonephros, which is the main source of RA adjacent to fetal gonad), 
Stra8 is still expressed normally in fetal ovary at e12.5 and e14.5, and meiosis is 
initiated at e13.5. Raldh2-null mutation is lethal so these embryos were supplied with 
low dose of RA maternal diet from e6.75 to e9.25; however according to the 
RARE-LacZ reporter, these fetal ovaries did not receive enough RA to trigger 
signalling (Kumar et al., 2011). They further found that in Raldh2-/- fetal testis, 
adding an inhibitor of Cyp26b1 also induced Stra8 expression, without the presence 
of RA or activation of RARE-LacZ reporter; and this might due to signalling from 
mesonephros as once they were removed, the effect disappeared (Kumar et al., 
2011). In addition, Trautmann et al. (2008) found that treating e13.5 mouse fetal 
testis with RA induces Stra8 expression, but unlike in e11.5 tissue, these gonads 
show no sign of meiotic recombination, suggesting there is another way in relatively 
more mature fetal testis to prevent the entry of meiosis. Therefore these studies 
indicate that meiosis initiation might not be completely dependent on Stra8, that 
Stra8 expression might not be solely induced by RA, and that Cyp26b1 may also 
inhibit Stra8 expression and meiosis through another pathway other than RA 
signalling.  
Several other genes might be additional candidate regulators of Stra8 expression. 
Dazl, which will be further discussed later in section 1.4, is essential for the 
RA-induced Stra8 expression and meiosis initiation; loss of Dazl almost completely 
ablates Stra8 expression, and also causes severely decreased expression of meiosis 
markers (Lin et al. , 2008). Muscle segment homeobox (Msh) homeobox (Msx) 1 
and Msx2, two homebox transcription factors, are also associated with the 
modulation of Stra8 expression and meiosis progression in mouse – Stra8 expression 
is reduced, although still far from completely quenched in the fetal ovary of Msx1 
/Msx2 double knockout mouse; these mice also have delayed meiosis and much 
fewer oocytes which reach the end of meiosis prophase I (Le Bouffant et al. , 2011).  
These challenging lines of evidence may partly explain differences in meiosis 
initiation-related gene expression in the human fetal ovary compared to the mouse. 
Childs et al. (2011) reported that, unlike the mouse, the human fetal mesonephros 
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may not be the only source of RA synthetic enzymes, and germ cells in the human 
fetal testis may not be completely shielded from RA. All three groups of ALDH1A 
genes (1, 2 and 3) are expressed in both the human fetal testis and ovary through the 
first and second trimesters (Childs et al., 2011). Furthermore, the level of ALDH1A2 
is strikingly higher in the human fetal testis than in either the human fetal ovary or 
mesonephros at 8-9 week gestation. This finding is consistent with the study of Le 
Bouffant et al. (2010), who found that ALDH1A1 and 2 are expressed in the human 
fetal ovary. RA signalling is very likely to be activated in germ cells in both the 
human fetal testis and ovary, as the RARs and Retinoid X receptors are all expressed 
in both fetal ovary and testis and localised to the germ cell nuclei (Childs et al., 
2011). In human fetal gonads, CYP26B1 expression is no longer male-specific, and 
its expression is even higher in fetal ovary at 14-16 weeks gestation (after the 
initiation of meiosis) than in the testis (Childs et al., 2011). RA, but probably not 
CYP26B1, regulates meiosis initiation in human female, as exogenous RA promotes 
meiosis in cultured ovary, and adding the pan-inhibitor of RARs or RA synthetic 
enzymes inhibits meiosis but adding an inhibitor of CYP26B1 has no effect (Le 
Bouffant et al., 2010). Interestingly, treating the human fetal testis at second trimester 
with RA also induces the expression of STRA8, but not the synapsis and 
recombination-associated genes SYCP3 and DNA meiotic recombinase 1 (DMC1), 
which is in agreement with the findings of Trautmann et al. (2008) on RA treated 
e13.5 mouse fetal testis. This suggests that although the expression pattern of 
meiosis-related genes are very different between human and mouse, there might be 
some conserved mechanisms of meiosis regulation between the two species. 
 
1.3.3 Meiosis prophase I in mammals 
The most remarkable meiotic events are synapsis and recombination. As mentioned 
in Section 1.3.1, during meiosis prophase I the homologous chromosomes pair and 
align (synapsis), connect with each other, and exchange genetic material 
(recombination). The word “synapsis” is derived from Greek word “συναψις” (which 
means “connection”) and was first applied by Moore (1895) over a hundred years 
ago, to describe the chromosomes’ behaviour at meiosis prophase I. Although this 
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phenomenon had been observed before Moore’s research, he is the first scientist who 
realised the importance of synapsis during the reproductive cycles as it is highly 
conserved between animals and plants (Moore, 1895). 
A lot of research has been performed on synapsis and recombination, and several 
critical steps and molecules are identified. One of the most important event of 
synapsis is the formation of synaptonemal complex (SC), which contains two axial 
lateral elements and a central element (Moses, 1958). In addition, cohesins form the 
cohesion complex which also contributes to this process by helping sister chromatids 
adhere to each other (Michaelis et al. , 1997). One of the major component of lateral 
elements is SYCP3 (Lammers et al. , 1994) (Dobson et al. , 1994), which is first 
expressed at pre-leptotene (Roig et al. , 2004). In human pre-leptotene germ cells, 
SYCP3 protein appears as aggregates, then becomes distributed as thin threads 
(loaded into chromosomes) and aggregated clusters at leptotene. These SYCP3 
threads continue to condense until pachytene, and finally begin to dissolve at 
diplotene, at which stage the aggregates disappear (Roig et al., 2004). Loss of Sycp3 
in mice causes male infertility due to germ cell apoptosis and arrested meiosis at 
zygotene; but germ cell development prior to this stage is not affected (Yuan et al. , 
2000). Further analysis reveals synapsis abnormalities, with less organised foci of 
recombination and failed formation of SCs (Yuan et al., 2000). In female mice, 
Sycp3-deficiency does not lead to complete loss of reproductive capacity, but litter 
sizes are significantly reduced due to increased embryo death, and aging females 
have further reduced litter sizes, demonstrating a shortened reproductive lifespan 
(Yuan et al., 2002). These phenotypes are caused by increased numbers of oocytes 
with aneuploidy due to disrupted formation of SCs and chiasmata, and abnormal 
recombination (Yuan et al., 2002). In humans, mutations in SYCP3 are also 
associated with infertility phenotypes in both sexes. A 1bp deletion of SYCP3 has 
been identified in azoospermic men, which causes a truncated SYCP3 protein and 
reduced ability of SYCP3 molecules to interact with each other to form threads 
(Miyamoto et al. , 2003). Two other mutations have been identified in women with 
recurrent miscarriages and no liveborn offspring; one mutation is a four nucleotide 
deletion and the other is a Single nucleotide polymorphism (SNP) (Bolor et al. , 
2009). The two patients both have reduced SYCP3 mRNA expression, and these 
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mutated SYCP3 proteins also show reduced ability of interaction and forming fibres, 
and therefore could be a potential factor of human infertility (Bolor et al., 2009).  
Another SC component, the central element SYCP1 is expressed later in germ cell 
development than SYCP3; from zygotene to dioplotene (Roig et al., 2004). The 
assembling of Sycp1 into the SC is partly affected by the loss of Sycp3, as Sycp1 
fibres show fragmented morphology in Sycp3-deficient mice compared to wild types 
(Yuan et al., 2000). In contrast, the cohesin proteins, including Recombination 
(REC)8, Stromal antigen (STAG)3, Structural maintenance of chromosome (SMC)1β 
and SMC3 are loaded onto chromatin before SYCP3 pre-leptotene in human germ 
cells, and their expression completely co-localises with SYCP3 on thickening 
chromosomes during the rest of prophase I (Garcia-Cruz et al. , 2010). 
During homologous recombination, to exchange genetic material between maternal 
and paternal chromosomes, DNA undergoes double strand breaks (DSB) and damage 
repair. A lot of proteins are involved in this process including Sporulation-deficient 
recessive mutant (Spo)11 homolog and Dmc1 (Barchi et al. , 2005), but one of the 
most important DSB markers is γ-H2AX, which is associated with DNA repair 
(Rogakou et al. , 1998). H2AX is a member of the histone H2A proteins, and 
γ-H2AX is its phosphorylated form on residue serine 139 which is a rapid response 
to DSB (Rogakou et al., 1998). H2AX-/- mice show multiple phenotypes associated 
with genome instability and DNA repair defects, and the males are sterile due to 
meiosis arrest at pachytene and germ cell apoptosis; the females are fertile but have 
reduced litter size (Celeste et al. , 2002). In male mice, γ-H2AX expression is almost 
exclusive to testis; strong γ-H2AX expression is found in primary spermatocytes 
from pre-leptotene to zygotene, then is only detectable on sex vesicle (the 
hetero-paired XY chromosomes) during pachytene, indicating that it may play a role 
during meiosis (Hamer et al. , 2003, Mahadevaiah et al. , 2001). In human males, 
γ-H2AX is found in leptotene spermatocytes, then it reduces during zygotene and is 
restricted to the sex vesicle at pachytene, very similarly to the dynamic changes in 
mouse, and finally becomes barely detectable at late diplotene (Roig et al., 2004). In 
human females, γ-H2AX expression is similar to that of male at leptotene and 
zygotene, except that at pachytene the γ-H2AX foci are still detectable, which 
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indicates that the de-phosphorylation of H2AX, i.e. the early steps of DNA damage 
repair progresses much more slowly in human female (Roig et al., 2004). 
The phosphorylation of H2AX is known to be regulated by Ataxia Telangiectasia 
Mutated (ATM), which is a serine/threonine protein kinase (Burma et al. , 2001, 
Keegan et al. , 1996). ATM is usually distributed in cell nuclei as an inactivated 
multimer or dimer, and once DSBs occur, it will auto-phosphorylate on serine residue 
1981 (phospho-ATM), which causes the dissociation of dimer to gain the kinase 
activity (Bakkenist and Kastan, 2003). In response to DNA damage, the activity of 
ATM rapidly increased without significant change of protein levels, and molecules 
move to the DSB sites, which co-localise with γ-H2AX (Andegeko et al. , 2001). In 
mouse meiotic germ cells, Atm is found distributed along synapsed chromosomes but 
is absent at asynapsed sites during zygotene and pachytene in both sexes (Keegan et 
al., 1996). However, cells isolated from Atm-/- mice show dramatically reduced 
phosphorylation of H2AX in response to irradiation induced DSB when compare to 
wild type, and this can be rescued by introducing ectopic ATM; the phosphorylation 
activity on H2AX is also confirmed by in vitro study using immunoprecipitated ATM 
protein (Burma et al., 2001).This demonstrates that that phospho-ATM is activated at 
least prior to leptotene when γ-H2AX occurs. Targeted disruption of Atm kinase 
domain in mouse causes growth defects, as well as infertility in both sexes due to 
abnormal synapsis, fragmented chromosome damage and meiosis arrest at 
zygotene/pachytene (Xu et al. , 1996).  
Another protein that helps to stabilise the genome during recombination is Testis 
expressed gene (Tex)19.1 (Ollinger et al. , 2008). The mouse has two Tex19 
homologues, Tex19.1 and 19.2, and the former is more identical to the single human 
homologue TEX19 (Kuntz et al. , 2008). Both human TEX19 and mouse Tex19.1 are 
detected in adult testis, and in mouse, the Tex19.1 protein is mainly distributed in the 
cytoplasm of spermatogonia and early spermatocytes which indicates that it is not 
directly interacting with the meiotic chromosomes in the nucleus (Kuntz et al., 2008, 
Ollinger et al., 2008). Tex19.1-/- male mice show subfertility phenotypes with no or 
reduced haploid germ cells, whilst females are still fertile and have no significant 
ovarian abnormality (Ollinger et al., 2008, Tarabay et al. , 2013). Further 
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investigation suggests that loss of Tex19.1 causes failed synapsis initiation and germ 
cell apoptosis from pachytene, which is due to abnormal recombination and DSB 
repair defects. Four-fold increased expression of retrotransposon MMERVK10C is 
detected in Tex19.1-/- mouse testis, and in situ hybridisation indicates that it is mainly 
distributed in meiotic spermatocytes (Ollinger et al., 2008). The activated 
retrotransposon element may contribute to non-homologous synapsis between 
chromosomes and meiotic defects (Bourc'his and Bestor, 2004), and therefore 
Tex19.1 stabilises genome by repressing the retrotransposons and maintains normal 
recombination. However, no study on the functions of human TEX19 during germ 
cell development has been performed so far, and its expression in human ovary 
remains unknown.  
 
1.4 DAZ family proteins 
1.4.1 Introduction 
The Deleted in Azoospermia (DAZ) family of proteins include DAZ, DAZL and 
BOLL. As the family name suggests, its first and characteristic member is DAZ, 
which was first identified by Reijo et al. (1995), when the researchers were screening 
for the azoospermia factor (AZF) on a deleted portion of Y chromosome; the deletion 
was likely to cause azoospermia in their patients. They also pointed out that DAZ 
might be an RNA-binding protein by analysing its amino acid sequences, and 
concluded that it contains an identical RNA recognition motif (RRM) to many RNA- 
or single-stranded DNA-binding proteins.  
A year later, another member of the DAZ family, DAZ-Like (DAZL, also called 
Dazla, Daz like, autosomal) was identified in mouse (Cooke et al. , 1996). Although 
BOLL (BOULE-LIKE) is the ancestor of DAZL and DAZ, and was first identified in 
Drosophila (wherein it is called boule (bol) by Castrillon et al.) in 1993, earlier than 
the other two members, it was the last one to be confirmed to belong to the DAZ 
family (Eberhart et al., 1996). 
The same group which identified Dazl also predicted that DAZ probably only existed 
on the Y chromosomes of primates (Cooke et al., 1996). Subsequent studies 
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confirmed that DAZ is only located on the Y chromosomes of humans, primates and 
old world monkeys (Saxena et al. , 1996), whilst DAZL is expressed in vertebrates, 
and BOLL in metazoans (Xu et al. , 2001). Evolutionally, BOLL is the ancestor and 
DAZL is derived from BOLL by duplication, then DAZL duplicated again to form 
DAZ (Haag, 2001). When Boll was identified in mouse, research compared the 
protein sequence of mouse Dazl, Boll and human DAZ, and concluded that they all 
have a highly-conserved RRM, plus a copy (or copies) of the characteristic DAZ 
repeat motif (Figure 1.2). Further investigation on human DAZ, DAZL and BOLL 
revealed that human DAZL and DAZ are 50% identical overall, with 82% identity 
between them in the first (N-terminal) two thirds of the protein including the RRM 
and DAZ repeat; human DAZL and BOLL are only 30% identical and the N-terminal 
two thirds of the protein is 37% conserved (Collier et al. , 2005). Interestingly, 
human DAZL and mouse Dazl are overall 88% conserved, which is higher than the 
conservation between human DAZ and DAZL (Collier et al., 2005). 
This literature review is focused on fetal ovary development; therefore, the 
male-specific Y chromosome gene DAZ will not be discussed. DAZL and BOLL are 
autosomal genes and involved in reproductive capacity, especially meiosis in both 
sexes, and will be discussed in detail, covering their expression, function and mRNA 
targets across species and sexes. 
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Figure 1. 2 General structures of DAZ family proteins.  
All three genes in DAZ family contain an RNA Recognise Motif (RRM), and DAZ repeat. 
The RRM and DAZ repeat are both highly conserved between the three genes. Both DAZL 
and BOLL only have a single copy of DAZ repeat, whilst DAZ has 7 to 24 copies (reviewed 
by Brook et al., 2009 ). 
 
 Image adapted from Brook et al., 2009 
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1.4.2 Deleted in Azoospermia-Like (DAZL) 
1.4.2.1 DAZL functions and co-factors 
As an RNA-binding protein, DAZL functions to bind to its mRNA targets and 
promote their translation, and possibly also increase their stability. 
The different functions of DAZL on mRNA regulation are possibly depended on the 
DAZL co-factors (see Table 1.1). The major co-factors of DAZ family proteins are 
Poly-A Binding Proteins (PABPs), which exist widely in eukaryotes. As their name 
suggested, PABPs have RRMs, which bind the 3’ poly-A tail of mRNA (Blobel, 
1973). Although the functions of PABPs vary, one of their most important roles is to 
promote translation by recruiting and interacting with translation initiation factors 
such as Eukaryotic translation initiation factor (eIF)4G (Wells et al. , 1998). It is 
known that the initiation of translation involves both the 5’ cap and 3’ poly-A tail of 
mRNA. The formation and degradation of the poly-A tail are called polyadenylation 
and deadenylation, respectively. Although translation and ribosome binding runs 
from 5’ to 3’, a lot of evidence suggests that during translation, mRNA forms a 
circular structure; the interaction between the 5’ cap and 3’ poly-A tail (closed-loop 
model) promotes the translation of mRNA, and PABP/eIF4G interaction is required 
for this process (reviewed by Kahvejian et al., 2001). 
As their name suggests, the binding of PABPs requires a poly-A tail, allowing 
translation to be activated; however, researchers found that a long poly-A tail is not 
always necessary for the initiation of translation (Collier et al., 2005). Collier et al. 
(2005) investigated the functions of Xenopus laevis (X. laevis) Dazl (Xdazl), mouse 
Dazl and human DAZ, DAZL and BOLL, by co-injecting one of these mRNAs which 
contains MS2 coding region together with luciferase reporter mRNA which contains 
MS2 binding sites into X. laevis oocytes; all of these co-injections could promote the 
translation of luciferase, despite variability in their ability to promote translation. 
They then found that all of the DAZ family proteins tested could interact with 
PABPs; once the region of Dazl which interacts with PABPs is removed, its ability to 
stimulate translation is completely lost and therefore PABPs are required for Dazl 
function (Collier et al., 2005). Further experiments performed with luciferase 
reporters with or without poly-A tails showed that Dazl could promote the translation 
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of both reporters, but its effect is much stronger on nonadenylated mRNA (8.5 fold 
increase) than on adenylated mRNA (2.8 fold) (Collier et al., 2005). Based on these 
findings, Collier et al. (2005) established the classic model of DAZL function 
(Figure 1.3). In this model, DAZL recognises and binds to its own binding sites in 
the 3’-Untranslated Region (3’-UTR) of its target mRNA, which have no or only 
short poly-A tails. DAZL then recruits co-factors such as PABPs, which bind to 








Figure 1. 3 The model of DAZL-PABPs interaction during initiation of mRNA translation.  
A) mRNA undergoes 3’ polyadenylation and forms a long poly-A tail (Green As) to recruit 
additional PABPs (Green PAB); (Red PAB) is recruited by short poly-A tail (Red As). PABPs then 
interacts with its co-factors to form a closed-loop structure to initiate translation. B) When DAZL 
is present, it binds to the 3’-UTR of the mRNA and recruits the additional PABPs (Green PAB) 
directly; polyadenylation is not necessary and translation is still stimulated. 4A/B/E/G indicate 
eIF4 factors; 40s, 40s ribosome; Paip, poly-A-binding protein-interacting protein. 
Images from Collier et al., 2005 
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Other DAZL co-factors include DAZ-Associated Proteins (DAZAP1 and DAZAP2). 
DAZAPs are also RNA-binding proteins but their functions remain unclear (Tsui et 
al. , 2000a). Unlike the binding between DAZL and PABPs through the N-terminal 
RRM region of DAZL, the interactions between DAZL and DAZAPs are reliant on 
the DAZ repeat; thus DAZAP can also interact with DAZ (Tsui et al., 2000a). 
DAZAP1 is mainly expressed in the germ cells of human testis and has two 
RNA-binding regions which are similar to a protein involved in pre-mRNA 
processing and nucleus-cytoplasm transport. The authors therefore predicted that 
DAZAP1 mainly regulates mRNA transport, and together with both DAZL and DAZ 
it may also regulate translation during spermatogenesis (Tsui et al., 2000a). Later 
studies suggested that Dazap1 is also expressed in mouse testis, has high sequence 
identity to its human homologue (over 80%) but is probably not involved in mRNA 
translation (Dai et al. , 2001). In contrast, another group reported that by regulating 
the phosphorylation of DAZAP, the DAZ-DAZAP complex may be associated with 
the stability and/or translation of mRNA (Morton et al. , 2006). 
Another co-factor of DAZL is PUMILIO-2 (PUM2). PUM2 is highly conserved 
during evolution – the identity between the C-terminal RNA-binding domain of 
human PUM2 and Drosophila pumilio is 80% (Zamore et al. , 1997). Drosophila 
pumilio was reported to be required for both embryo and germ cell development 
(reviewed by Fox et al., 2005). Human PUM2 was found to interact with DAZ, as 
DAZ could co-precipitate with PUM2 protein when both were expressed in yeast; the 
interaction between DAZL and PUM2 was confirmed by yeast two-hybrid analysis 
(Moore et al. , 2003). Furthermore, PUM2 is co-expressed with DAZ or DAZL in 
both human testis and ovary (Moore et al., 2003). Additional evidence was provided 
by Fox et al. (2005), who demonstrated that the binding sites of both DAZL and 
PUM2 are present on the 3’-UTR of human Severe Depolymerization of Actin 1 
(SDA1) Domain containing (SDAD)1 mRNA, and therefore SDAD1 might be 
regulated by the interaction of DAZL and PUM2. In Drosophila, pumilio represses 
translation by deadenylation (Wreden et al. , 1997), and as it is highly conserved 
with human PUM2, it is possible that the human DAZL/PUM2 interaction also 
functions as repressing translation. 
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Table 1. 1 Important DAZL co-factors and their functions 
DAZL-interacting protein Molecular function(s) 
PABPs i) Translation initiation factor 
 
ii) mRNA stability and deadenylation 
 
iii) Translational repressor 
 
iv) Nonsense-mediated mRNA decay 
  
DAZAPs i) mRNA transport (prediction) 
 
ii) Stability and/or translation of mRNA 
  
PUM2 
i) Translational repressor of CPE-dependent 
translation 
 
ii) Translational activator of CPE-dependent 
translation 
 
iii) Direct translational repressor 
Adapted from Brook et al., 2009  
Interestingly, a recent study identified a new splicing isoform of mouse Dazl 
(Dazl_Δ8), which could repress but not stimulate translation in embryonic stem cells 
(ESCs) but not germ cells (Xu et al. , 2013); the normal form of Dazl also seems to 
have this effect. Dazl_Δ8 is expressed in both mouse ESCs and germ cells in vivo 
and co-localises with the normal form; after being overexpressed into ESCs, the 
protein expression of Mouse vasa homolog (Mvh), Oct3/4 and SRY-box containing 
gene (Sox) 2 all decreased, and luciferase assays with reporter genes carrying the 
3’-UTRs of these target genes further confirmed repression of their translation (Xu et 
al., 2013). This suggests that Dazl may have both stimulatory and repressive effects 
on translation. 
Although the mechanisms remain unclear, there are also studies suggest that 
zebrafish Dazl (Zdazl) could not only promote the translation of its mRNA targets, 
but could also increase their stability. Two studies performed on zebrafish revealed 
such functions on Tudor domain-containing protein 7 (Tdrd7) (Takeda et al. , 2009) 
and Hu antigen proteins (Hu) HuB (Wiszniak et al. , 2011). Tdrd7 is expressed in the 
germ line of zebrafish and can be degraded by microRNA miR-430 mediated 
deadenylation, thereby repressing its translation (Mishima et al. , 2006). By 
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co-injecting Green Fluorescent Protein (GFP) reporter mRNA containing Tdrd7 
3’-UTR (Tdrd7-GFP), negative control reporter mRNA with wild type or mutated 
Zdazl mRNA into one-cell stage zebrafish embryos, it was observed that wild type 
Zdazl specifically increased GFP expression 4.2 fold, and this was also completely 
repressed by miR-430; once the RRM or DAZ region of Zdazl was absent, the 
enhancement became less significant (Takeda et al., 2009). Further research revealed 
that Zdazl binding sites indeed existed on the 3’-UTR of Tdrd7, and co-injecting 
Zdazl mRNA with A-capped Tdrd7-GFP mRNA which could not be translated led to 
the increased length of poly-A tail, suggesting that Zdazl was promoting 
polyadenylation without the requirement of translation (Takeda et al., 2009). 
Furthermore, when the Tdrd7-GFP mRNA lacked miR-430 binding site, co-injection 
of Zdazl further increased its poly-A tail (Takeda et al., 2009). Similar experiments 
were also performed with a Zdazl-GFP mRNA reporter, and the study demonstrated 
that Zdazl itself is also a target of miR-430 mediated deadenylation, and it could 
protect its own mRNA from degradation and increase expression (Takeda et al., 
2009). Using the same technique, Wiszniak et al. (2011) identified another potential 
Zdazl target, HuB, which is a maternally originated and germ cell specific 
RNA-binding protein; overexpressing Zdazl could promote the expression of 
mCherry mRNA reporter fused with HuB 3’-UTR (HuB-mCherry) 3.4 fold compared 
to expressing the reporter alone, and in situ hybridisation indicated that 
HuB-mCherry mRNA was enriched as well (Wiszniak et al., 2011). Although it is 
still unclear whether Zdazl can promote both the stabilisation and translation of HuB, 
or whether this is also through increased polyadenylation, stabilising its mRNA 
target seems to be another important function of DAZL and thus it might regulate 
these targets at post-transcription level rather than only at translation level. 
 
1.4.2.2 DAZL expression and phenotypes in model animals 
DAZL expression is mainly detected in the germ lines of vertebrates, and found to 
play a critical role during meiosis and probably early embryo development. This 
section will review the expression of Dazl in a wide range of model animals, from 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
Chapter 1. Literature Review 
32 
 
fish, frog to mammals (including mouse, rat, goat, porcine and bovine) and also the 
phenotypes caused by the mutation/absence of Dazl. 
1.4.2.2.1 Fish 
In fish, Dazl is detected in many species including zebrafish (Maegawa et al. , 1999), 
medaka (Xu et al. , 2007), rainbow trout (Li et al. , 2011a) and gibel carp (Peng et al. 
, 2009). Surprisingly, despite zebrafish being widely used as a model animal, Zdazl 
expression during early germ cell development has not been investigated in detail. It 
is known that Zdazl is expressed in the adult gonads of zebrafish in both sexes 
(Maegawa et al., 1999). In situ hybridisation suggests that Zdazl transcripts are 
mainly distributed in the spermatogonia and early spermatocytes in the testis 
(Maegawa et al. , 2002). In stage I oocytes in the ovary, (which are undergoing 
meiosis before diplotene arrest) (Selman et al. , 1993), Zdazl is localised near the 
nucleus; after stage I, meiosis is arrested and Zdazl dynamically changes location, 
moving strictly to the vegetal cortex, (Kosaka et al. , 2007). After fertilisation, in 
early embryogenesis, the maternal Zdazl mRNA begins to translocate from vegetal 
cortex to the embryonic cleavage furrows (Kosaka et al., 2007), and dramatically 
decreases at late blastula stage (Maegawa et al., 1999).  
Studies on rainbow trout (Li et al., 2011a) and medaka (Xu et al., 2007) have 
provided further detail. In rainbow trout, Dazl mRNA is expressed in the gonads of 
both sexes as well (Li et al., 2011a). In adult trout ovary, Dazl expression persists 
during oogenesis, from undifferentiated oogonia to stage III oocytes, which are just 
beyond the resumption of meiosis (Selman et al., 1993), and peaks at stage II and III 
(Li et al., 2011a). In the trout testis, Dazl expression is also detectable from the 
spermatogonial stage, and persists to round spermatids (Li et al., 2011a).  
In medaka testis, Dazl expression is detected at both mRNA and protein level in 
spermatogonia and spermatocytes but in contrast to the rainbow trout, Dazl mRNA is 
absent from spermatids (Xu et al., 2007). The mRNA expression of Dazl in female 
medaka is more similar to that in rainbow trout – it persists during oogenesis, the 
highest level is seen in stage II and III oocytes, then deceases at later stages. 
However, protein expression is slightly different; Dazl protein is more abundant in 
oogonia and early oocytes (Xu et al., 2007). Dazl expression during medaka 
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embryogenesis has also been investigated by the same group. Similar to zebrafish, 
maternal Dazl expression is detectable from zygote until blastula stage, and 
interestingly, it also later appears in putative PGCs (Xu et al., 2007).  
In gibel carp, Dazl is also expressed by both sexes; Dazl protein is found in PGCs, 
persists during their proliferation and differentiation, and is continuously expressed 
in later stages from oogonia to mature oocytes (Peng et al., 2009). As in zebrafish, 
the translocation of Dazl mRNA and protein from adjacent to the nucleus to the 
vegetal cortex is also observed in later stage I oocytes of gibel carp. After fertilisation, 
Dazl mRNA and protein migrates again to the blastomere, then decreases at early 
gastrulation (Peng et al., 2009). In males, both Dazl mRNA and protein are mainly 
detected in spermatogonia and spermatocytes, but not in spermatids and spermatozoa 
(Peng et al., 2009).  
Overall, in fish, Dazl shows germ cell/embryogenesis-specific expression. It is 
inherited maternally from the one-cell embryo stage and persists until gastrulation 
then decreases; but when putative PGCs differentiate, Dazl is again expressed and 
continues through the whole of oogenesis but its distribution dynamically changes 
from perinuclear to vegetal cortex as the oocytes mature. In males, Dazl expression 
decreases or disappears at the spermatid stage. This suggests that Dazl expression in 
fish might play important roles during both germ cell development and 
embryogenesis; the minor inconsistencies between fish species are possibly due to 
evolution. 
 
1.4.2.2.2 Xenopus  
Xdazl was first identified by Houston et al. (1998) from a library of Xenopus oocytes. 
Their further investigation reveals that its transcript is firstly detectable in the 
cytoplasm of oocytes from post-metamorphic froglets; these oocytes are at early 
diplotene stage, and at later stages Xdazl shows a dynamic translocation as seen in 
the fish as the oocytes mature (see section 1.4.2.2.1), transferred from perinuclear 
area to the vegetal cortex (Houston et al., 1998). Mita & Yamashita’s (2000) showed 
that Xdazl protein is most abundant in oogonia and very early (pre-vitellogenic, stage 
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I) oocytes which are undergoing meiosis (Dumont, 1972), but it is not detected 
(when using immunohistochemistry) in later stage I oocytes, then reappears at stage 
IV, but it was found to be expressed across all stages of oogenesis by Western 
blotting (Mita and Yamashita, 2000). 
In testis, Xdazl is expressed in some spermatogonia but mainly presents in 
spermatocytes which are undergoing meiosis; spermatids and spermatozoa do not 
show Xdazl expression (Houston et al., 1998). Analysis of Xdazl protein suggests 
that it is continuously expressed from spermatogonia to spermatids, but undetectable 
in spermatozoa; secondary spermatogonia and spermatocytes (both primary and 
secondary) show strong staining (Mita and Yamashita, 2000). 
Xdazl mRNA expression is also found in embryos. During embryogenesis, the 
maternal Xdazl localises in germ plasm, which exists in flies, fish and frogs and 
contains the factors which will pre-determine the germ cells; therefore Xdazl 
expression appears closely related to the formation of putative PGCs, and this is 
supported by the positive Xdazl signals detected in these PGCs (Houston et al., 
1998). The Xdazl protein was also found in the germ plasm of embryos from 
blastulae to early tailbud stage and in PGCs it is only expressed until early tailbud 
stage and then is soon interrupted afterwards (Houston and King, 2000). Other 
research, however, suggests that Xdazl protein has an even distribution pattern in the 
cytoplasm of the early embryo rather than being restricted to the germ plasm, and 
disappears after gastrulation; it is then re-expressed in post-migration PGCs (Mita 
and Yamashita, 2000). 
By silencing maternal Xdazl mRNA (with injected antisense oligodeoxynucleotides), 
researchers were able to study the function of Xdazl during early germ cell 
development in Xenopus. They found that despite the formation of PGCs being 
normal, the number of PGCs which are located at the dorsal mesentery during 
migration is largely reduced or completely absent, and two out of three ovaries 
lacked germ cells (Houston and King, 2000). Further study revealed that the PGCs 
failed to move from ventral endoderm into the dorsal mesentery; and these 
phenotypes could be rescued in some cases by injecting extra Xdazl mRNA into these 
embryos (Houston and King, 2000). This suggests that in Xenopus, maternal Xdazl is 
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Mouse Dazl, which is located on chromosome 17, was first identified Cooke et al. in 
1996. Dazl transcripts were examined in a range of different tissues and found to be 
expressed specifically in the gonads of both sexes; and was undetectable in testes 
without germ cells, which suggests that expression is germ cell-specific (Cooke et 
al., 1996, Seligman and Page, 1998). With northern blotting, further investigation 
suggests that in mouse fetal gonads, Dazl transcripts are detectable from e11.5 when 
germ cells settle in the gonads but prior to sex differentiation (Seligman and Page, 
1998). Dazl expression then increases at e13.5 and e14.5, which is coincident with 
the initiation of meiosis in the female (Seligman and Page, 1998). After that Dazl 
expression decreases to half of its peak level at e16.5. In the female, Dazl is barely 
detectable by puberty, probably as a consequence of the loss of oocytes, whilst in the 
male its expression level is 100-fold higher than that in female (Seligman and Page, 
1998).  
Studies which generated anti-Dazl antibodies and applied immunohistochemistry to 
investigate its protein expression further confirmed that mouse Dazl is likely to be 
exclusively expressed in germ cells (Reijo et al. , 2000) .Weak staining in granulosa 
cells of developing follicles in pre-pubertal ovary has also been reported (Ruggiu et 
al., 1997); this might be due to cross-reaction as it has not been reported by other 
studies. In mouse testis, Dazl protein is found in gonocytes, spermatogonia and 
spermatocytes, and most abundantly in pachytene spermatocytes (Reijo et al., 2000, 
Ruggiu et al., 1997). In the female, Dazl is detected in the cytoplasm of germ cells in 
fetal and pre-pubertal ovaries, and also in the peripheral cytoplasmic area of oocytes 
in follicles of adult mouse (Ruggiu et al., 1997). Before the first division of the 1-cell 
embryo, Dazl protein expression is up-regulated during the maturation of oocytes 
until Metaphase II (MII) and the zygote stage, by recruiting the Dazl mRNA to 
polysomes without a change in overall level of transcripts. Strong cytoplasmic Dazl 
expression is also present in pre-implantation embryos from the 2-cell stage; the 
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latest known expression period is the blastocyst (Pan et al. , 2008). Both the 
granulosa and embryo Dazl expression challenge the theory of specific Dazl 
expression in germ cells, however without any additional evidence provided by other 
studies and methods, it is unclear whether the weak Dazl signal in granulosa cells is 
genuine or a cross-reaction. Despite Dazl being found in pre-implantation embryos, it 
is possible that this expression is maternal, inherited from egg. Therefore, this thesis 
will discuss Dazl expression in terms of it being germ cell specific. 
The translation of Dazl is initially promoted by Cytoplasmic Polyadenylation 
Element Binding protein (CPEB) which is important for cytoplasmic 
polyadenylation, but positive feedback is also involved (Chen et al. , 2011). Dazl 
knock down by morpholino oligonucleotides results in delayed resumption of 
meiosis during oocyte maturation; the phenotypes include fewer oocytes completing 
meiosis I and defects at MII transition. Both phenotypes could be rescued by 
injecting human DAZL mRNA or protein, but the rescue is only partial for the latter 
(Chen et al., 2011). 
A translocation from nucleus to cytoplasm of Dazl protein during spermatogenesis 
was reported in male mice. In fetal gonocytes, Dazl shows both nuclear and 
cytoplasmic expression, then is mainly detected in the nucleus in spermatogonia, and 
finally becomes cytoplasm specific in spermatocytes, which is consistent with entry 
into meiosis (Reijo et al., 2000). This translocation is also observed in the testis of 
primates, including human and marmoset (Reijo et al., 2000, Ruggiu et al. , 2000) 
(See Section 1.4.2.3).  
In the rat, Dazl protein is also germ cell-specific, and its most abundant pachytene 
expression in testis is conserved with that of mouse (Ruggiu et al., 2000); the 
up-regulated timing at pachytene was demonstrated as well (Rocchietti-March et al. , 
2000). Interestingly, the nuclear to cytoplasmic translocation of Dazl is not observed 
in rat; it is consistently localised to the cytoplasm from the gonocyte to the 
spermatocyte stage (Ruggiu et al., 2000).  
Dazl is essential for mouse germ cell development. Indeed, the Dazl-deficient 
phenotype has been investigated in great detail in mouse. Ruggiu et al. (1997) 
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generated the Dazl-deficient (DazlTm1Hgu/Tm1Hgu) mouse on an outbred background, 
and found that these mice were infertile, with severe, almost complete germ cell loss 
by six to eight weeks after birth in both sexes. This is due to increased germ cell 
apoptosis which initiates in fetal life, possibly at e19.5. At e15.5 however, the germ 
cells in fetal gonads are still undistinguishable from those in WT mice, with meiosis 
initiated and reaching pachytene in ovaries. The heterozygote (DazlTm1Hug/+) mice are 
fertile, but display a higher ratio of abnormal sperm when compared to the wildtype 
controls(Ruggiu et al., 1997).  
Further investigation based on the same strain of Dazl-deficient mice suggests that in 
the female, germ cell loss actually begins from e17.5 and all the germ cells are 
depleted by day 4 after birth (Saunders et al. , 2003). Interestingly, the heterozygous 
female mice with reduced Dazl expression seemed to have larger litter sizes, possibly 
resulting from an increased number of antral follicles (McNeilly et al. , 2011). 
Furthermore, these follicles had a larger area of granulosa cells were more sensitive 
to follicle-stimulating hormone (FSH) (McNeilly et al., 2011). Ovaries with a 
complete loss of Dazl and follicle structures are still able to produce normal level of 
estrogen, very likely by the presence of surviving steroidogenic cells, but increased 
FSH and decreased inhibin levels are detected in plasma of heterozygotes (McNeilly 
et al. , 2000). 
In Dazl-deficient males, during the first wave of spermatogenesis (day 2 to 19 after 
birth), germ cell loss begins from day 7 onwards, and they already show 
abnormalities (such as multinucleated germ cells) as early as at day 2 and 4 
(Saunders et al., 2003). The germ cells in the testes of Dazl-deficient mice show 
delayed meiotic entry at day 9 when most in WT are at pre-leptotene, and 
spermatogenesis in Dazl-deficient mice finally arrests when the germ cells enter 
meiosis, and rarely progresses beyond leptotene (Saunders et al., 2003). Another 
study suggests that the most advanced germ cell type present in 
DazlTm1Hgu/DazlTm1Hgu mice is pachytene spermatocytes, and most germ cells in the 
testis of Dazl-deficient mice are actively mitotically dividing type A spermatogonia, 
which display impaired differentiation (Schrans-Stassen et al. , 2001). Comparison of 
the gene expression profile of DazlTm1Hgu/Tm1Hgu mouse testis to those of wild type 
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littermates indicated reduced expression of genes involved in germ cell development, 
including the genes associated with advanced spermatogonial development, entry 
into meiosis and meiosis prophase I (leptotene to pachytene) (Maratou et al. , 2004). 
Some genes involved in spermatogonia development and embryonic testis are also 
found strongly associated with ovary development. Although meiosis is initiated in 
the Dazl null mouse, the effect of losing Dazl on gene expression begins as early as 
day 5 after birth, when the only germ cell type in the testes are type A spermatogonia 
(Maratou et al., 2004).  
By backcrossing the DazlTm1Hgu/Tm1Hgu mice onto a C57BL/6 mouse strain, Lin & 
Page (2005) established a strain of inbred Dazl-deficient mice on the C57BL/6 
genetic background. Instead of maintaining germ cells until after birth, male inbred 
DazlTm1Hgu/Tm1Hgu mice were born with almost no germ cells due to increased 
apoptosis (Lin and Page, 2005). At e13.5, there were no major differences in germ 
cell number or morphology between WT and DazlTm1Hgu/Tm1Hgu. However from e14.5, 
more apoptotic germ cells occurred in the inbred DazlTm1Hgu/Tm1Hgu mice and the 
surviving germ cells maintained condensed chromatin like those in early e12.5-e13.5 
gonads, whilst those of WT testes had a more diffuse appearance (Lin and Page, 
2005). Germ cell apoptosis continued at e15.5, and by e17.5 most germ cells in the 
Dazl-null gonads are lost. The gene expression profile revealed by in situ 
hybridisation suggests that the mRNA level of several germ cell-specific genes, such 
as Mvh, Stella and Oct4 are slightly decreased at e13.5, and further reduced at e15.5; 
Mvh and GCNA protein expression are also decreased at e14.5 and e15.5, 
respectively (Lin and Page, 2005).  
Human DAZ and DAZL transgenes could partly rescue the DazlTm1Hgu/Tm1Hgu 
phenotypes in murine testis (Slee et al. , 1999, Vogel et al. , 2002). Both transgenes 
could significantly increase the number of surviving germ cells, and promote the 
differentiation from spermatogonia to primary spermatocytes (i.e. rescue the 
dysregulated initiation of meiosis), but this was still not sufficient to restore the 
fertility of DazlTm1Hgu/Tm1Hgu mice. The difference is that the human DAZ but not the 
DAZL transgene significantly increased the number of spermatocytes that reached 
pachytene stage, and meiosis in DAZL transgene mice still showed 
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leptotene/zygotene arrest as in DazlTm1Hgu/Tm1Hgu mice (Slee et al., 1999, Vogel et al., 
2002). This reveals the both conservation and differences between mouse Dazl and 
human DAZ/DAZL. Notably, human DAZL transgene did not show any rescue effect 
on Dazl deficient phenotypes in female mice (Vogel et al., 2002), this may imply that 
even in the same species, Dazl functions may not be completely conserved between 
male and female during gametogenesis. 
Recently, Dazl has been found to be involved in the maintenance or repression of 
pluripotency in mouse PGC and/or ES cells. In female Dazl-deficient mice, 
expression of the early germ cell markers Oct3/4, Stella and c-Kit is down-regulated, 
and embryonic germ cell lines (pluripotent derivatives of PGCs) cannot be 
established using germ cells from Dazl-deficient fetal gonads. The efficiency of in 
vitro differentiation from Dazl-null ES cells to germ cells is also reduced, and these 
cells show lower expression of pluripotency markers and higher expression of 
pro-apoptotic markers when compared with wild type or heterozygotes (Haston et al. 
, 2009). A splicing variant of Dazl (Dazl_Δ8) seems to repress the translation of Mvh 
and Oct4 in mouse ES cells but not in germ cells (Xu et al., 2013), implying that 
Dazl may play different roles in ES and germ cells. A recent paper also suggests that 
Dazl represses pluripotency in PGC-like cells by suppressing the translation of 
related genes Sox2 and Sal-like 4 (Sall4), but in contrast with two previous papers, 
the expression of Oct4 is unaffected; moreover, Dazl also seems to repress the 
expression of apoptosis-associated genes Caspase 2, 7 and 9 (Chen et al. , 2014). 
Besides the post-transcriptional regulation of mRNA targets, Dazl may also be 
associated with transport of mRNA. Lee et al. (2006) reported that in male germ 
cells, Dazl could interact with the light chain of dynein (Dlc), which is part of the 
dynein-dynactin motor complex. The two proteins could be co-precipitated with each 
other when using either antibodies. Dazl may gain the ability of moving through 
microtubule network, allowing it to bind with and transport its mRNA targets, 
including Testis specific protein-1 (Tpx1), Cdc25C (via 5’-UTR) and Mvh. mRNA 
transportation by Dazl is also relevant to the formation of stress granules, 
cytoplasmic particles which contain abundant messenger ribonucleoproteins and 
which cells use to limit their translation by storing RNAs when subjected to cellular 
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stress. When treated with the toxin arsenite which can induce the stress granule, most 
Dazl protein translocates into stress granules (Lee et al., 2006). This translocation is 
confirmed by another study which demonstrated that Dazl was also involved in the 
formation of stress granules under heat stress in mouse male germ cells. This protects 
these cells from heat-induced apoptosis by storing specific signalling molecules and 
blocking the apoptotic pathway (Kim et al. , 2012). 
To summarise, increased Dazl expression at e13.5, most abundant expression at 
pachytene in both mouse and rat, and meiosis arrest phenotypes in DazlTm1Hgu/Tm1Hgu 
outbred mice indicates that Dazl may play an important role at meiosis entry and 
prophase I, although its increased expression at e13.5 occurs in both sexes rather than 
being female specific implies that it may not be completely meiosis associated. In 
addition, Dazl is also involved in germ cell differentiation and stress protection. Its 
expression in pre-implantation embryos implies that Dazl may be necessary during 
the process of early embryo development, and the loss of germ cell phenotypes, 
especially prior to meiosis in inbred mice, suggests that Dazl is an important 
contributor to germ cell survival.  
However, it is necessary to point out that most of this research was focused on male 
reproduction. Although Dazl is known to be continuously expressed in the germ cells 
of mouse ovary from fetal life to adulthood (Ruggiu et al., 1997), where it seems to 
regulate the maturation of follicles by modulating their sensitivity to FSH (McNeilly 
et al., 2011), Dazl expression or phenotypes in female mouse are far less clearly 
described. Therefore, how Dazl regulates mouse oogenesis is yet to be investigated in 
depth. 
 
1.4.2.3 Human DAZL expression, mutation and phenotypes 
The human homologue of DAZL was first identified by Saxena et al. (1996) from an 
adult human testis cDNA library, and originally named “DAZH (DAZ Homologue)”. 
It is located on chromosome 3 and was confirmed to be expressed at a lower level in 
adult human ovary than testes, and not expressed in any other tissues examined. 
DAZL expression has been widely investigated and was found in human gonads 
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(Anderson et al., 2007, Dorfman et al. , 1999, Moore et al., 2003, Reijo et al., 2000, 
Ruggiu et al., 2000, Tung et al. , 2006a, Xu et al., 2001), pre-implantation embryos 
and inner cell mass (ICM) (Cauffman et al. , 2005), undifferentiated embryonic stem 
(ES) cells (Clark et al. , 2004), and potentially, in corpus luteum (Pan et al. , 2009). 
DAZL expression in human testis has been reported in several studies. In the adult, 
the protein occurs almost through all the stages of spermatogenesis, including 
spermatogonia, early and late spermatocytes, spermatids and it was also found in 
mature spermatozoa (Lin et al. , 2001, Moore et al., 2003, Reijo et al., 2000, Ruggiu 
et al., 2000, Tung et al., 2006a, Xu et al., 2001). In fetal testis, DAZL was also 
expressed at first and second trimester at both mRNA and protein level; its mRNA 
slightly increased at second trimester, and its protein seemed to be mainly distributed 
in the nucleus of gonocytes, with no or weak cytoplasmic expression (Anderson et 
al., 2007, Reijo et al., 2000, Ruggiu et al., 2000). Interestingly, two groups reported 
at almost the same time that both human and mouse Dazl show a dynamic 
distribution from nucleus to cytoplasm during differentiation (Reijo et al., 2000, 
Ruggiu et al., 2000), although their conclusions are slightly different. According to 
Reijo et al. (2000), DAZL is expressed in both nucleus and cytoplasm in gonocytes, 
then in nucleus and part of cytoplasm in spermatogonia, and finally becomes 
cytoplasmic-specific in both spermatocytes and spermatids; however Ruggiu et al. 
(2000) reported that DAZL is already completely transferred to the cytoplasm by the 
spermatogonia stage, and not found in any other germ cell types later than 
spermatocytes. The former finding is supported by Moore et al. (2003) and Xu et al. 
(2001)’s research, which also suggests that human DAZL is expressed in not only 
spermatogonia and spermatocytes, but also in post-meiotic germ cells in testis, whilst 
Lin et al. (2001) found that DAZL is only expressed in spermatogonia and 
spermatocytes in adult testes.  
In the human ovary, DAZL is also expressed from the fetal period at both mRNA and 
protein level, and DAZL mRNA levels increase significantly (20 fold) in the second 
trimester when compared to that in the first trimester (Anderson et al., 2007). DAZL 
protein showed weak staining during first trimester as in fetal testis, but in second 
trimester, it becomes very clear and is mainly distributed in the cytoplasm of meiotic 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
Chapter 1. Literature Review 
42 
 
germ cells (Anderson et al., 2007, Dorfman et al., 1999). DAZL shows limited 
co-localisation with OCT4, and partly co-localises with VASA. In addition, after 
measuring the nuclear diameters, an indicator of germ cell maturation, Anderson et 
al. (2007) found that DAZL/VASA co-expressed germ cells have bigger nuclei than 
DAZL single-positive cells, but they are smaller than VASA single-positive cells, 
implying that DAZL might be absent in more mature germ cells in human fetal 
ovary. Dorfman et al. (1999) looked at the DAZL protein expression in 19 week 
gestation fetus and adult (37 and 44 years old) ovaries, and found that expression 
occurred in oogonia, primary and secondary follicles, and is most intense in the 
cytoplasm of developing oocytes; consistently, Moore et al. (2003) also found that 
DAZL is expressed in the cytoplasm of oocytes in adult ovary. Furthermore, DAZL 
transcript expression in mature (from Germinal Vesicle (GV) to MII) oocytes is 
reported by Cauffman et al. (2005). The nuclear to cytoplasmic translocation of 
DAZL in female has not been reported by these previous researches due to the 
lacking of studies on human fetal ovaries, however it is possible that this transfer is 
conserved between male and female in both primates and mouse. 
Although DAZL expression is believed to be germ cell-specific, it also appears in 
several other kinds of tissues/cells. As it is expressed in oocytes, it is not a surprise 
that DAZL also appears in zygotes and early embryos. Cauffman et al. (2005) 
investigated DAZL mRNA expression in human oocytes, zygotes and 
pre-implantation embryos, and found that DAZL transcripts are detectable in almost 
all oocytes, zygotes and 4-cell embryos they examined with only one exception. 
Surprisingly, although DAZL is expressed by only about 52% of 5-8 cell embryos, it 
soon recovered to its previous level (100% of embryos) in 9-13 cell embryos, 
implying a transition from maternal to embryonic expression (Cauffman et al., 
2005). The same research group also found that DAZL expression seems to be 
associated with the quality of embryos; all the DAZL negative blastocysts were 
marked as not suitable for transfer during in vitro fertilisation (IVF), and the DAZL 
mRNA levels between suitable and unsuitable embryo groups show significant 
differences (Cauffman et al., 2005). In separated ICM and trophectoderm (TE) from 
blastocysts using mechanical techniques, DAZL is detectable in both kinds of 
embryos which are marked as best quality (Cauffman et al., 2005). Interestingly, 
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DAZL was undetectable in most ICM cells when separated by immunosurgery (Clark 
et al., 2004). In addition, DAZL mRNA is also found endogenously in several human 
ES cell lines (both XX and XY) and their spontaneous early-differentiated colonies 
as well as embryoid bodies (EBs) (Cauffman et al., 2005, Clark et al., 2004). 
Together, embryonic DAZL expression may imply that it plays a role in 
differentiation in early embryos. 
Other research has reported that DAZL protein is expressed in the human corpus 
luteum and interacts with CDC25A as a transcription factor (Pan et al., 2009). 
However, these observations are only based on the co-immunoprecipitation with 
anti-CDC25A or DAZL antibodies using human corpus samples, without applying 
any RT-PCR or immunostaining against DAZL. Therefore, this claim still needs 
more evidence to support it. 
In humans, the relationship between DAZL expression/mutations and reproductive 
capacity has been investigated. A study based on a male population in Taiwan found 
that DAZL mRNA levels were lower (but not significantly so) in patients with 
hypospermatogenesis compared with patients with normal spermatogenesis, although 
the protein was still expressed in spermatogonia and spermatocytes (Lin et al., 2001). 
These data do not however clarify the relationship between DAZL and normal 
spermatogenesis. Based on the same population, Teng et al. (2012) identified three 
SNPs in the DAZL promoter, and one of them (-792G→A) seemed to affect the 
binding of transcription factor Nuclear respiratory factor 1 (NRF-1) and interrupt 
interactions with other transcriptional factors such as SP1. Importantly, this SNP was 
negatively associated with sperm quality, including concentration and motility. As 
the methylation of the Dazl promoter has been reported to be a negative regulator of 
its expression in pigs, possibly by affecting Specificity protein 1 (Sp1) binding 
(Linher et al. , 2009), it might be that the -792G→A base change involves a similar 
pathway. The abnormal methylation of DAZL promoter and associated phenotypes 
have also been reported by two other studies (Li et al. , 2013a, Navarro-Costa et al. , 
2010). Moderate or severe hypermethylation is only detected in patients with 
spermatogenic defects (Li et al., 2013a). Using similar methods, Navarro-Costa et al. 
(2010) compared the DAZL methylation between the sperm of normozoospermic 
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(NZ) and oligoasthenoteratozoospermic (OAT) men. They found that the frequency 
of non-methylation was lower in defective sperm from NZ men, and was decreased 
in those with OAT. Therefore, it is clear that abnormal high DAZL methylation in 
human sperm is associated with spermatogenesis defects. 
Mutations of DAZL have also been identified and associated with human 
reproductive parameters (Tung et al., 2006b, Tung et al., 2006c). Seven SNPs, one of 
which located on exon 2 whilst others are on the DAZL 3’-UTR, are found 
associated with different reproductive phenotypes (Tung et al., 2006b). Interestingly, 
all seven SNPs seem to be associated with male reproductive capacity by increasing 
both the total sperm count and total motile count, however three of them are 
negatively associated with female parameters, including earlier age of ovarian 
failure/menopause and promoting premature ovarian failure. This may indicate 
important roles in the establishment of the primordial follicle pool. This also implies 
complex DAZL functions in both sexes, and according to the authors, this may due to 
either DAZL mRNA stabilisation/translation by different factors, or the differences in 
translation initiation complexes involving DAZL between male and female (Tung et 
al., 2006b). In addition, four missense DAZL mutations are also identified; their 
positions and relative phenotypes are listed in Table 1.2 (Tung et al., 2006c). None of 
these mutations were found in fertile controls, which strongly suggests that they are 
associated with subfertility phenotypes. 
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Table 1. 2 Human DAZL polymorphisms and phenotypes  
Exon Change  Occurrence  
  Sex  Genotype Phenotype 
2 Pro6→His6 Female  Heterozygous Spontaneous early menopause at age 45.  
3 children previously 
2 Asn10→Cys10  Male  Homozygous Azoospermia 
  Female  Heterozygous Familial early menopause at age 44. 
4 children previously 
2 Ile37→Ala37 Female  Heterozygous Spontaneous early menopause at age 43.  
1 child previously. 
5 Arg115→Gly115 Female Homozygous Spontaneous premature ovarian failure at 
age 34. 0 children previously. 
     
Adapted from Tung et al., 2006c 
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Beside in vivo research, in vitro experiments also reveal the key DAZL function of 
promoting germ cell differentiation. DAZL is expressed in undifferentiated human 
ES cells at both mRNA and protein levels along with several other pre-meiotic germ 
cell markers, this may indicate either a similar molecular programme between germ 
and ES cells, or that ES cells spontaneously tend to differentiate into germ cells 
(Clark et al., 2004). Under differentiation conditions, DAZL expression decreases 
and ES cells begin to express the germ cell marker VASA and meiosis marker SYCP1; 
however they also express both post-meiotic marker GDF9 (female-specific) and 
Tektin1 (TEKT1) (male-specific), no matter whether they are originally XX or XY 
(Clark et al., 2004). A later attempt at deriving human germ cells from ES cells was 
performed by Medrano et al. (2012), who overexpressed VASA and/or DAZL in 
human ES or induced pluripotent stem cells (iPSCs), and found that although VASA 
alone could promote germline formation and meiosis progression, the best efficiency 
for driving meiosis occurred following DAZL overexpression, (based on detection of 
the morphology of SYCP3 staining (elongated) and the number of haploid cells), 
whilst the combination of VASA and DAZL overexpression slightly decreased this 
effect. The function of DAZL in promoting primordial germ cell differentiation and 
meiosis from human ES cells was further confirmed by Kee et al. (2009). Again they 
induced primordial germ cells from ES cells using VASA-GFP overexpression, and 
then silenced DAZL expression with short hairpin RNA (shRNA) in these cells. The 
number of VASA-GFP positive cells dramatically decreased to about 50% after the 
silencing of DAZL, and this could be rescued by overexpressing DAZL. By observing 
the elongation of SYCP3, they also found that DAZL and BOLL show similar ability 
of promoting meiosis in XX cell lines, but DAZ is also necessary for the same 
progress in XY cell lines. By overexpressing DAZL, BOLL and DAZ together, 
haploid cells are also formed from 2% of these ES cells, and they express mature 
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sperm marker Acrosin (ACR). Together, these results suggest that DAZL functions to 
both promote germ cell differentiation and meiotic progression. 
To summarise here, DAZL expression is found in both human germ cells and early 
embryos, and it is associated with both male and female subfertility phenotypes. It 
may function in two aspects, i.e. regulating pluripotency/differentiation, and 
promoting meiosis progression. However, the mechanism underlying these 
modulations remains largely unknown, and one of the keys of understanding DAZL 
function is to identify its mRNA targets. 
 
1.4.2.4 RNA binding capacity and potential targets of DAZL 
Although DAZL shows multiple functions during germ cell and early embryonic 
development, the number of potential DAZL mRNA targets identified so far is very 
limited.  
The basis of identifying DAZL target mRNAs is to investigate its binding sites, by 
testing the binding specificity between DAZL protein/RRM with particular RNA 
sequences. Houston et al. (1998) first characterised the binding motif of potential 
Xdazl targets using homopolymeric RNA, and demonstrated that Xdazl tends to 
recognise poly-U and poly-G RNA and therefore is likely to bind U or G rich 
sequences in vivo. This finding was extended by Tsui et al. (2000b), who first tested 
the binding capacity of human/mouse Dazl and human DAZ to RNA, and found that 
their binding to poly-U is more stable than to poly-G; further investigation using 
partly deleted DAZL protein constructs suggests that the RRM is the key region to 
recognise the poly-U motif whilst the DAZ repeat may be relevant to poly G binding, 
and therefore the RRM is mainly responsible for RNA binding. The study further 
looked at the subcellular distribution of Dazl in vivo; after separating an extract of 
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mouse testis into nuclear, mitochondrial and postmitochondrial fractions, Dazl 
mainly occurred in the postmitochondrial supernatant (over 75%), most of which 
co-migrated with the polysomes; RNase treatment disassociated these polysomes and 
significantly reduced the Dazl component in the postmitochondrial supernatant (Tsui 
et al., 2000b). Together with the detection of Dazl in endogenous poly-A 
ribonucleoprotein (RNP) particles, the evidence pointed to the conclusion that Dazl 
is associated with activated translational regulation through poly-U binding (Tsui et 
al., 2000b). Further advances were made by Jiao et al. (2002), who first screened the 
common recognition motif of Dazl and clearly identified several potential targets. By 
co-precipitating RNP with Dazl from mouse testis extract, they identified Tpx1, 
Peptidylglycine alpha-amidating monooxygenase (Pam), Telomeric repeat binding 
factor 2 (Trf2), G-rich RNA sequence binding factor 1 (Grsf1), Proteosomeα7/C8 
subunit (Pα7/C8) and Histocompatability antigen precursor 47 (H47) as potential 




Each single nucleotide in this sequence appears at least four times in the 
aforementioned target genes and two nucleotides which share a common position 
appears at least three times. N means any nucleotide. 
This 26-nucleotide sequence was named the Dazl-binding site (DBS) and was further 
confirmed by generating appropriate oligonucleotides and binding them with Dazl 
(Jiao et al., 2002). In addition, this research also found that Cdc25A, a homologue of 
the fly bol target twine could bind Dazl as well, but its homologue gene Cdc25C 
could not (Jiao et al., 2002). However, other research reached the opposite 












A G U A U A A 
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vitro binding assay, and binding was abolished when four mutations were introduced 
into the Dazl RRM. Interestingly, although Dazl is believed to regulate its mRNA 
targets through the 3’-UTR, the Dazl binding sites of Cdc25C are located on the 
5’-UTR (Venables et al., 2001). A more precise Dazl binding motif was described by 
this research as well; compared to Tsui et al. (2000b)’s broad poly-U and poly-G rich 
theory, the range was further narrowed down to extreme U-rich sequences 
interrupted by G, with binding slightly weakened when G is replaced by C, or was 
further weakened but still not completely quenched if replaced by A. Therefore, the 
Dazl binding motif is most likely to be (G/CUn)n (Venables et al., 2001).  
A year later, the recognition motif of Zdazl was also reported, although different 
from that of mammals; the common binding sequence of Zdazl is GUUC (Maegawa 
et al., 2002). The sufficiency of recognising GUUC by Zdazl was confirmed by 
binding assays performed using mutated RNA probes (Maegawa et al., 2002). The 
GUUC motif is also found on the 3’-UTR of fly twine, and when it was conjugated 
with luciferase vector and co-transfected with Zdazl in monkey kidney cell CV1, 
luciferase activity was increased but this effect would disappear once GUUC motifs 
were removed (Maegawa et al., 2002). In addition, GUUC was also identified in the 
3’-UTR of Zdazl mRNA itself, thus Zdazl mRNA translation is enhanced by its own 
protein (Maegawa et al., 2002).Auto-regulation of Dazl mRNA translation by Dazl 
protein was later found to occur in mouse as well (Chen et al., 2011). Further 
investigation indicated that multiple binding sites are also important for enhanced 
translation, as one or two copies of GUUC on an artificial 3’-UTR was not sufficient 
to stimulate significantly increased luciferase activity (Maegawa et al., 2002). The 
importance of the RRM domain of Zdazl was also investigated: by introducing a 
F91A mutation into the RRM, the RNA binding capacity of Zdazl was completely 
lost, whilst it was unaffected if the DAZ motif was deleted (Maegawa et al., 2002). 
Therefore in Zdazl, as with mouse Dazl, RNA recognition and binding is through the 
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RRM, and the DAZ repeat is thought to be required for translation activation via 
polysome binding (Maegawa et al., 2002).  
Beside Zdazl itself, two additional Zdazl targets were also identified in zebrafish. 
Tdrd7, (which is expressed in zebrafish PGCs) is down-regulated by microRNA 
miR-430, (Takeda et al., 2009), and Zdazl inhibits the microRNA-mediated 
repression and activate the expression of Tdrd7 by stabilising its mRNA, possibly by 
inducing polyadenylation at the same time, which is consistent with Collier et al. 
(2005). Both the GUUC and GUUA elements were found on the 3’-UTR of Tdrd7, 
and when mutated (GU→CA) in the 3’-UTR attached to a GFP reporter gene, the 
stimulation effect is lost (Takeda et al., 2009). Zdazl is also a target of miR-430, and 
can protect its own mRNA from degradation and stimulate protein expression 
(Takeda et al., 2009). A similar protective effect of Zdazl on HuB, another germ 
cell-specific maker that is expressed maternally, was also investigated (Wiszniak et 
al., 2011). 3’-UTR-mediated degradation of HuB was detected in differentiated 
somatic cells during embryo development, however both the mRNA and protein 
levels of an mCherry reporter fused to the HuB 3’-UTR were increased in somatic 
cells overexpressing Zdazl (Wiszniak et al., 2011). The F91A mutation of Dazl 
(Maegawa et al., 2002), which leads to loss of RNA-binding capacity, prevented this 
effect (Wiszniak et al., 2011). Therefore, Zdazl may function to both stabilise HuB 
and/or stimulate its translation. In contrast to Tdrd7, the defined GUUC motif is not 
found on the 3’-UTR of HuB, instead a 30-nucleotide sequence may act as the Zdazl 
recognition site (Wiszniak et al., 2011). 
In mammals however, the sequence (G/CUn)n has been confirmed as a DAZL 
binding site by several studies, and a lot of potential mRNA targets have been 
identified, mostly in rodents. Reynolds et al. (2005) isolated several potential Dazl 
mRNA targets in both rat and mouse using co-immunoprecipitation and microarrays, 
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and identified the Mvh as a definitive Dazl target. Almost all the potential Dazl 
targets contain the (G/CUn)n
 motif, or be more accurate, U(2-10)[G/C]U(2-10), and 
five putative binding sites were found in the 3’-UTR of Mvh (Reynolds et al., 2005). 
Binding of Dazl to the Mvh 3’-UTR was completely abolished when all the five sites 
were mutated (Reynolds et al., 2005). Injecting Xenopus oocytes with Dazl-encoding 
RNA, followed by injection of RNA encoding a luciferase reporter gene fused to the 
Mvh 3’-UTR confirmed that Dazl enhances Mvh translation (Reynolds et al., 2005). 
In addition, the similar phenotypes (meiosis arrest around leptotene/zygotene) 
observed between Dazl and Mvh null mice, and the low level of Mvh protein in the 
testes of Dazl-deficient mice, also provide further evidence that Mvh translation is 
stimulated by Dazl (Reynolds et al., 2005).  
Sycp3 was also identified as a Dazl target (Reynolds et al., 2007). Both mouse and 
rat Sycp3 contain the U(2-10)[G/C]U(2-10) motif in their 3’-UTRs, and direct 
binding of Dazl RRM to mouse Sycp3 3’-UTR was confirmed (Reynolds et al., 
2007). Furthermore, Dazl could also stimulate the translation of luciferase reporter 
conjugated to the Sycp3 3’-UTR, and mutation of the binding sequence ablated the 
increase in luciferase activity (Reynolds et al., 2007). The relationship between Dazl 
and Sycp3 was also investigated in vivo; by crossing C57BL/6 Dazl heterozygote 
mice to CD1 Dazl+/+ mice and then intercrossing the offspring, to recapitulate the 
original Dazl-deficient mice that were generated on an outbred background 
(Reynolds et al., 2007, Ruggiu et al., 1997). The male mice displayed meiosis arrest 
at leptotene/zygotene at 7 days after birth, and the protein level of Sycp3 decreased 
to between 11 and 55 percent of that in wild type mice, suggesting that Dazl 
stimulates, but is not essential for, the translation of Sycp3 in vivo (Reynolds et al., 
2007). In addition, Dazl is also necessary for RA-induced Stra8 expression, and other 
meiosis markers Dmc1, Spo11, Sycp3 and Rec8 all decreased in Dazl knockout mice 
(Lin et al., 2008), although a direct RNA-protein interaction for these mRNAs has 
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not been proven (except for Sycp3). Although not investigated in the same depth as 
Mvh and Sycp3, mouse Tex19.1, Testis-specific serine kinase (Tssk)1, 2 and 4 are also 
reported to be potential mRNA targets of Dazl (Zeng et al., 2008, Zeng et al., 2009). 
These mRNAs all contain the U(2-10)[G/C]U(2-10) binding sites on their 3’-UTR 
and are found to be bound directly by Dazl. Surprisingly, the translation of Tex19.1 
seems to be repressed, rather than increased, by Dazl when Dazl and luciferase 
reporter fused with Tex19.1 3’-UTR are co-injected into zebrafish embryo (Zeng et 
al., 2009).  
Beside Tex19.1, a repression function of Dazl on its mRNA targets has recently been 
reported in mouse by several groups, and is mainly related to roles in stem cell 
pluripotency and/or differentiation (Chen et al., 2014, Xu et al., 2013). As discussed 
in Section 1.4.2.1 and 1.4.2.2.3, one study identified a new mouse Dazl variant 
Dazl_Δ8, and suggests that it down regulates the translation of Mvh, Oct3/4 and Sox2 
in mouse embryonic stem cells (Xu et al., 2013). This research is extended by a 
recent report, which investigated Dazl function in both ES cell- derived PGC-like 
cells and PGCs in vivo (Chen et al., 2014). During the differentiation of ES cells, 
Dazl expression initially declines, but then increases again at later stages, 
accompanied with dynamic expression changes of stage-specific germ cell markers, 
and is consistent with the gene expression pattern during germ cell development in 
vivo (Chen et al., 2014). Cytoplasmic granular Dazl expression was also observed, 
which is consistent with Xu et al. (2013)’s study as well (Chen et al., 2014).  
Several new co-factors of Dazl, i.e. Insulin-like growth factor 2 mRNA binding 
protein 1 (IGF2BP1), Fragile X mental retardation protein (FMRP), Fragile X mental 
retardation (FXR)1 and 2) were identified and co-localised with Dazl granules, and 
FMRP is known as a translation inhibitor (Chen et al., 2014). Using RIP and 
microarrays, 120 potential Dazl targets with proper Dazl binding sites were 
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identified, among which Sox2, Sall4, Suppressor of zeste 12 homolog (Suz12), Zinc 
finger protein 42 (Zfp42) and Zic family member of the cerebellum 3 (Zic3) are 
involved in the maintenance of pluripotency, and Sox2, Sall4 and Suz12 proteins are 
expressed in the gonads of Dazl-deficient mice whilst they are absent in wild type 
mice, consistent with a failure of these germ cells to differentiate. In addition, the 
translation of apoptosis-associate genes Caspase2, 7 and 9 are also down-regulated 
by Dazl in fetal mice gonads, suggesting that Dazl may also act to prevent apoptosis 
(Chen et al., 2014). However, the function of Dazl in limiting pluripotency is partly 
challenged by another report, which indicated that loss of Dazl in fetal male gonads 
resulted in reduced expression of pluripotency markers such as Nanos2 and 3, Pum2, 
Stella and Oct4 whereas the opposite was true in females (Haston et al., 2009). The 
reportedly reduced Sycp3 expression is consistent with previous study however, and 
Sycp3 protein alignment, i.e. proper loading on chromosomes, is also affected by 
Dazl knockout (Haston et al., 2009).  
Another candidate Dazl target is Tpx2, identified by Chen et al. (2011). It contains 
multiple Dazl binding sites and co-precipitated with Dazl protein from oocyte lysate. 
When Dazl is knocked down in oocytes, the activity of luciferase reporter fused with 
3’-UTR of Tpx2 also significantly decreased, suggesting that Tpx2 translation is 
directly up-regulated by Dazl binding to its 3’-UTR (Chen et al., 2011). 
Far fewer potential DAZL target mRNAs have been identified in humans, but the 
regulation of VASA and SYCP3 by DAZL seems to be conserved between humans 
and mice (Kee et al., 2009), although more evidence is needed. In differentiating 
human ES cells, the percentage of VASA-positive cells is significantly reduced when 
DAZL is silenced by shRNA, and could be rescued by overexpressing DAZL. The 
percentage of cells showing properly-elongated SYCP3 is also increased by 
overexpressed DAZL in both XX and XY ES cells, suggesting that SYCP3 could be 
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a human DAZL target as well (Kee et al., 2009). However, direct binding between 
these two targets and human DAZL has not been confirmed so far. Using yeast 
three-hybrid assay, SDAD1 was shown to be bounds by with DAZL and its co-factor 
PUM2 through its 3’-UTR, but the effect of DAZL on SDAD1 mRNA translation 
remains unknown (Fox et al., 2005). Similarly, human TSSK1, 2, 4 and 5 are also 
reported to be bound by DAZL through their 3’-UTRs but no further investigation 
was performed so far (Zeng et al., 2008). 
The binding site of DAZL was also investigated on molecular basis by studying the 
crystal structure of RRM from Dazl, the GUU triplet were reported as the sufficient 
RNA recognise motif, and again the RRM of DAZL alone is confirmed to be 
responsible for RNA-binding by kinked and extended β strands (Jenkins et al. , 
2011). This study also provided the molecular explanation of the aforementioned 
Arg115→Gly115 mutation in humans which is associated with premature ovarian 
failure and sterility (Tung et al., 2006c), as the Arg115 directly contacts with the U3 
in GUU triplet and therefore the mutation leads to severe 50-fold weaker 
RNA-protein interaction when compared to wild type. It also confirmed direct 
binding between Dazl and Mvh or Sycp3, and pointed out that multiple Dazl 
molecules could bind to several copies of GUU in a single RNA (Jenkins et al., 
2011).  
In conclusion, DAZL mRNA targets are identified in a range of species, and cover 
both germ cell development and differentiation. DAZL not only stimulates 
translation, but also could increase mRNA stability or repress translation. However, 
only Mvh and Sycp3 have been confirmed to be Dazl targets in vivo so far with 
sufficient evidence, and all the other targets identified so far, especially those in 
human, are still putative. Furthermore, the novel repression and mRNA stabilisation 
functions of Dazl have only been identified in mouse and zebrafish respectively, and 
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are yet to be confirmed with more evidence and expanded to more species. It is also 
worth pointing out that most of this work has only been performed in males, and 
despite Dazl-deficient female animals and humans displaying various subfertility 
phenotypes, little is known about Dazl’s role(s) during oogenesis. Therefore, to 
understand how DAZL functions during germ cell development, it is important to 
identify human DAZL targets, especially in females, and find out how they are 
modulated as well. 
 
1.4.3 BOLL 
1.4.3.1 BOLL functions and Co-factors 
Despite being the ancestor and the first member identified in DAZ family, studies on 
BOLL are very limited when compared with DAZL.  
Like DAZL, BOLL also interacts with proteins from PABP family, although this 
interaction was only confirmed by yeast two-hybrid assay using the C-terminus of 
PABP1 (Collier et al., 2005). The stimulation of translation by human BOLL was 
also confirmed by tethered luciferase assay (Collier et al., 2005). Another common 
co-factor of DAZL and BOLL is PUM2, which can interact with BOLL homodimers 
in a two-hybrid yeast assay (Urano et al. , 2005). However, the mechanism of 
BOLL-PUM2 interaction seems to be different from the DAZL-PUM2, and 
BOLL-PUM2 cannot bind with the 3’-UTR of SDAD1, which is a potential mRNA 
target of DAZL-PUM2 complex (Urano et al., 2005). 
In C. elegans, cpb-3 was identified as a co-factor of boll in vivo as well, because they 
are partly co-expressed in the gonads, and can be co-precipitated with each other 
from worm extracts when performing immunoprecipitation using antibodies to either 
protein (Hasegawa et al. , 2006).  
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Because of the lack of research, the mode of BOLL action is still unknown; however, 
as it also interacts with PABP1 and stimulates translation, it is possible that BOLL 
functions through a similar pathway as DAZL (See section 1.4.1 and Figure 1.3). 
 
1.4.3.2 BOLL expression, functions and phenotypes in model animals 
Although not as widely investigated as DAZL, BOLL expression has been described 
in various model animals including Drosophila, worms, fish, mouse, goats and cows. 
The association between bol and infertility was first identified in Drosophila in 1993, 
by globally generating and screening gene mutations which cause male sterility 
(Castrillon et al., 1993). The genes identified were associated with defects of 
different stages during germ cell development, and bol was categorised as a meiotic 
entry defect, as meiosis did not occur and germ cells formed abnormal 
multi-nucleated cells, or contained various sizes of nuclei (Castrillon et al., 1993). 
The nebenkern, a special mitochondrial structure in insect male germ cells also 
became abnormally large, which all pointed to abnormal nuclear division 
accompanied by lack of cytokinesis (Castrillon et al., 1993). Therefore, bol seems to 
be necessary for spermatogenesis in Drosophila. Further investigation revealed that 
bol is only expressed in the germ cells of male flies, and indeed, bol-deficient 
females are still fertile (Eberhart et al., 1996). Despite their spermatocytes being 
normal, flies with either decreased bol expression or truncated bol transcripts (3.0kb 
to 1.1kb) display similar spermatogenesis defects, including no entry of meiosis, 
arrest at meiotic prophase or completely loss of germ cells (Eberhart et al., 1996), 
and this could be partially rescued (increased meiotic and post-meiotic germ cells) by 
germline transformation with a human BOLL expression vector (Xu et al. , 2003). 
The meiosis defects are caused by abnormal behaviour of a cell cycle-related protein 
Cyclin A, which is degraded in the nuclei of wild type germ cells soon after the 
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G2/M transition, but persists in those of bol mutants. Subsequently, the centrosomes 
failed to reach the poles, and both separation of chromosomes and nuclear division 
stopped, causing meiosis arrest before metaphase (Eberhart et al., 1996). With 42% 
conservation, the human BOLL transgene could also partly rescue the phenotypes of 
Drosophila bol mutation, and the morphology of germ cells is undisguisable with 
that of germ cells rescued with fly bol; however, neither of the transgenes 
successfully restored fertility. Further analysis suggests that 11 genes which show 
reduced expression in bol mutants are restored by both transgenes, including the 
potential bol target twine (Xu et al., 2003) (see Section 1.4.3.4). 
In contrast to the exclusive expression in germline of other animals, Drosophila bol 
was also found expressed endogenously in neurons during metamorphosis, and 
seems to act as a negative factor of axon pruning. However, this was only observed 
when bol is overexpressed in neurons, and loss of bol did not show any obvious 
effect and therefore it might be redundant rather than necessary during this process 
(Hoopfer et al. , 2008). 
boll null-mutation in C. elegans also shows a sex-biased phenotype but only in 
hermaphrodites rather than in males, and the sperm produced by hermaphrodites is 
not affected. No oocytes were found in the gonads of boll-deficient hermaphrodites, 
therefore, boll in C. elegans is crucial for oogenesis (Karashima et al. , 2000). 
Further examination suggests that pre-meiotic mitosis is normal, but meiosis is 
arrested at pachytene in female germ cells in boll mutant worms, with mitotic-like 
small nuclei, and cell death by apoptosis (Karashima et al., 2000). The defects seen 
in boll mutants partially overlap with those caused by cpb-3 mutation, which 
includes deficient oogenesis and pachytene arrest, and as they show partial 
co-localisation in vivo, the two proteins may share similar functions or act together at 
specific stages of oogenesis (Hasegawa et al., 2006). The female-specific function of 
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worm boll was confirmed using mutant feminised or masculinised hermaphrodites; 
loss of boll resulted in no mature oocytes being formed but normal spermatogenesis 
in these two mutants respectively (Karashima et al., 2000). Consistent with its 
pachytene arrest phenotype, C.elegans boll transcripts show dynamic expression 
changes during germ cell development; expression commences prior to meiosis, 
accumulates at the mitosis to meiosis transition and is most abundant at pachytene, 
before being dramatically down-regulated in mature oocytes (Karashima et al., 
2000).  
boll expression and phenotypes were also investigated in flatworm (Macrostomum 
lignano), a less popular model animal (Kuales et al. , 2011). Three different splice 
variants (Macrostomum lignano boll (Macbol) 1, 2 and 3) were identified, all 
containing a conserved RRM and a DAZ repeat. Both Macbol1 and 2 are expressed 
in the male germline, in primary spermatocytes or secondary 
spermatocytes/spermatids respectively (Kuales et al., 2011). Knockdown of Macbol1 
with RNAi caused increased size of the testes but an absence of mature sperm, due to 
degenerated primary spermatocytes at later stages (Kuales et al., 2011). Oogenesis 
and the morphology of spermatogonia and early spermatocytes are unaffected 
(Kuales et al., 2011). Knockdown of Macbol2 had no effect on gametogenesis. 
Interestingly, like human and Drosophila boll, Macbol1 could also partially rescue 
the boll-mutant phenotypes in flies, although the rescued animals are still sterile and 
produce sperm with abnormally-shaped nuclei (Kuales et al., 2011). Macbol3 is 
expressed in oocytes and developing eggs, but not in oogonia or early oocytes. 
Knockdown of Macbol3 resulted in disrupted egg maturation and sterility, but early 
oogenesis, including meiosis seemed to be unaffected (Kuales et al., 2011). This is 
distinct from the Macbol1 phenotypes in male germline and meiosis arrest 
phenotypes in flies and C.elegans. 
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boll expression has also been described in fish, namely rainbow trout and medaka (Li 
et al., 2011a, Xu et al. , 2009). In rainbow trout, boll is expressed in the germ cells of 
both sexes. In female, it is expressed by differentiating oogonia just prior to meiosis, 
increases at meiosis and then decreases (Li et al., 2011a). It also shows dynamic 
distribution at different stages of oogenesis (Li et al., 2011a). In oogonia, it forms 
small particles around the nucleus, then is distributed evenly in small oocytes, but 
forms condensed patches later and re-disperses again shortly afterwards (Li et al., 
2011a). In contrast, during spermatogenesis boll expression peaks at the 
spermatogonia stage and is barely detectable in spermatids (Li et al., 2011a). 
Notably, although boll is co-expressed with dazl in same oocyte, they are distributed 
in different regions, which is consistent with Xu et al. (2009)’s finding in medaka. In 
males, dazl and boll mRNA show different expression patterns – boll is distributed 
evenly whilst dazl forms speckles (Xu et al., 2009). In medaka, boll is also expressed 
in both sexes (Xu et al., 2009) . However, unlike the male rainbow trout, boll 
expression is most abundant in meiotic spermatocytes, and it shows a distinct 
spatial-temporal distribution compared to dazl, which is most abundant in 
spermatogonia, decreases in spermatocytes and is undetectable in spermatids (Xu et 
al., 2009). In female medaka, boll expression persists from pre-meiotic stage, is weak 
in oogonia and peaks at early meiosis, and is distributed differently from dazl 
transcripts as described before (Xu et al., 2009). In addition, boll is also detectable in 
early medaka embryos, which implies maternal origin and later becomes exclusively 
expressed in migrating and post-migrat ory PGCs (Xu et al., 2009). However, the 
phenotypes associated with boll-deficiency have not been investigated in fish so far; 
therefore its relationship with dazl and functions during germ cell development 
remain unknown.  
In the mouse, Boll is highly expressed in adult testis but not in ovary, although low 
levels of transcript are detectable in fetal ovaries (Shah et al. , 2010), and Xu et al. 
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(2001) predicted that it is probably not expressed at protein level in the ovary. Boll 
protein is undetectable in PGCs or spermatogonia, but occurs in the cytoplasm of 
spermatocytes and is expressed through meiosis, most abundantly at late pachytene 
or diplotene and persists until the spermatid stage (Xu et al., 2001). A Boll-mutant 
(lacking the RRM) outbred mice strain was generated to study its function, and it 
again shows a sex-specific phenotype - only the Boll mutant male mice are sterile, 
whilst female are fertile with no significant difference of litter size with wild type or 
heterozygotes (VanGompel and Xu, 2010). The male mice do not produce elongating 
spermatids or mature sperm, and this seems to result from a block during 
spermatogenesis, which is comparable with the Drosophila bol phenotype (Shah et 
al., 2010). However, in-depth studies reveal that the block does not occur at meiosis 
but is post-meiotic (VanGompel and Xu, 2010). Meiosis progresses normally in the 
Boll-mutant mouse testis when checked with either morphology of germ cells or 
meiosis markers (Sycp3, Replication protein A (RPA) and MutL homolog (MLH)) 
staining, and the abnormality happens at the round spermatid stage (VanGompel and 
Xu, 2010). Most round spermatids do not mature but form multinuclear giant cells 
(cysts) and then enter apoptosis (VanGompel and Xu, 2010). This phenotype is not 
associated with any significant expression change of known spermatogenesis factors 
and therefore may indicate that Boll is regulating the maturation of round spermatids 
through a novel, unknown pathway (VanGompel and Xu, 2010). 
Finally, Boll expression has also been studied in large mammals such as goat and 
cow (Li et al. , 2013b, Zhang et al. , 2009). In goat, Boll is detected at a very low 
level before and during puberty, and is highly expressed in germ cells of adult testis 
at both mRNA and protein levels (Li et al., 2013b). It also shows low or no 
expression in the testes of animals with azoospermia (Li et al., 2013b). Although the 
Boll-null phenotype has not been investigated in goat, overexpression of Boll in male 
germ stem cells (mGSCs) leads to increased expression of several germ cell or 
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meiosis markers, including Stra8, Sycp3, Cdc25a, Cdc2 and Vasa, suggesting that 
Boll may promote meiosis in male goats (Li et al., 2013b). Similarly, bovine Boll is 
also highly expressed in the adult testis, and is low or undetectable in testis with 
spermatogenesis defects such as in cattle-yaks (Zhang et al., 2009). 
To conclude, Boll expression and phenotypes strongly indicate that it is associated 
with germ cell development, but is sex-biased and related to different stages of 
gametogenesis depending on species.  
 
1.4.3.3 BOLL expression and human subfertility 
The expression pattern of BOLL in human gonads and its relationship with 
subfertility phenotypes have been widely studied, but almost only in males.  
Xu et al. (2001) first investigated human BOLL in detail, and found that it is located 
on Chromosome 2. In human testis, BOLL is expressed at both mRNA and protein 
levels, and seems to be undetectable in ovary using Northern blotting (Xu et al., 
2001). An anti-BOLL antibody was also generated, and it reveals that BOLL protein 
is expressed from the pachytene spermatocyte stage, peaks at late pachytene and 
persists during meiosis until the early spermatid stage in human adult testis, similar 
to the pattern seen in mice (Xu et al., 2001). However, another study suggests that 
BOLL protein is expressed from leptotene, peaks at pachytene and begins to reduce 
at diplotene, finally disappearing in round and elongating spermatids (Luetjens et al., 
2004). Consistent with this study, research on human and primates testes suggests 
that BOLL protein expression is restricted to the germ cells at first meiotic division, 
begins at zygotene and peaks at pachytene; but this pattern varies in five primate 
species, from restricted pachytene expression to persistent post-meiotic expression in 
round spermatids (Tung et al., 2006a). Again, this is confirmed by Kostova et al. 
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(2007)’s study, which suggests that BOLL protein is only expressed during meiosis I 
and is most abundant at pachytene. This expression pattern is different from that of 
DAZ or DAZL, which are abundant in both the nuclei and cytoplasm of 
spermatogonia, as well as in the cytoplasm of meiotic spermatocytes (Xu et al., 
2001).  
As in flatworms, three kinds of BOLL variants namely B1, B2 and B3 are also 
identified in human due to different splicing of exon 1, and are expressed in the 
normal testes roughly at the relative ratio of 80:220:1 (Kostova et al., 2007). The 
levels of all three in patients with meiosis arrest show a shifted ratio of B1:B2:B3 to 
209:190:1, in another word, increased B1 ratio is negatively related with successful 
meiosis; therefore B2 may be most important whilst B1 may have negative regulatory 
functions in spermatogenesis (Kostova et al., 2007). Several other studies also 
correlated BOLL expression to male reproductive phenotypes. Luetjens et al. (2004) 
found that BOLL mRNA is completely missing in the testes of 18 patients with 
complete meiosis arrest despite spermatocytes being present, and decreased BOLL 
expression is found in twelve patients with mixed atrophy (display variable levels of 
spermatogenic damage in tubules). Although three additional patients had germ cells 
more advanced than spermatocytes, BOLL expression was still absent in their testes 
(Luetjens et al., 2004). In two other studies, BOLL expression has been tested for 
predicting the success of sperm retrieval in patients with spermatogenic failure using 
testicular sperm extraction (Lin et al. , 2005) (Kleiman et al. , 2011). One of the 
studies suggests that the threshold level of BOLL to distinguish the success or failure 
of sperm retrieval is 0.5 relative to GAPDH with a 100% specificity and sensitivity, 
and it may also represent the lowest level of BOLL required for the completion of 
meiosis (Lin et al., 2005). Other research investigated the potential of both BOLL 
and Chromodomain protein, Y-linked 1 (CDY1) for prediction of the retrieval of 
sperm. Despite the increased level of BOLL transcripts again are found to be an 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
Chapter 1. Literature Review 
63 
 
effective measure of whether sperm retrieval will be successful, it is less sensitive 
when compared with CDY1, and the latter alone is sufficient for prediction (Kleiman 
et al., 2011). 
In conclusion, human BOLL is expressed mainly during the first division of meiosis 
and most abundant at pachytene, and its transcription level is positively correlated 
with the production of mature sperm. Although the mechanism is unknown, based on 
its expression period and ability of promoting G2/M transition in bol-mutant flies 
(Xu et al., 2003), human BOLL is most likely to be crucial for spermatogenesis and 
play a role during meiosis prophase I, especially at G2/M transition and pachytene. 
However, although Shah et al. (2010) reported that Boll mRNA is expressed in 
mouse ovary, all the research has been based on the male, which is probably due to 
the prediction that it is not translated in the ovary (Xu et al., 2001). Indeed, BOLL 
shows sex-biased expression and phenotypes in model animals. Therefore 
considering its comparable expression between human and mouse, it is still possible 
that human BOLL mRNA is expressed during fetal life in the ovary as well.  
 
1.4.3.4 Potential targets of BOLL 
The recognition motif of BOLL has not been investigated so far, and therefore it is 
difficult to identify its potential mRNA targets. However, when investigating the 
DAZL binding motif, Jenkins et al. (2011) mentioned that despite BOLL not being 
able to absolutely recognise the GUU triplet sequence in mRNAs that DAZL does, 
the conservation of β strand structures may indicated that the mode of RNA 
recognition is conserved between DAZ family proteins. A study on zebrafish also 
suggests that the Zdazl could bind to the potential boll target twine (see below), and 
the Zdazl binding motif GUUC is also found on the 3’-UTR of twine (Maegawa et 
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al., 2002). This possibly indicates that DAZL and BOLL share some common 
recognition sequences, and therefore possibly share mRNA targets. 
As early as the Drosophila bol phenotypes were defined in 1996, Eberhart et al. 
(1996) already realised that these phenotypes are identical to those of twine 
mutations, a homologue of mammal CDC25 phosphatase which is required for 
meiosis initiation. Disruption of twine causes failure of entry into meiosis (Castrillon 
et al., 1993), and a single nucleotide mutated twine allele tweZ0758 leads to arrest after 
the first meiosis division in male Drosophila (Maines and Wasserman, 1999). The 
phenotype of the latter mutation was caused by reduced transcription of twine, and 
homozygous tweZ0758 flies with only one copy of bol failed to enter meiosis, identical 
to flies with complete loss of bol or twine (Maines and Wasserman, 1999). It was 
possible therefore that twine was regulated by bol. Consistent with this, the 
expression of a twine reporter gene was found to be decreased in bol mutant flies, 
and twine expression independent of bol was sufficient to rescue the meiosis 
initiation phenotype in bol-mutant Drosophila, both further suggest that bol regulates 
the translation of twine (Maines and Wasserman, 1999). 
In humans, CDC25A has been reported to be regulated by BOLL (Lin et al. , 2009). 
CDC25A mRNA is co-precipitated using anti-BOLL antibodies from extracts of 
BOLL transfected HeLa cells (Lin et al., 2009), and it is detected using RT-PCR with 
primers against 3’-UTR of CDC25A, which suggests that BOLL directly binds with 
the 3’-UTR of CDC25A (Lin et al., 2009). A 21-nucleotide sequence 
(AGGUGUAGGUGGGUUUUUCUU), which is conserved among vertebrates, 
appears responsible for the RNA recognition by BOLL, as it alone is sufficient to 
form a RNA-protein complex with BOLL (Lin et al., 2009). Mutation of this motif 
from UUUUU to CCCCC reduces the binding efficiency, suggesting that the U-rich 
region is necessary for BOLL recognition and binding (Lin et al., 2009). Whilst 
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co-transfecting BOLL with luciferase reporter fused with CDC25A 3’-UTR in HeLa 
cells results in increased luciferase activity (indicating increased translation of the 
reporter mRNA), the CDC25A mRNA level is unaffected after BOLL transfection 
(Lin et al., 2009). This effect disappears if the 21-nucleotide recognition sequence is 
absent in the reporter mRNA, suggests that BOLL is stimulating the translation of 
CDC25A through its 3’-UTR (Lin et al., 2009). In vivo, CDC25A is first expressed in 
the cytoplasm just prior to metaphase of meiosis I and persists until spermatid 
elongation, which partly overlaps with BOLL expression (Lin et al., 2009). In 
patients with spermatogenic failure, both BOLL and CDC25A protein levels are 
decreased, due to reduced number of spermatocytes (Lin et al., 2009). CDC25A 
protein is also undetectable in men with complete meiosis arrest accompanied by 
absence of BOLL (Luetjens et al., 2004), suggesting that CDC25A is possibly 
regulated by BOLL in human testes. 
Besides CDC25A, Stra8 has also been identified as a potential Boll target mRNA in 
goat (Li et al., 2013b). Both mRNA and protein levels of a luciferase reporter 
conjugated with goat Stra8 3’-UTR are up-regulated after co-transfected with Boll in 
goat mGSCs, and this is likely a direct regulation (Li et al., 2013b). In addition, both 
Boll and Stra8 protein expression could be promoted by RA treatment in 
Boll-transfected goat mGSCs (Li et al., 2013b), again implying that Boll is 
functionally-associated with meiosis. 
Finally, although it remains unclear whether BOLL is expressed in the human ovary, 
it is worth mentioning that BOLL can regulate VASA expression in human XX but 
not XY ES-derived PCG-like cells (Kee et al., 2009). Silencing of BOLL does not 
significantly decrease the number of VASA-GFP positive cells, but overexpressing 
BOLL strongly promoted the number of these cells (Kee et al., 2009). Similarly, 
BOLL could also promote the elongation of SYCP3 during synaptonemal complex 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
Chapter 1. Literature Review 
66 
 
formation in germ cells derived from both XX and XY cells (Kee et al., 2009). 
Therefore, VASA and SYCP3 also could be regulated by BOLL, and BOLL might 
have distinct functions and be important during human oogenesis as well as 
spermatogenesis. In this case, it is necessary to find whether BOLL is expressed 
during oogenesis in the human ovary, especially during fetal life, and investigate how 
it regulates meiosis by looking for its potential mRNA targets. 
 
1.5 Aims of PhD 
The critical stages of human oogenesis - germ cell differentiation and entry of meiosis 
- occur during fetal life. Compared to the extensive studies performed on human testis, 
knowledge of how this process is regulated in the ovary remains limited.  
The DAZ family RNA-binding proteins (DAZ, DAZL and BOLL) are crucial 
regulators of germ cell development and meiosis. As DAZ is Y-linked, only DAZL and 
BOLL may play a role during human oogenesis. Although DAZL is known to be 
expressed in the human fetal ovary, whether BOLL is expressed is unclear. DAZL 
mutations are associated with subfertility phenotypes and reproductive parameters in 
both sexes, including premature ovarian failure, early menopause, azoospermia and 
(motile) sperm count, although the mechanisms underlying these are unknown. Our 
understanding of DAZL and BOLL functions is restricted by the lack of identified 
human DAZL/BOLL mRNA targets, although some have been identified in mice and 
other model organisms.  Therefore, to understand how DAZL and BOLL regulate 
germ cell development in the human fetal ovary, it is necessary to determine their 
expression patterns, and identify the target mRNAs they regulate. 
Based on the information above, I propose the following hypotheses: 
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1. DAZL and BOLL show different expression patterns during human oogenesis, 
and these expression patterns may reflect distinct roles for these proteins in 
regulating this process. 
2. DAZL plays a critical role in regulating human oogenesis by controlling the 
translation of mRNAs encoding key proteins involved in germ cell 
development. 
 
The work in this thesis aimed to test these hypotheses, by addressing the following 
specific research questions: 
1. Where and when are DAZL and BOLL expressed in the human fetal 
ovary, and what is the relationship between their expression patterns?  
As BOLL protein expression in the testis peaks at pachytene, it is likely to appear in 
the fetal ovary during the early stages of meiosis prophase I if it is expressed in the 
females, but little is known about its expression in the female fetus. DAZL is known be 
to expressed in the human fetal ovary, but the relationship between DAZL expression, 
BOLL expression, and germ cell development remains unclear. Thus, the first aim of 
this thesis is to address hypothesis 1 above, by to establishing a detailed expression 
profile for DAZL and BOLL in the human fetal ovary to reveal their possible functions 
during oogenesis.  
 
2. What are the mRNA targets of human DAZL and BOLL? 
DAZL and BOLL are RNA-binding proteins, which modulate germ cell development 
by regulating the translation, and potentially the stability of their mRNA targets. 
Therefore, to understand the functions of DAZL and BOLL, identifying their mRNA 
targets is essential. Although some mRNA targets have been identified in model 
organisms, and Dazl and Boll mutant phenotypes likely arise from dysregulated target 
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mRNA expression/translation, no definitive mRNA targets have been identified in 
humans except CDC25A. Thus, the second aim of this thesis is to address hypothesis 2 
above, by establishing whether putative mRNA targets of DAZL and BOLL that have 
previously been identified in mice are regulated by human DAZL or BOLL, and to 
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Chapter 2 General Materials and Methods 
2.1 Cloning and transformation 
2.1.1 Preparation of LB agar dishes and broth 
Luria Bertani (LB) agar plates were prepared by dissolving one pack of LB Agar 
EZMix Powder (Sigma-Aldrich, Dorset, UK) in 500ml dH2O, and autoclaving.  
Autoclaved agar was melted in a microwave oven, and allowed to cool to 55°C 
before the addition of antibiotics (ampicillin (Sigma-Aldrich; final concentration of 
100μg/ml) or kanamycin (Sigma-Aldrich; final concentration of 25μg/ml – both from 
1000× stocks diluted in dH2O and filter sterilized using 0.22μm membrane filter 
(Millipore, Watford, UK) and stored at -20°C)).  To prepare LB agar plates, LB agar 
containing antibiotics was poured into 10cm dishes (about 20-25ml per dish 
(Greiner-BioOne)), left for 5-10min to solidify, then stored upside down at 4°C for 
up to 1 month.  Before culture, the dishes were warmed at 37°C, with lids opened 
upside down for 30min to remove excess water.  
LB broth was made from the LB Broth powder (Sigma-Aldrich) by dissolving 20g 
LB Broth powder in 1L dH2O which was then sterilized by autoclaving.  Antibiotics 
were added as required at the concentrations detailed above.  
2.1.2 Transformation of competent E.coli 
To amplify vectors, DH5α Escherichia coli (E. coli; Library Efficiency DH5α 
Competent Cells (Invitrogen, Paisley, UK) or NEB 5-α Competent E. coli (High 
Efficiency; New England Biolabs, Herts, UK) were used for transformation. 10ng 
plasmid DNA was mixed with 50μl competent E. coli and incubated on ice for 30min, 
followed by heat shock at 37°C for 1min, or at 42°C for 40 seconds (s). The E. coli 
were then incubated on ice for 2min, mixed with LB broth (no antibiotics) to achieve 
final volume of 1ml and cultured at 37°C, 200 revolutions per minute (rpm) in a 
1.5ml eppendorf tube. After 45min, 100μl of the culture was spread onto a 10cm LB 
agar plate, and the remaining 900μl centrifuged at 5000rpm for 3min, the supernatant 
discarded and the pellet resuspended in 100μl LB broth and spread onto a 10cm LB 
agar plate (to achieve final seeding densities of 1/10th and 9/10th).  Both plates were 
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stood face up for 5min to allow the liquid to be absorbed before being incubated at 
37°C overnight inverted.  
 
2.2 Plasmid DNA Extraction 
2.2.1 Mini-preparation of plasmid DNA from bacteria (mini-prep) 
Individual E. coli colonies were picked and inoculated into 5ml LB broth containing 
antibiotics in a 50ml polypropylene tube (Greiner Bio-One, Stonehouse, UK), and 
incubated at 37°C, with shaking at 220rpm overnight.  For mini-preps, the High 
Pure Plasmid Isolation Kit (Roche Applied Sciences, West Sussex, UK) was used as 
per the manufacturer’s instructions. 3-5ml of the bacterial culture was centrifuged at 
5000rpm for 3min, the supernatant discarded, and the pellet resuspended in 250μl 
Suspension Buffer (2.5mg RNase A added into 25ml buffer and stored at 4°C before 
use). 1 volume of Lysis Buffer was added and mixed gently by pipetting.  After 
5min incubation at room temperature, 350μl ice-cold Binding Buffer was added to 
the lysate and mixed vigorously by shaking, followed by 5min incubation on ice. The 
lysate was then centrifuged at maximum speed for 10min and the supernatant 
transferred to a High Pure filter tube.  The column was then centrifuged at 
maximum speed for 1min to remove the excess liquid, and then washed by adding 
700μl Wash Buffer II to the column and spinning at 13000g for 1min.  The column 
was finally placed in a nuclease-free 1.5ml eppendorf tube, and the plasmid DNA 
eluted by adding 100μl dH2O to the column and centrifuging at 13000g for 1min. 
2.2.2 Maxi-preparation of plasmid DNA from bacteria (Maxi-Prep) 
Individual E. coli colonies were picked and inoculated into 5ml LB broth containing 
antibiotics in a 50ml polypropylene tube (Greiner Bio-One), incubated at 37°C , 
220rpm for 8 hours, and then added to added to 400ml LB broth (containing 
antibiotics) and cultured at 37°C, 220rpm overnight. For maxi-preps, the 
NucleoBond Xtra Maxi Plus kit (Machery-Nagel, Düren, Germany) was used 
according to the manufacturer’s instructions.  200-400ml E. coli were centrifuged at 
4700rpm at 4°C for 15min in SIGMA 6K15 high capacity centrifuge (Sigma 
Laborzentrifugen, Osterode am Harz, Germany). The pellets were resuspended in 
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12ml Buffer RES (10mg RNase A added to 150ml buffer and stored at 4°C before 
use) and transferred to a 50ml polypropylene tube (Greiner Bio-One).  Bacteria 
were lysed by adding 12ml Buffer LYS, inverting for 5 times to mix, and incubating 
at room temperature for 5min.  At the same time, a NucleoBond Xtra column was 
equilibrated by applying 25ml Buffer EQU to the rim of filter and allowing the 
column empty by gravity flow.  The bacterial lysis was stopped by neutralization 
with 12ml ice-cold Buffer NEU, and the tube inverted for 10-15 times to mix.  The 
suspension was immediately applied to the filter of equilibrated NucleoBond Xtra 
column.  When the column had emptied, the filter was washed by adding 15ml 
Buffer EQU and the flow-through discarded. The column was then washed again 
using 25ml of Buffer WASH (flow through discarded) and the plasmid DNA was 
eluted by applying 15ml of Buffer ELU to the column, and the flow-through/eluate 
collected.  To concentrate the plasmid, 10.5ml isopropanol was added to the 15ml 
eluate and mixed well by vortexing.  After 2min incubation at room temperature, 
the mixture was loaded into a 30ml syringe, and pressed slowly through the 
NucleoBond Finalizer.  The precipitate on the NucleoBond Finalizer was then 
washed by pressing 5ml 70% ethanol (prepared from absolute ethanol (VWR, 
Lutterworth, UK) and MilliQ-filtered dH2O) through the Finalizer, and finally dried 
by pressing air through the Finalizer for at least 6 times.  To elute the purified 
plasmid DNA, 1ml Buffer TRIS was pressed through the NucleoBond Finalizer 
using 1ml syringe, the flow-through collected and used to repeat the process. 
After elution, the concentration of plasmid from both mini- and maxi-prep was 
determined using NanoDrop 1000 Spectrophotometer (NanoDrop, Wilmington, 
USA), and the quality of plasmid was determined by 0.8% (w/v) agarose gel 
electrophoresis (see Section 2.5 above for the methods). 
2.2.3 Preparation of glycerol stocks of bacteria 
If necessary, 0.5ml transformed E.coli were mixed with 1 volume of sterilised 
glycerol for long-term storage at -80°C. 
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2.3 RNA extraction and cDNA synthesis 
2.3.1 RNA micro-prep 
For small-scale isolation of total RNA from cells and tissues, the RNeasy Micro-prep 
kit (QIAGEN, Crawley, UK) was used. Tissue or cells were first lysed in 350μl 
Buffer RLT (containing 1% (v/v) β-mercaptoethanol (β-ME; Sigma-Aldrich) and 
homogenized well using a hand-held pellet-pestle homogenizer and centrifuged in a 
benchtop microcentrifuge at 10000g for 2min. Lysates were stored at -20°C (short 
term) or -80°C (long term) or processed immediately by adding 1 volume of 70% 
(v/v) ethanol to lysate and mixing by pipetting. The mixture was loaded onto an 
RNeasy MinElute spin column and centrifuged at 10000g for 30s and the 
flow-through discarded. 350μl Buffer RW1 was added to the column and spun at 
10000g for 30s again to wash the precipitate, and the flow-through discarded. 10μl 
DNase I was diluted in 70μl Buffer RDD and applied to the membrane of the column 
to remove contaminating genomic or plasmid DNA for 15min at room temperature. 
The DNase was removed by adding 350μl Buffer RW1 to the column and spinning at 
10000g for 30s, and the collection tube and flow through discarded. The column was 
placed in a new collection tube, and the membrane washed by adding 350μl Buffer 
RPE and centrifuging at 10000g for 30s, followed by adding 500μl (v/v) 80% 
ethanol to the column and centrifuging at 10000g for 2min. The collection tube was 
replaced again, and the membrane was dried by spinning at max speed for 5min with 
the column lid open. The RNA was eluted by adding 14μl dH2O directly onto the 
membrane and spinning at max speed for 1min, and this step was repeated once 
using the flow-through to increase the yield. 
2.3.2 RNA mini-prep 
mRNA from cells grown in 10cm dishes or 6-well plates were extracted using the 
RNeasy Mini-prep kit (QIAGEN) and NucleoSpin RNA II kit (Machery-Nagel). 
For the RNeasy kit, cells were lysed by 600μl Buffer RLT (containing 1% (v/v) 
β-ME) and the lysate homogenized for 30s using a hand-held pellet pestle 
homogenizer. 1 volume of 70% (v/v) ethanol was added to the lysate, mixed by 
pipetting and the mixture transferred to an RNeasy column which was then 
centrifuged at 10000g for 30s, and the flow-through discarded. The column was 
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washed by adding 350μl Buffer RLT and spinning at 10000g for 30s, and the 
flow-through again discarded. 10μl DNase I was mixed with 80μl Buffer RDD, and 
directly applied on the membrane of column for 20min at room temperature to digest 
the DNA. The DNase I was removed by adding 350μl Buffer RW1 to the column and 
spinning at 10000g for 30s. The collection tube was replaced after this step, and the 
membrane washed by adding 500μl Buffer RPE and spinning at 10000g for 30s, and 
this step was repeated a second time, with the centrifugation time extended to 2min. 
To elute the RNA, columns were placed in a nuclease-free 1.5ml eppendorf tube and 
30-50μl nuclease-free dH2O was added to each column, and the columns were 
centrifuged at max speed 1min. This step was repeated using the flow-through to 
increase the RNA yield. 
When using the NucleoSpin kit, cells were lysed in 350μl Buffer RA1 containing 1% 
β-ME. The lysate was cleared by loading onto a NucleoSpin Filter and centrifuging 
at 11000g for 1min. 1 volume of 70% ethanol was added to the flow-through, and 
mixed well by pipetting. The samples were then loaded onto the NucleoSpin RNA II 
column, and spun at 11000g for 30s. The collection tube was replaced and the 
membrane of column was desalted by adding 350μl Buffer MDB to the column and 
centrifuging at 11000g for 1min, and the flow-through discarded. Contaminating 
DNA was digested by adding 95μl Reaction Buffer (containing 9.5μl rDNase I) to 
the membrane and incubating at room temperature for 15min. To stop the reaction, 
200μl Buffer RA2 was loaded to the column and spun at 11000g for 30s. The 
collection tube was replaced again, and the membrane was washed again by adding 
600μl Buffer RA3 to the column and centrifuging at 11000g for 30s, then adding 
250μl Buffer RA3 and centrifuging at 11000g for 2min. To elute the RNA, the 
column was placed in a nuclease-free 1.5ml eppendorf tube. 30-50μl of nuclease-free 
dH2O was added to each column, and the column centrifuged at 11000g for 1min. 
This step was repeated using the flow-through to increase the RNA yield. 
2.3.3 cDNA synthesis 
Before cDNA synthesis, the concentration of mRNA was determined by NanoDrop, 
and mRNA was diluted in dH2O (Ambion, Austin, USA) to a volume of 16μl. This 
was divided in two, and half of the mRNA (8μl, 500 or 1000ng) was used for + 
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reverse transcriptase (RT) reactions whilst the other half was for negative -RT 
reactions.  
The SuperScript VILO cDNA Synthesis Kit (Invitrogen) or the Maxima Universal 
First Strand cDNA Synthesis Kit (Thermo Scientific, Waltham, USA) were used for 
cDNA synthesis, and the components of the reaction mix was similar for each. For 
the +RT reaction, each reaction mix contained 8μl diluted mRNA, 4μl 5×RT mix, 6μl 
dH2O and 2μl Enzyme mix (final volume 20 μl). The reaction mix of –RT was 
similar to the +RT, but the Enzyme mix was replaced by dH2O. 
The reaction mix was then loaded on the PTC-100 Thermo Cycler (MJ Research Inc, 
Reno, USA), and run on the following programmes: 
VILO: 25°C for 10min, 42°C for 60min, 85°C for 5min. 
Maxima: 25°C for 10min, 50°C for 15min, 85°C for 5min. 
The same kit was used throughout an experiment, with no mixing/comparison of 
samples prepared using kits from different manufacturers. 
2.4 Reversed transcription polymerase chain reaction (RT-PCR) 
2.4.1 Design and preparation of oligonucleotide primers for PCR 
First introduced by Mullis and Faloona (1987), PCR has become one of the most 
widely used molecular techniques in modern medical research. PCR enables the 
amplification of a specific region of double-stranded DNA using two oligonucleotide 
primers, and a thermostable DNA polymerase enzyme. For RT-PCR, primers were 
designed to cross exon-exon junctions (except the primers for luciferase vectors as 
the sequence does not contain an intron) to prevent amplification from contaminating 
genomic DNA. Exon sequences of target genes were found using Ensembl Genome 
Browser (http://www.ensembl.org/index.html), by searching the gene by name or 
GenBank ID. Primers were designed using online primer design software Primer3 v. 
0.4.0 (http://bioinfo.ut.ee/primer3-0.4.0/primer3). Square brackets were added to the 
input sequence to designate the sequence which should be included in the PCR 
product and to make sure the primers were across exon-exon junctions; if the target 
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gene had different splicing then the common part of mRNA variants was selected. 
The general settings of the software were as default, except 2 options as follows: 
Product Size Ranges: 150-300, Max Self Complementarity: 3.00 or 5.00 
These settings were to make sure the primers had approximate equal GC contents 
and melting temperature, appropriate product size for qRT-PCR and lowest 
self-complementarity or 3’ self-complementarity to reduce the possibility of forming 
primer-dimer. 
Primer pairs selected by the software were checked using the nucleotide blast 
function on the Basic Local Alignment Search Tool (BLAST) website 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the human Reference RNA Sequence 
(refseq_rna).  
Lyophilized primers (Integrated DNA Technologies, Leuven, Belgium or Invitrogen) 
were dissolved in dH2O to make the 100μM solutions for long-term stock, and 25μM 
working solutions were made from the stocks by dilution with dH2O. 
2.4.2 RT-PCR (end-point) 
RT-PCR was performed using either the ImmoMix Red Mix or MyTaq HS Red Mix 
(BIOLINE), with the same reaction setup for both kits. cDNA reactions were used 
undiluted, or diluted (with dH2O) at 1/2 or 1/5 (v/v). Each reaction mix contained 
0.5μl forward/reverse primers (0.625μM each primer), 10μl 2×ImmoMix Red or 
2×MyTaq HS Red mix, 8μl dH2O (Ambion) and 1μl cDNA template. For each gene, 
both RT+ and RT- cDNA reactions were used (to indicate whether DNA 
contamination had occurred). Samples were run on a PTC-100 Thermo Cycler (MJ 
Research Inc) with the following programmes:  
ImmoMix Red: 95°C for 10min, (95°C for 30s, 58 or 60°C for 30s, 72°C for 
45s)×30-35 cycles, 72°C for 10min 
MyTaq HS: 95°C for 1min, (95°C for 15s, 60°C for 15s, 72°C for 10s)×30-35 cycles 
The products of RT-PCR were analysed using agarose gel electrophoresis (Section 
2.5 below). 
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2.4.3 RT-qPCR (quantitative PCR) 
By adding fluorescent dyes which specifically bind to double-stranded DNA, it is 
possible to quantify the production of PCR products by measuring the amount of 
fluorescence in a PCR reaction at the end of each PCR cycle (Higuchi et al. , 1992). 
In this study, RT-qPCR was performed using the SYBR Green PCR Master mix 
(Applied Biosystems, Warrington, UK) and Brilliant III Ultra-Fast SYBR Green 
QPCR Master Mix (Agilent Technologies, Wokingham, UK). cDNA reactions were 
usually diluted in dH2O at 1/10 for quantification, and for cDNA reactions from 
Actinomycin D (ActD) treatment, RNA immunoprecipitation or to detect genes 
expressed at a low level (TEX19 and TSSK2) the dilution could be up to 1/2 or 1/5. 
To make the standard curves, the cDNA reactions were diluted 1/10, 1/25, 1/100, 
1/250, 1/1000, 1/2500, 1/10000. 
Reactions containing the SYBR Green PCR Master mix were prepared using 0.2μl 
each of the forward and reverse primers (0.5μM each primer), 5μl 2×SYBR Green 
mix, 3.6μl dH2O and 1μl diluted cDNA. When using the Brilliant III kit, each 
reaction contained 0.2μl each of the forward and reverse primers (0.5μM each 
primer), 5μl 2×SYBR Green mix, 3.45μl dH2O, 0.15μl 1/50 diluted Reference Dye in 
dH2O and 1μl diluted cDNA. Each +RT cDNA sample was performed in duplicate 
(two wells) and –RT reactions done once. 
qPCR reactions were run on ABI 7900HT machines (Applied Biosystems), using the 
SDS 2.4 software (Applied Biosystems). The Detector was set to be SYBR and 
Quencher was Non-Fluorescence. For regular quantification, the task of samples was 
set to be UNKNOWN or the NTC; when running  standard curves, the task of 
samples was set to be Standard or NTC and the values of dilutions of cDNA were 
entered as decimals (e.g. a 1/10 dilution becomes 0.1).  
The setup of PCR programmes was as follows: 
For the ABI kit setup: 
2-Steps qPCR: 50°C for 2min, 95°C for 10min, (95°C for 15s, 60°C for 1min)×40 
cycles 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
 
Chapter 2. General Materials and Methods 
77 
3-Steps qPCR: : 50°C for 2min, 95°C for 10min, (95°C for 15s, 58°C for 15s and 
72°C for 45s)×40 cycles (for RPL32 (as internal control), TEX14, TEX19 and 
GRSF1)  
For the Brilliant III kit setup: 
95°C for 3min, (95°C for 5s, 60°C for 15s)×40 cycles 
All the PCR programmes were followed by an additional dissociation (melt curve) 
stage which was 95°C for 15s, 60°C for 15s and 95°C for 15s again to check the 
specificity of PCR products. This was determined by the presence of a single 
overlapping peak in all samples (Ririe et al. , 1997). 
After the PCR programme finished, the standard curves were automatically 
generated by the software (by plotting CT value against relative cDNA concentration) 
after the PCR programme was finished. Ct values from regular quantifications were 
exported as text file by SDS 2.4. Averaged Ct values (difference ≤1.5 cycles between 
replicates) of +RT cDNA duplicated wells were taken as the final Ct values. 
In qPCR, the standard curve programme gave the slope value for each pair of primers 
to indicate the amplifying efficiency (E) of the reactions. When E=2, which was the 
ideal situation indicating target DNA perfectly duplicated after each cycle, the slope 
value=-3.32 based on the equation E=10(-1/slope). Slope value <-3.32 suggesting low 
efficiency, whilst >-3.32 meaning efficiency was too high and unspecific PCR 
products (e.g. primer-dimer) were formed. An R2 value was also obtained along with 
the slope value which was indicating the correlation coefficient of the standard curve, 
and only slope value with the R2≥0.98 was accepted for qPCR analysis. The 
expression level of each gene was analysed using the formula Relative 
Amount=10(Ct/slope), and then compared to the level of RPL32 as relative expression 
using Microsoft Excel 2003 or 2010. 
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Table 2. 1 Primer List 
Gene Forward (5’→3’) Reverse (5’→3’) 
Product 
Size 
BOLL TATAAGGATAAGAAGCTGAACATTGGT CGAAGTTACCTCTGGAGTATGAAAATA 171bp 
CDC25A AGATAGCAGTGAACCAGG TGCATCGGTTGTCAAGG 202bp 
CRISP2 CAAAGGTGGGCAAACAAGTG GCAATTCCACAGCCTACCTG 245bp 
CTNNB1 TGCAGTTCGCCTTCACTATG ACTAGTCGTGGAATGGCATC 142bp 
DAZL GAAGGCAAAATCATGCCAAACAC CTTCTGCACATCCACGTCATTA 186bp 
DNMT3L* GCAGCAGCCCTCATCCCCATG TGCAATAAGATCTCTGCCTGTCC 135bp 
ERCC1 CCTCAAGGAGCTGGCTAAGA AATGTGGTCAGGAGGGTCTG 228bp 
GAPDH GAACGGGAAGCTCACTGGCAT GTCCACCACCCTGTTGCTGTAG 306bp 
GRSF1 AAGGCATCCACATCTTCATTG CCTGGTCATGCACTATGGAA 232bp 
Luciferase GGCTTCTTCAGCAACGCTAT GCAGCAGGGTGTCTATCCAT 211bp 
RPL32 CATCTCCTTCTCGGCATCA AACCCTGTTGTCAATGCCTC 153bp 
SOX17 AGCAGAATCCAGACCTGCAC CTTCAGCCGCTTCACCTG 185bp 
SRY ACAGTAAAGGCAACGTCCAG ATCTGCGGGAAGCAAACTGC 300bp 
SYCP3 AGCCGTCTGTGGAAGATCAG CAACTCCAACTCCTTCCAGC 197bp 
TERF2 AAGCAGTGGTCGAATCCAGT GCATCTTCTGCTGGAAGGTC 225bp 
TEX14 CGGTCATTGGAGAAAAGGAA GGAGAGACACACAGCCATCA 248bp 
TEX19 GAAGACAACTGGGACCCTGA CCTCCTGAGGCCATAGTTCA 220bp 
TSSK2 CCTCTGACGGACGGATCTAC GCTTGGAGAAGCCAAAGTCA 237bp 
VASA AAGAGAGGCGGCTATCGAGATGGA CGTTCACTTCCACTGCCACTTCTG 238bp 
*DNMT3L primers were from Gokul et al. (2007) Epigenetics 2:2, 80-90. 
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2.5 Agarose gel electrophoresis 
Agarose (BIOLINE, London, UK) was added to 50 or 100ml 1×Tris-acetate-EDTA 
(TAE) buffer (containing 0.04M Tris-acetate, 0.01M Ethylenediaminetetraacetic Acid 
(EDTA), pH8.0; prepared by diluting 50×TAE buffer (484g Trizma Base 
(Sigma-Aldrich), 114.2g glacial acetic acid and 100ml 0.5M EDTA diluted in 
distilled water (dH2O) to make the final volume of 2l) with water and microwaved 
until completely dissolved. GelRed (Biotium, Hayward, USA) was added to the 
solution (1/10000, volume by volume (v/v) to enable visualization of nucleic acids 
under ultraviolet (UV) light. 
Gels were run in 1×TAE buffer (sufficient to cover the gel) in either Mini-Sub Cell 
GT or Wide Mini-Sub Cell GT gel tanks (Bio-Rad, Hemel Hempstead, UK). For 
PCR products (in which the loading dye was incorporated into the master mix (as 
described above in Section 2.4), 10μl samples were directly loaded onto 2% (weight 
by volume (w/v) gels.  For plasmids, 6×Loading Buffer (Promega, Southampton, 
UK ) was added to DNA solution containing 500ng DNA (Promega) before loading 
onto 0.8% gels (w/v).  500ng, 100bp or 1kb DNA ladders (Promega or BIOLINE) 
were also added to the gel to enable determination of DNA fragment size.  Gels 
were run at 80-100V for 45-90 minutes (min).  Gel images were taken under UV 
light using a GeneFlash Transilluminator (Syngene, Cambridge, UK) and Video 
Copy Processor Model P91 (Mitsubishi, Herts, UK). 
 
2.6 Cell culture 
To thaw frozen cells (stored at -80°C in Bambanker (ANACHEM, Luton, 
Bedfordshire, UK)), the tube containing frozen cells was warmed in 37°C water bath 
until a small piece of was ice left. 1ml warm fresh media (see below) was then added 
to the cells slowly, and the mix was transferred to 15ml polypropylene tube (Greiner 
Bio-One), following by adding 10ml warm fresh media to the tube. The cells were 
centrifuged at 300g for 5min, and resuspended in 10ml fresh media gently by 
pipetting. The cells were then transferred to a 25cm2 flask (Corning, Tewksbury, 
USA) for culture. 
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HEK293 cells were cultured in Modified Eagle’s Medium (MEM) +GlutaMAX 
(Gibco, Paisley, UK) supplemented with 10% (v/v) Fetal Bovine Serum (FBS; 
Gibco). TCam-2 cells (obtained from Professor Leendert Loijenga) were cultured in 
RPMI1640 (Gibco) containing 10% (v/v) FBS and 2mM L-Glutamine (Gibco) in a 
humified incubator (37°C, 5% CO2.) 
At 70-90% confluency, cells were passaged 1:4 to 1:8 to new flasks. The media was 
aspirated, and cells washed twice with Ca2+-free phosphate buffered saline (PBS; 
Gibco), then incubated with 1.5ml 0.05% (v/v) Typsin/EDTA (Gibco) at 37°C for 
2-3min. The trypsinization was stopped by adding 8.5ml complete media (as above) 
and 1.25ml (1/8 passage) or 2.5ml (1/4 passage) cell suspension was added to 20ml 
media in new 75cm2 flasks (Corning). 
 
2.7 Transfection and following treatment 
For transfection, HEK293 or TCam-2 cells were trypsinzed, added to fresh media of 
appropriate volume in the plates/dishes 24 hours prior transfection to achieve 70-80% 
(HEK293) or 80-100% (TCam-2) confluence at the time of transfection (for plating 
density and media volume see Table 2.2). Plasmid DNA and transfection reagent 
TansIT-LT1 (Mirus, Madison, USA) were mixed at a ratio of 1:3 (μg:μl) in 
serum-free OPTI-MEM (Gibco) and incubated at room temperature for 20-30min. 
The culture media was changed before the transfection mixture was added onto the 
cells. The volume of culture media and transfection mix was described below in 
Table 2.2. After 24h, the media was changed again and cells were harvested 48h after 
transfection for further analysis if no following treatment required.
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Number of cells 
(HEK293) 
Number of cells 
(TCam-2) 
OPTI-MEM 





10cm Dish 12ml 2.5×10
6 1×106 1.5ml 15μg 45μl 
6-well plate 2ml 3×10
5 1.5×105 250μl 2.5μg 7.5μl 
12-well plate 1ml 1.2×10
5 6×104 100μl 1μg 3μl 
24-well plate 0.5ml 6×10
4 3×104 50μl 0.5μg 1.5μl 
96-well plate 100μl 2×10
4 1.2×104 9μl 0.1μg 0.3μl 
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2.7.1 Establishment of stably-transfected TCam-2 Cells 
To establish a stable cell line, TCam-2 cells were plated in 10cm dishes and 
transfected with pCMV6-Entry, -DAZL or -BOLL vectors (ORIGENE, Rockville, 
USA) according to the amounts detailed in Table 2.2, and cultured in media 
contained 300μg/ml G418 (100mg/ml stock, Invivogen, Toulouse, France) after 48 
hour transfection. Cells were split regularly afterwards, and were harvest after 1 
month for further analysis. 
2.7.2 mRNA stabilisation assay 
HEK293 cells were first plated in 12-well plates and transfected with either 
pCMV6-Entry or –DAZL vectors for 48h, and then the cells were further cultured in 
media containing 5μg/ml Actinomycin D (ActD; Sigma-Aldrich, diluted 5mg/ml in 
Dimethyl Sulphoxide (DMSO; Sigma-Aldrich) and stored at -20°C) or DMSO alone 
(as vehicle control) for 24h. The cells were lysed in Buffer RLT at time 0 and 24h 
after ActD treatment for mRNA extraction. 
2.7.3 Time course of exogenous DAZL and BOLL expression 
HEK293 cells were first plated in 6-well plates and transfected with pCMV6-DAZL 
or BOLL vectors, and were lysed using 100μl RIPA (Radioactive 
ImmunoPrecipiation Assay, 50mM Tris-HCl pH7.0, 1% (v/v) IGEPAL CA-630, 0.5% 
(w/v) Na-deoxycholate, 0.1% (w/v) Sodium dodecyl sulfate (SDS), 150mM NaCl, 
2mM EDTA, all from Sigma-Aldrich, except HCl from Fisher Scientific) buffer per 
well at time 12h, 24h, 36h, 48h, 60h, 72h after transfection for Western blotting and 
semi-quantification (for the methods refer to Section 2.13 below). Untrasfected cells 
were lysed at time 0 as a negative control. 
 
2.8 Fluorescence-activated cell sorting (FACS) 
Cells can be labelled with fluorescent markers which can be charged with different 
electrostatic signals and then further separated by flow cytometry (Bonner et al. , 
1972). To prepare the cells for FACS, TCam-2 cells were first plated in 10cm dishes 
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and co-transfected with both Enhanced Green Fluorescence Protein (EGFP) vectors 
and pCMV-DAZL vectors (1:1, w/w), or single transfected with same amount of 
EGFP vectors. Mock transfections (cells treated with only Transfection reagent 
TransIT-LT1 (Mirus)) were also set up as negative control. After 48h, the cells were 
trypsinized and filtered with 40μm cell strainer (BD Biosciences, Oxford, UK) to 
remove big clumps, then washed in PBS for twice and finally resuspended in 800μl 
to 1.2ml PBS containing ≤1% (v/v) FBS to achieve a cell density of 1-2 million/ml. 
The cells were then sent to the FACS lab in CIR (MRC Centre for Inflammation 
Research) for FACS, using the BD FACSAria II System (BD Biosciences). Before 
sorting, 1μl 4',6-diamidino-2-phenylindole (DAPI; Sigma-Aldrich) were added to the 
cells to stain the nucleus of dead cells and to separate the live and dead cells during 
the FACS. The mock transfected cells were used as standard to set up the gating. 
Singlets of cells were determined by FSC (Forward SCatter detector) and SSC (Side 
SCatter detector), which could represent the cell size and cell granularity/internal 
complexity, respectively; the area beside the diagonal between FSC-A (area) and 
FSC-H (height) was indicating the singlets, and the living cells were preliminarily 
isolated as dead cells had lower FSC-A and higher SSC-A. The GFP gate (emission 
B 525/50-A) and DAPI gate (emission UV 450/50-A) was then set up using the 
mock transfected sample as it was GFP- and so could be the control to determine the 
threshold of GFP gate. Generally the cells had UV 450/50-A values ≤1.2-1.3×102 
(low or no DAPI staining) were considered as living cells, and the B 525/50-A 
boundary between GFP+ and GFP- was at 1.2-1.4×102. The DAZL/GFP 
co-transfected cells were then loaded on the machine and pre-test was performed 
before the sorting to slightly adjust and confirm the settings. 
RPMI1640+L-GlutaMAX containing 20% (v/v) FBS was used as collection media of 
sorted cells, and only live GPF+ and GFP- cells were collected. The parameters of 
collected cells were briefly checked on the machine using all the gates described 
before. The cells were then either washed twice with PBS and lysed in 15 to 45μl 
(depending on the cell numbers) RIPA buffer for Western blotting (see Section 2.13), 
or centrifuged and lysed in 350μl Buffer RLT for mRNA extraction (micro-prep). 
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2.9 RNA-immunoprecipitation (RIP)  
2.9.1 Preparation of RIP samples 
RIP was first developed by modifying chromatin immunoprecipitation to study 
protein-RNA interactions (Gilbert et al. , 2004). For the RIP, cells were plated in 
10cm dishes to achieve appropriate confluency and transfected with pCMV6-Entry or 
pCMV-DAZL vectors (TCam-2), or co-transfected with pCMV6-Entry or 
pCMV-DAZL vectors combined with luciferase vectors with either GAPDH or 
TEX14 3’-UTR (HEK293). After 48h transfection, cells were trypsinized and washed 
with ice-cold PBS for twice, and then lysed in 1 volume of lysis buffer (containing 
10mM HEPES pH7.0, 100mM KCl, 5mM MgCl2, 0.5% IGPAL CA-630, 1mM 
dithiothreitol (DTT), 0.25% (v/v) RNase Inhibitor and 0.5% (v/v) Proteinase 
Inhibitor. All chemicals from Sigma-Aldrich and diluted with dH2O, except the 
RNase/Protein inhibitors which were from the RIP kit (Millipore) and added to the 
buffer just before use). The lysate was incubated on ice for 5min and centrifuged at 
10000g for 15min at 4°C. The supernatant was stored at -80°C as 100μl aliquots if 
not be used immediately. 
2.9.2 Immunoprecipitation of DAZL protein 
Before RIP, the potential RNase contamination from the environment was removed 
by wiping all the surface of bench and equipment using the RNaseZAP (Ambion). 
The Magna RIP RNA-Binding Protein Immunoprecipitation Kit (Millipore) was used 
for RIP. To prepare the magnet agarose beads, 50μl beads per reaction was taken 
from the kit, washed with 500μl Wash Buffer twice and resuspended in 100μl Wash 
Buffer, incubated with Rabbit anti-DAZL antibody (Cell Signaling, Hitchin, UK) 
1/40 at room temperature for at least 30min. After incubation, the beads were washed 
3 times with 500μl Wash Buffer, and resuspended in 900μl RIP buffer containing 
860μl Wash Buffer, 35μl EDTA and 5μl RNase Inhibitor per reaction. 100-120μl cell 
lysate was then added to the beads, and incubated at 4°C, rotating for at least 4h. 
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2.9.3 Isolation of DAZL co-precipitated RNA 
After the incubation, the beads were washed with Wash Buffer for 6 times, and then 
digested in 150μl Proteinase K buffer containing 117μl Wash Buffer, 18μl Proteinase 
K and 15μl 10% (w/v) SDS at 55°C for 30min. 
After digestion, the beads were discarded, and 50μl dH2O was added to the 150μl 
supernatant of each sample to make up the volume of 200μl. 700μl Buffer RLT, 
followed by 500μl absolute ethanol was added to the diluted supernatant and mixed 
well by pipetting. The mixture was then loaded onto the RNeasy MinElute spin 
columns (QIAGEN) and the flow-through was discarded after spinning at 10000g for 
30s. The precipitate was then washed by adding 500μl Buffer RPE and spinning at 
10000g for 30s, followed by adding 500μl 80% (v/v) ethanol and spinning at 10000g 
for 2min. The collection tube was replaced after washing, and the membrane of the 
column was dried by spinning at maximum speed with lid open for 5min. The 
column was then placed in a nuclease-free 1.5ml eppendorf tube, and the RNA was 
eluted by adding 14μl dH2O to the membrane of column and spinning at maximum 
speed for 1min, and this step was repeated using the flow-through to increase the 
yield. The concentration of eluted RNA was determined using the NanoDrop, and 
afterwards the RNA was converted to cDNA for both + and –RT using the Maxima 
kit as described in Section 2.3.3. 
 
2.10 Luciferase 3’-UTR assay 
2.10.1 Experimental procedure of 3’-UTR assay 
The principle of luciferase 3’-UTR assay is shown in Figure 2.1. Cells are transfected 
with luciferase vectors conjugated with the 3’-UTR of the target gene. The substrate 
is catalysed by Renilla luciferase, which is produced by the transfected cells with the 
generation of luminescence. The amount of luminescence will be altered if the 
expression of luciferase is modulated through the 3’-UTR by other added factors 
such as DAZL. Therefore, by detecting the change in luminescence, it is possible to 
investigate how the expression of luciferase is modulated by the regulators and 
whether it is through 3’-UTR. 
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HEK293 or TCam-2 Cells were plated in white 96-well plates with clear base 
(Thermo Scientific) to achieve appropriate confluence 16-24h prior transfection and 
then cells were co-transfected with pCMV-DAZL or pCMV6-Entry vectors plus 
LightSwitch RenSP Luciferase vectors (SWITCHGEAR GENOMICS, Menlo Park, 
USA) which were conjugated with no-, GAPDH or TEX14 3’-UTR (1:1, w/w). Each 
combination of vectors was repeated in triplicate and the culture media was replaced 
by 100μl fresh regular media per well after 24h. 
After 48h transfection, the luciferase assay was performed using LightSwitch 
Luciferase Assay kit (SWITCHGEAR GENOMICS). Before performing the assay, 
the solid Assay Substrate was reconstituted in 100uL Substrate Sovlent and stored as 
20 μl or 30μl aliquots at -20°C for up to 1 month. The Assay Buffer was warmed at 
37°C for at least 1h (hour), and then the substrate was diluted 1/100 (v/v) in the 
Buffer. 100μl diluted substrate per well was then added directly to the 100μl culture 
media and mixed by shaking the plate on plate shaker for 15s. The plate was then 
incubated at room temperature for 30min, protected from light.   
To read the strength of luminescence, the plate was loaded on FLUOstar OPTIMA 
(BMG LABTECH, Bucks, UK) using OPTIMAR software, read under 
luminescence/end-point mode, 2s for each well and the gain was set to 4059. The 
data was exported using OPTIMAR-Data Analysis as an .xls file. 
To analyse the data, Microsoft Office Excel 2010 was used. The readings of triple 
wells were averaged, and the luminescence values was normalised using those values 
from cell transfected by Empty and GAPDH vectors following the manufacturer’s 
instructions to minimise the affection between different conditions. Briefly, the 
average signal for each construct (Empty or GAPDH) under different conditions 
were calculated, then the ratio of each treatment’s luminescence value to the average 
was calculated. Then the ratios from different constructs (Empty and GAPDH) but 
same treatment was averaged, and the original luminescence values were divided by 
these averaged ratios to normalise. Finally the normalised data was analysed using 
GraphPad Prism to find out the significance between each treatment. 
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Figure 2.1 Diagram of 3’-UTR luciferase assay.  
A) The assay system without DAZL. The luciferase gene is translated into luciferase protein, and 
when substrate is added, this protein will catalyse the substrate and stimulate luminescence. B) 
The assay system with DAZL. DAZL protein could bind to the 3’-UTR of the target gene, which is 
conjugated with luciferase gene, and then promote the translation. This will lead to the 
production of more luciferase protein in the system and enhanced catalytic ability; therefore 
once the substrate is added, the luminescence will be stronger. 
Figure by Dr Andrew Childs  
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2.10.2 Data normalisation for luciferase 3’-UTR assay 
The data normalisation of the data generated by luciferase 3’-UTR assay was 
performed following the instructions from the manufacturer’s website 
(http://switchgeargenomics.com/sites/default/files/pdf/LightSwitch_3UTRnorm.pdf). 
The whole process will be explained quoting part of the original protocol, with 
sample data as below. 
In this study, there was two experimental conditions (co-transfection with DAZL or 
empty vector), and luciferase vectors no 3’UTR or conjugated to the GAPDH 
3’-UTR were used as controls for normalisation. It was assumed that the data 
obtained in one experiment was shown in Table 2.3, and the average signal of 
controls under the two conditions were calculated (19.3 and 66.4 for empty or 
GAPDH, respectively).  
Table 2. 3 
Experimental 3'-UTR  Controls 
  3'-UTR EMPTY GAPDH 
Condition 1 46.6 20.5 68.6 





The next step was to calculate the ratio of each control’s luminescence to the 
average, as shown in Table 2.4. 
Table 2. 4 
Controls 
  EMPTY GAPDH 
Condition 1/Average  20.5/19.3 68.6/66.4 
Condition 1 Ratio =1.06 =1.03 
Condition 2/Average  18.6/19.3 64.1/66.4 
Condition 2 Ratio =0.94 =0.97 
 
And then the ratios under each condition were averaged as shown in Table 2.5. 
Table 2. 5 
Controls Control Average 
  EMPTY GAPDH 
 Condition 1 Ratio 1.06 1.03 1.045 
Condition 2 Ratio 0.94 0.97 0.955 
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And finally, the raw data was divided by the average control ratios obtained in Table 
2.5 for normalisation, and these values (bold numbers in Table 2.6) were used for 
further analysis. 
Table 2. 6 
Experimental 3'-UTR  Controls 
  3'-UTR EMPTY GAPDH 
Condition 1/Average Ratio 46.6/1.045 20.5/1.045 68.6/1.045 
Condition 1 Normalised =44.59 =19.62 =65.65 
Condition2/Average Ratio 13.3/0.955 18.1/0.955 64.1/0.955 
Condition 2 Normalised =13.93 =18.95 =67.12 
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2.11 Human dissection and tissue collection 
The human fetuses (8-20 week gestation) were obtained from termination of 
pregnancy, and the ethical approval was obtained from Lothian Research Ethics 
Committee (study code LREC 08/S1101/1). The donation of human tissue was 




=652). Most abortions were performed using medicine methods but the termination 
of pregnancy at 10-14 week gestation (not include 14 week) were performed by 
surgical methods (vacuum aspiration after administration of misoprostol 
200mg/vagina). 
All the fetuses used in this study were morphologically normal. The gestational age 
was determined using ultrasound before termination, and was then further confirmed 
by measuring crown-rump length of the first trimester fetuses or the foot length of 
the second trimester fetuses. The gender of first trimester fetuses was determined by 
PCR for the SYR gene and following agarose gel electrophoresis (see Section 2.12), 
and the one of second trimester fetuses was determined by the morphology of 
external genitalia and gonads.  
The fetal gonads were then removed from the fetuses using sterilised tools and rest in 
PBS before next step. For RNA extraction or Western blotting, the extra-ovarian 
tissue was removed using sterilised syringe needles and the ovaries were either lysed 
in Buffer RLT (for RNA extraction, see Section 2.3) or RIPA buffer (for Western 
blotting, see Section 2.13), or immediately frozen on dry ice and stored at -80°C for 
long-term storage. For tissue processing for immunohistochemistry, see Section 
2.15.1. 
 
2.12 Mouse dissection and tissue collection 
Mouse fetal gonads were obtained from C57BL6 mouse embryos. The mice were 
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kept on a 12h light/dark cycle from 7am each day at 19-21°C and fed ad libitum, 
according to UK Home Office and local University of Edinburgh ethical standards. 
The appearance of a vaginal plug was designated as e0.5.  
The pregnant mice were killed by cervical dislocation and the uteri were isolated and 
stored in PBS on ice while dissecting other fetuses. The fetal gonads were isolated at 
day e13.5, e15.5 and e18.5, and the gonads of the neonatal mice were also isolated, 
both under dissecting microscope and using sterilised tools. The gender of fetuses 
was determined by the location and morphology of gonads. For the tissue processing 
of immunohistochemistry see Section 2.15.1. 
 
2.13 SRY genotyping 
The PCR for the SRY gene was performed to determine the gender of human first 
trimester specimens. Tissue (hand or foot) was digested in 100μl 25mM 
NaOH/0.2mM EDTA at 95°C for 20min, and then neutralised using 100μl 40mM 
Tris on ice. The lysate was then mixed vigorously by vortex, and spun briefly.  
Each PCR reaction contained 5μl supernatant from the tissue lysate, 12.5l 
2×ImmoMix Red, 0.5l SRY forward/reverse primer (see Table 2.1 primer list for the 
sequence of SRY primers and product size) and 6.5l water, and an extra reaction 
containing human male genome DNA was also set up as positive control. The PCR 
programme was 95°C for 10min, (95°C for 30s, 58 or 60°C for 30s, 72°C for 
45s)×30-35 cycles, 72°C for 10min. The PCR product was analysed by agarose gel 
electrophoresis (for the methods refer to Section 2.5 on agarose gel electrophoresis 
above). The appearance of band indicated male and absence of band indicated 
female. 
It is necessary to mention that although the positive control was performed using the 
SRY primers and human male genomic DNA, we could not exclude the possibility of 
false positive results, especially if the tissue was collected and/or the genotyping was 
performed by male staff. Therefore, in future, female genomic DNA should also be 
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included as a negative control to ensure no contamination occurred in the 
experiments. 
 
2.14 Protein extraction and western blotting 
2.14.1 Preparation of protein and determination of concentration 
RIPA buffer containing 50mM Tris-HCl pH7.0, 150mM NaCl, 1% (v/v) IGPAL 
CA-630 and 0.25% (w/v) Na-Deoxycholate (all from Sigma-Aldrich except HCl 
from Fisher Scientific, Loughborough, UK) was used to lyse the cells. One Complete 
Protease Inhibitor Cocktail Tablet (Roche Applied Sciences) was added to 10ml 
RIPA buffer before use and the buffer was stored at 4°C up to 1 month afterwards. 
Tissue or cells were washed with PBS twice, and then lysed by directly adding RIPA 
buffer to them; tissue suspension was homogenized. The lysate was centrifuged at 
13000g for 3min at 4°C and the supernatant contained protein. The protein was 
stored at -20°C for short-term or at -80°C for long-term storage, and thawed slowly 
on ice before use. 
The concentration of protein was detected using the DC Protein Assay kit (Bio-Rad). 
Before the assay, standard BSA samples (0.125, 0.25, 0.5, 1.0μg/μl) were prepared 
by diluting Bovine Serum Albumin (BSA) Standards (2mg/ml, Thermo Scientific) in 
RIPA buffer, and Reagent S was added to Reagent A 1/50 to make Reagent A’. 
Standard or protein samples were loaded to 96-well microplate as duplicates 5μl per 
well, followed by adding 25μl Reagent A’ and 200μl Reagent B each well. The 
samples were mixed on a plate shaker briefly, and incubated at room temperature for 
15min, protected from light. The plate was finally scanned on Multiskan EX 
microplate (MTX LAB SYSTEMS, Vienna, USA) reader at 620nm. The 
concentration of each sample was calculated by comparing the absorption with the 
standard curve generated from BSA samples on the same plate, using Microsoft 
Excel 2003 or 2010. 
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2.14.2 Sodium dodecyl sulfate- polyacrylamide gel electrophoresis 
(SDS-PAGE) 
Protein samples (from Section 2.14.1 above) were mixed with 4×SDS gel-loading 
buffer (625mM Tris-HCl pH6.8, 5% (v/v) glycerol, 2% (w/v) SDS, 0.0025% (w/v) 
Bromophenol Blue, 10% (v/v) β-ME (all from Sigma-Aldrich, except HCl from 
Fisher Scientific) and boiled for 6min to denature, cooled on ice for 2min and 
centrifuged. Up to 30μg or 30μl of protein was loaded per well onto pre-cast gels (12% 
or 4-20% 12-well Precise Tris-HEPES gels (Thermo Scientific) or 12% 10-well 
Mini-PROTEAN TGX Precast Gel (Bio-Rad). 6μl SeeBlue Plus2 (Life Technologies, 
Paisley, UK) or PageRuler Plus (Thermo Scientific, Waltham, USA) pre-stained 
protein standards were also run to enable approximate determination of protein sizes. 
Precise Tris-HEPES gels were run in 1×Tris-HEPES Running Buffer (prepared by 
diluting 20×Tris-HEPES Running Buffer (Thermo Scientific) with dH2O) in an 
XCell SureLock Mini-Cell tank (Invitrogen) at 120V for 1-1.5 hours. 
Mini-PROTEAN TGX Precast Gels were run in 1×Tris-Glycine running buffer 
(prepared by diluting a 10×stock (129g Trizma Base, 144g glycine, 100ml 10% (w/v) 
SDS (all from Sigma-Aldrich) in a final volume of 1L) with dH2O) in a 
Mini-PROTEAN Tetra Cell (Bio-Rad) tank at 200V for about 1 hour. 
2.14.3 Western blotting 
The technique of transferring electrophoretically separated proteins from gel to a 
membrane (originally nitrocellulose membrane) and detecting them with antibodies 
was developed by Towbin et al. (1979). Following PAGE, protein gels were washed 
in dH2O (2×5min), and incubated in 1×transfer buffer (prepared by diluting 
10×Pierce Fast Semi-Dry Transfer Buffer (Thermo Scientific) with dH2O) for 10min 
on a rocker with gentle agitation. Immobilon-FL PVDF membrane (Millipore) was 
cut into 7×9cm squares (equivalent to one mini-gel), activated by soaking in 
methanol (Fisher Scientific) for 1min, washed in dH2O for 1min and also incubated 
in transfer buffer for 10min. 2 pieces of western blotting filter paper (Thermo 
Scientific) were cut to the same size as the PVDF membrane and soaked in transfer 
buffer for at least 3min before transfer. These were then assembled into a blot 
sandwich (order from bottom: 1 layer of filter paper, PVDF membrane, protein gel 
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and finally 1 layer of filter paper) and loaded onto a Fast Semi Dry Blotter (Thermo 
Scientific). The transfer was run at 25V for 7-9min. 
After transfer, the membrane was stained using Ponceau S Solution (Sigma-Aldrich) 
and washed with dH2O until water was not pink to check the quality of transfer, and 
then blocked in blocking buffer (Bløk - FL Fluorescent Blocker (Millipore) mixed 
1:1 (v/v) with 1% (v/v) PBS-T (Tween) for at least 1h. The membrane was then 
incubated in 1ml or 5ml primary antibody diluted in blocking buffer at 4°C overnight. 
The information and concentration of antibodies used in Western blotting was 
described below in Table 2.7. PBS was made from 10×PBS stock (100 Phosphate 
buffered saline tablets (Sigma-Aldrich) dissolved in 2L dH2O), and 1ml Tween-20 
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Table 2. 7 Antibodies used for Western Blotting 
Primary Antibody Manufacturer Species Raised Dilution 
DAZL Abcam Mouse 1/200 
DAZL Cell Signalling Rabbit 1/1000 
BOLL Abcam Mouse 1/100 
FLAG Sigma Mouse 1/500 
Myc Stanta Cruz Mouse 1/200 
α-tubulin Sigma Mouse 1/5000 
 
On day2, The membrane was washed in 0.05% (w/v) PBS-T for 15min once, then 
washed again for 5min for 4 times, and incubated with 5-10ml 1/10000 diluted 
fluorescence-conjugated secondary antibody (Donkey anti-IgG of the species of 
primary antibody, all from Invitrogen) for 1h at room temperature. The membrane 
was then washed in 0.05% PBS-T for 5min twice and in PBS for 5min once, and 
stored in PBS at 4°C before scanning.  
2.14.4 Semi-quantification of Western blotting 
Membranes were scanned on the Odyssey Infrared Imaging System and the Odyssey 
software (Li-Cor Biosciences, Cambridge, UK).To quantify the strength of bands, 
rectangles of same size were added to the image of blots using the Odyssey software; 
each rectangle completely covered a single band and did not overlap each other. The 
colour intensity was measured automatically and the report was exported as text file 
by the software. The intensity of band was calculated as the average intensity 
subtracted the background intensity, and the intensity of target bands were 
standardized by dividing the values of the bands of α-tubulin in corresponding lanes 
using Microsoft 2003 or 2010. 
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2.15 Immunohistochemistry (IHC) 
2.15.1 Tissue fixation, processing and slide prep 
Most immunohistochemistry experiments were performed by myself, except the 
work on mouse were performed by honoured student Kayleigh Stewart under my 
supervision.   
Before immunohistochemistry, the human fetal ovaries were fixed in Bouin’s Fluid 
(Clin-Tech, Guildford, UK) overnight or 4% Neutral Buffered Formalin (NBF, 
Clin-Tech) for 2-3 hours, whilst the dissected mouse gonads were fixed in 4% NBF 
for 3-4 hours, and then transferred to 70% ethanol for temporal storage.  
The tissue was then sent to the SuRF @ QMRI (Queen's Medical Research Institute 
Shared University Research Facilities) in CRH (The University of Edinburgh/MRC 
Centre for Reproductive Health) to be finally embedded as paraffin blocks using 
HistoStar Embedding Workstation (Therom Scientific).  
The paraffin embedded tissue blocks were cut as 5μm sections using a Leica 
RM2125 microtome (Leica). The fresh cut sections were floated into a 37°C water 
bath to smooth and then mounted onto electrostatically charged glass slides (Leica). 
The slides were incubated at 50°C overnight to dry and finally stored in dry place at 
room temperature. 
2.15.2 Tissue dewax and rehydration 
To dewax, the paraffin-embedded sections on glass slides were immersed in xylene 
(VWR) for 5min twice, and then rehydrated by immersing in 100% (v/v) ethanol 
twice for 20s, and then in 90%, 80%, 70% (v/v) ethanol once each for 20s. The slides 
were then rinsed in tap water to remove the excessed ethanol and stored in tap water 
until being progressed to the next step. 
2.15.3 Haematoxylin and eosin (H&E) staining 
Slides were taken from newly prepared sections every 10 slides to check the quality 
of specimen. The rehydrated slides were first incubated in haematoxylin (Leica) for 
5min to stain the nucleus (blue) and then rinsed in tap water and the staining was 
checked under microscope. This step might be repeated until the staining was 
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sufficient. Then the slides were washed in acid alcohol (70% (v/v) ethanol with 1% 
(v/v) 37.5% (w/v)  HCl) for 5s to remove the excessed background staining and 
rinsed again in tap water, then the colour was developed by incubating in Scott's Tap 
Water Substitute (CellPath, Powys, UK) for 30s. The slides were then rinsed again in 
tap water and finally immersed in eosin (Leica) for 20s to stain the cytoplasm (pink) 
and rinsed in tap water.  
2.15.4 Antigen retrieval 
The rehydrated slides were antigen retrieved in 250ml 0.01M citrate buffer pH6.0 
(made from 10×citrate buffer stock; 1L stock was made from 820ml 0.1M sodium 
citrate (Sigma-Aldrich) and 180ml 0.1M citric acid (Sigma-Aldrich), and the pH was 
adjusted to 6 using 5M NaOH (VWR) in a water bath in a Decloaking Chamber 
(Biocare Medical, Concord, USA). The programme was 125°C for 30s and then 
slowly cooled to 90°C for 10s. The slides were then rinsed in tap water and rested in 
water before next step. 
2.15.5 Non-specific blocking  
The slides were rinsed 3 times in dH2O, and then incubated at room temperature in 
either 3% (v/v) hydrogen peroxidase (30% (v/v) stocks, Fisher Scientific) diluted in 
methanol (Fisher Scientific) for 30min on rocker, or Peroxidase Blocking Reagent 
(Dako, Cambridge, UK) was added to the sections 100μl per slide and incubated for 
10min to block the action of endogenous peroxidase. After that, the slides were 
rinsed in dH2O 3 times again and then washed in Tris-Buffered Saline (TBS, for 
3,3'-Diaminobenzidine (DAB) immuno) or in PBS (for fluorescence immuno) for 
5min twice. Both TBS and PBS were made from 10×stocks; for TBS, 121.1g Trizma 
Base (Sigma-Aldrich) and 170g NaCl (Sigma-Aldrich) was dissolved in 2L dH2O 
and the pH was adjusted to 7.4 using 37.5% (w/v) HCl (Fisher Scientific) to make 
the 10×stock. For PBS, see Section 2.13.3 above for the methods of making 
10×stock. 
The slides were then blocked by the serum block at room temperature for 30min. The 
block containing 20% (v/v) normal animal serum (Biosera, Uckfield, UK) and 5% 
(w/v) BSA (Sigma-Aldrich) diluted in PBS, and the species of serum were the same 
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species in which the secondary antibody was raised in. For mouse tissue, if the 
primary antibody was also raised in mouse, then the Rodent Block Buffer from 
Mouse on Mouse Polymer IHC Kit (Abcam, Cambridge, UK) was applied on the 
tissue instead of regular serum block. After the serum blocking, the slides were 
washed again in PBS or TBS for 5min twice, and the slides for DAB immunos were 
further blocked by avidin and biotin blocks (VECTOR LABORATORIES, 
Peterborough, UK), each for 15min followed by 5min TBS wash×2 afterwards. 
2.15.6 Primary antibody incubation 
The primary antibody was diluted in serum block and applied 100μl per slide to the 
sections. The appropriate concentration of primary antibody was determined by 
applying different ranges of dilution of antibody on the sections and processing the 
whole work flow, until find out the best primary antibody concentration which could 
generate sufficient staining with lowest background. 100μl serum block without any 
antibody was applied on one slide as negative control. The slides were then covered 
by small pieces of parafilm to protect the sections from drying out, and incubated at 
either 4°C overnight or room temperature for 1h. The information and concentration 
of antibodies used in immunos was described below in Table 2.8. 
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Manufacturer Visualisation Methods 
DAZL Abd Serotec Mouse 





1/500 Goat anti-Mouse peroxidase fab Abcam TSA Fluorescence 
DAZL Cell Signaling Rabbit 
1/100 Goat anti-Rabbit biotinylated Vector DAB 
1/500 (tissue) or 1/2000 (cells) Goat anti-Rabbit peroxidase fab Abcam TSA Fluorescence 
BOLL Abcam Mouse 
1/50 (old) or 1/200 (new) Goat anti-Mouse peroxidase fab Abcam TSA Fluorescence 
1/50 Mouse-on-Mouse HRP polymer Abcam DAB 
1/200 Mouse-on-Mouse HRP polymer Abcam TSA Fluorescence 
SYCP3 Abcam Rabbit 1/50000 Goat anti-Rabbit peroxidase fab Abcam TSA Fluorescence 
Phospho-ATM Rockland Mouse 1/200 Rabbit anti-Mouse peroxidase Vector TSA Fluorescence 
SOX17 R&D Systems Goat 1/500 Horse anti-Goat peroxidase Vector TSA Fluorescence 
DNMT3L Abcam Rabbit 1/5000 Goat anti-Rabbit peroxidase fab Abcam TSA Fluorescence 
LIN28 Abcam Rabbit 1/500 Goat anti-Rabbit biotinylated Vector 
Streptavidin-Conjugated 
Fluorescence 
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2.15.7 Secondary antibody incubation 
On day2, the slides were washed in PBS or TBS for 5min twice, and the secondary 
antibody was diluted in serum block at 1/200-1/500. 100μl antibody was applied on 
the sections per slide and incubated at room temperature. The incubating time was 
depending on the variations of antibodies. The biotinylated antibodies or antibodies 
conjugated with peroxidase were incubated for 30min, and the fluorophore 
conjugated antibodies were incubated for 1h. For the mouse tissue sections with 
primary antibody raised in mouse, Mouse on Mouse HRP Polymer from Mouse on 
Mouse Polymer IHC Kit was applied 1 drop per slide instead of regular secondary 
antibody, and incubated at room temperature for 30min as well. 
2.15.8 DAB staining and streptavidin- conjugated fluorescence 
staining 
For the slides incubated with biotinylated secondary antibody, Streptavidin HRP 
(Horse Radish Peroxidase, VECTOR LABORATORIES, Peterborough, UK) diluted 
1/1000 in PBS (for DAB staining), or Streptavidin-conjugated fluorophore 
(Molecular Probes, Invitrogen) diluted 1/200 in PBS (for Streptavidin-conjugated 
fluorescence staining) was applied 100μl per slide to the sections and incubated at 
room temperature for 30min or 1h respectively, protected from light. The slides were 
then washed with TBS for 5min twice. No further step was required for 
Streptavidin-conjugated fluorescence staining afterwards. 
For the slides incubated with Mouse on Mouse HRP Polymer, the DAB staining was 
directly processed after the step of secondary antibody, without incubation of HRP. 
For the DAB staining, the Liquid DAB+Substrate Chromogen System (Dako) was 
used. Before the staining, 1 drop DAB+Chromogen solution was added to 1ml 
Substrate Buffer and mixed well by vortex to make the work solution. The DAB 
work solution was then immediately added to the sections (100μl per slide) and the 
colour development was observed under microscope one by one. Once the staining 
was sufficient, the slides were immersed in TBS to stop the reaction. The slide of 
negative control was incubated with DAB for 5min to ensure the sufficient 
developing time.  
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2.15.9 Tyramide staining 
For the Tyramide staining, the TSA (Tyramide Signal Amplification) Plus Cyanine 3 
(Red), Cyanine 5 (Blue) or Fluorescein (Green) System (PerkinElmer, Cambridge, 
UK) was applied. Before use, the solid Fluorophore Amplification Reagent was 
reconstituted in 150μl DMSO to make the Fluorophore Amplification Reagent Stock 
Solution and the solution was stored at 4°C for up to 3 month. To make the working 
solution, the stock solution was diluted 1/50 in the 1×Plus Amplification Diluent, 
protected from light. 
The working solution was then added directly on the sections which were incubated 
with peroxidase conjugated secondary antibody or Mouse on Mouse HRP Polymer, 
50μl per slide and protected from light. After 10min, the slides were immersed in 
PBS to stop the reaction and washed in PBS for 5min twice. 
2.15.10 Double or triple fluorescence staining 
The double staining was only applied to the slides which were previously stained 
with Tyramide, as the protocol would remove all the antibodies applied to the tissue 
during previous staining, and all the washing steps after the incubation of primary 
antibody were changed to wash with 0.05% (v/v) PBS-T for 5min plus PBS for 5min 
to decrease the background staining. 
After the Tyramide staining and following washes, slides were microwaved in 
boiling 0.01M citrate buffer for 2.5min before resting in the buffer at room 
temperature for 40min to cool. This step was to remove both the primary and 
secondary antibodies. The slides were then rinsed in PBS, and processed to 
non-specific blocking and its following steps as described before in Section 2.14.5.  
For triple staining, the two previous staining also needed to be both done with 
Tyramide, and the slides were again microwaved in citrate buffer as described in this 
section and then the staining steps were repeated from non-specific blocking. 
2.15.11 Counter stain, tissue dehydration and mounting 
The work flow of counter staining with DAB slides was similar to the H&E staining, 
but without Eosin staining.  
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To gradiently dehydrate the tissue, slides were immersed in 70%, 80%, 95% (v/v) 
ethanol for 20s once each, and then in 100% ethanol for 20s twice, and finally 
incubated in xylene for 5min for twice. The slides were then immersed in fresh 
xylene and directly mounted with Pertex (Histolab, Gothenburg, Sweden) and 
Premier Cover Glass (Leica), and the bubbles on sections were removed by applying 
pressure using forceps. The slides were then left on ventilated downdraft table to dry 
and stored in dry place at room temperature. 
To counter stain fluorescence sections, DAPI diluted 1/500 or 1/1000 in PBS were 
applied to the sections, 100μl per slide and incubated at room temperature for at least 
15min, protect from light. The slides were then washed with PBS for 5min twice, and 
mounted with Permaflur Aqueous Mounting Medium (Thermo Scientific) and 
Premier Cover Glasses (Leica) were directly applied without dehydration, and the 
slides were stored at 4°C, protected from light after drying. 
 
2.16 Fluorescence immunocytochemistry 
To prepare the slides, cells were first plated in 4-well or 8-well chamber slides 
(Millipore or Nalge Nunc International, Thermo Scientific). After required treatment, 
the cells were washed with ice-cold PBS, and fixed in ice-cold methanol (Fisher 
Scientific) for 20min on ice. The cells were then washed again with ice-cold PBS for 
twice, and stored at 4°C resting in PBS for up to 1 month. 
For immunocytochemistry, the cells were washed in PBS at room temperature for 
5min, and then blocked and also permeabilised by adding permeabilisation to the 
cells and incubating at room temperature for 20min. The component of 
permeabilisation was similar to serum block (refer to Section 2.14.5 above for the 
recipe) but containing 0.2% (v/v) IGEPAL CA-630 (Sigma-Aldrich). 
The cells were then stained as described above from Section 2.14.6, but the volume 
of diluted antibodies and Tyramide varied from 25 to 50μl per chamber depending on 
the size of chambers. After the counter stain, the chambers were removed following 
manufacturer’s instruction, and the slides were mounted with Permaflur Aqueous 
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Mounting Medium (Thermo Scientific) and Premier Cover Glass (Leica), then stored 
at 4°C, protected from light after dried. 
 
2.17 Nuclear diameter measurement and cell counting 
It had been demonstrated that the nuclear diameter of germ cells increases during 
development (Hilscher et al. , 1974). Correlation of this parameter with the germ cell 
development has been confirmed in the human fetal ovary (Anderson et al., 2007, 
Martins da Silva et al., 2004), indicating that it can be used as a marker of 
development. Therefore, nuclear diameter measurement was used in this study to 
indicate the germ cell maturation. 
The images of fluorescence stained whole sections were taken using LSM 710 
Confocal Microscope (Carl Zeiss, Oberkochen, Germany) and Zen 2009 or 2011 
software (Carl Zeiss). 
For nuclear diameter measurement, 10 random pictures with scale bars were picked 
manually from each image, containing both the edge and central area. The pictures 
were then moved to Seterology System (Carl Zeiss), and each nucleus was measured 
at pixels on two axial directions (longest and shortest) using the measure function of 
Image-Pro Plus software (Media Cybernetics, Rockville, USA). The average of two 
numbers was calculated as the final diameter. By relative to the scale bars, the 
original pixel unit was transferred to μm unit. 
To count the cells, the image of whole section or 2-6 random pictures picked 
manually from images were used depending on the size of sections. To count the 
cells, plugin Cell Counter of ImageJ (NIH) was used. Cells were sorted to different 
groups by the pattern of co-localisation, and the number of cells in each group was 
counted manually by selecting the cell types and clicking cells of corresponding 
group once per cell. The numbers of clicks were automatically recorded as cell 
numbers by the plugin, and the results were finally exported as Microsoft Excel files 
using ImageJ. 
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The data were analysed using Microsoft Excel 2003 or 2010 and GraphPad Prism 5 
software. The normality of data was analysed by D'Agostino & Pearson omnibus 
normality test. As the results showed that these were not normally distributed, the 
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Chapter 3. Validation of Novel Methodologies 
3.1 Introduction 
The previous chapter describes in detail the methods applied in my research Most of 
these were developed based on manufacturer’s protocol and/or published works, and 
thus further discussion of them is not required.  
However, in this study, novel primers designed by myself, new antibodies and 
methods were also utilised. Despite some of them being used in, or reported by other 
studies, they had not been used in our lab and/or for the same experiments before. 
Therefore, it is necessary to validate these new materials/methods. In this chapter, I 
show how I verified these new materials and methods to make sure that the results I 
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3.2 Results 
3.2.1 Validating the specificity of PCR primers 
Most of the primers used in my experiments were designed by me (for detailed 
design methods and primer list see Section 2.4.1 and Table 2.1). They were then 
checked on BLAST website (see Section 2.4.1) in Nucleotide Blast against human 
reference RNA sequence with default settings except the “Expect threshold” option 
was adjust to 1000, and only primers with low self-complementarity and high 
specificity (i.e the first several nucleotides at 5’ end were not identical to any other 
human reference RNA sequence) were selected, to reduce the possibility that 
non-specific products would be amplified.  
The PCR products generated with these primers were not sequenced. Instead, to test 
them, all primers were initially used in end-point PCR reactions using +RT and –RT 
human fetal ovary cDNA samples as template, and the products of these were run in 
agarose electrophoresis with ladders to see whether they were the predicted size (see 
Sections 2.4 and 2.5). RPL32 primers were also used as a positive control to detect 
whether the PCR was working properly and whether there was contamination in the 
–RT samples. After electrophoresis, all tested primers show a clear single band of the 
correct predicted size (except a faint band of 150bp appeared in the +RT of TEX14), 
indicating that these are the expected products (Figure 3.1). Although the gel images 
of four primer pairs are shown here (as examples), this procedure was applied to all 
the primers used. 
For qRT-PCR, the primers were first used to create a standard curve (Figure 3.2) of 
serially-diluted human fetal ovary cDNA (Section 2.4.3), during which the melt 
curves that revealed the amplifying efficiency were also recorded (Figure 3.3). 
Figure 3.2 shows the standard curves (slope value) of selected primer pairs, and 
when slope=-3.32 the DNA is ideally duplicated during each reaction cycle. The R2 
values that represented the correlation coefficient of these stand curves were also 
calculated and all were around 0.99. The melt curves of all primer pairs showed only 
single peak, suggesting that for each primer pair, only a single amplicon was 
produced in the qRT-PCR reaction include TEX14, which showed an unspecific band 
in end-point PCR. The melt curve peaks of different primer pairs clustered around 
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79-89ºC, all above the Tm value of primers, indicating that the size of these products 
is above those of the primers (Figure 3.3). The melt curves were also created during 
every qRT-PCR performed to make sure that only a single product of consistent 





Figure 3. 1 The agarose gel images of PCR products generated from selected primer 
pairs using human fetal ovary cDNA as template.  
TEX14 and SOX17 primers were designed by me, and TEX19 and RPL32 primers were 
designed by staff of our lab. The predicted size of the products was TEX14=248bp, 
TEX19=220bp, SOX17=185bp, RPL32=153bp. Bands matched the right size when 
compare with ladders. No bands were detected in the –RT reactions. 
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Figure 3. 2 Standard curves of selected primer pairs for qRT-PCR.  
The slope values represent the efficiency of qRT-PCR. The slope value of each primer pairs 
are as follows: TEX14=-3.48, TEX19=-3.23, SOX17=-3.74 and RPL32=-4.07. The R2 values 
recorded in all my experiments were around 0.99, suggesting that the scattered points in 
each slope showed a high linear dependence. 
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Figure 3. 3 The melt curves of qRT-PCR products using selected primers used during 
the PhD project.  
All the products showed a single, unique peak ranges between 79 to 89ºC, indicating that only 
a single specific amplicon was generated during the qRT-PCR. 
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3.2.2 Specificity of the Dazl and Boll antibodies on mouse 
To test the antibodies, we first performed DAB immunohistochemistry for Dazl and 
Boll on sections of adult mouse testis, before performing fluorescence 
immunohistochemistry, using rabbit anti-Dazl and mouse anti-Boll antibodies (see 
Section 2.15). No commercial available anti-Boll antibody has been shown to be 
specific on mouse, therefore we used the mouse anti-Boll antibody which can detect 
human BOLL. As the tissue is from mouse, and the Boll antibody raised in mouse, 
the Mouse on Mouse Polymer IHC kit (Abcam) was used for Boll staining. Each 
experiment was performed on sections from at least two individuals. Figure 3.4 show 
the images at both 10× and 40× magnification. Dazl is mainly distributed in the 
cytoplasm of germ cells at earlier stage of development (from spermatogonia to 
pachytene) across the edge of tubules, and it also show some weak staining in round 
spermatids (Figure 3.4), which is consistent with published data (Nicholas et al. , 
2009, Ruggiu et al., 1997). Boll expression is absent from spermatogonia and germ 
cells at early stage of development but dramatically increases in germ cells at later 
stages of meiosis prophase I (especially pachytene), and has some strong staining in 
round spermatids as well (Figure 3.4). This is also consistent with a previous report 
(VanGompel and Xu, 2010). No signal was detected in the negative control (primary 
antibody replaced by serum block), and these data suggest that our Dazl and Boll 
antibodies are both working effectively and specifically on mouse tissue. For a more 
accurate validation of antibodies, the combination of primary antibodies and the 
corresponding peptides which were used to raise them is a more robust choice of 
negative control. However, none of these peptides were commercially available from 
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Figure 3. 4 DAB immunohistochemistry performed on adult mouse testis with rabbit 
anti-Dazl and mouse anti-Boll antibodies.  
Left panels (A, C and E) are the 10× low power images to show the general distribution. 
Both Dazl and Boll are extensively expressed in the tubules. A) Dazl is distributed in germ 
cells at earlier stages which are located at the periphery of tubules whilst Boll is absent in 
these cells. C) Boll is extensively expressed in germ cells at later stage of meiosis 
prophase I. Right panels (B, D and F) are high resolution 40× images to show the details of 
the staining. B and D) Dazl but no Boll is expressed in the spermatogonia (arrows), and 
both proteins are expressed in pachytene spermatocytes (arrowheads) and round 
spermatids (asterisks). E and F) No non-specific staining detected in negative controls. 
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3.2.3 DAZL and BOLL proteins are successfully expressed in 
HEK293 cells after transfection 
To identify potential DAZL/BOLL targets, we transfected human cell lines with 
plasmid vectors encoding recombinant human DAZL or BOLL (with FLAG and Myc 
epitope tags) and compared mRNA target expression with empty vector transfected 
cells. We first used HEK293 cells to see whether DAZL/BOLL proteins were 
expressed successfully after transfection. Cells were transfected with either 
pCMV6-DAZL, pCMV6-BOLL or pCMV6-Entry (the latter being an empty vector, 
and will be referred to subsequently as the ‘Control’). Western blotting was 
performed to detect protein expression 48h after transfection. As the recombinant 
DAZL/BOLL proteins are FLAG-tagged, three primary antibodies (anti-DAZL (AbD 
Serotec), anti-BOLL (Abcam) and anti-FLAG (Sigma-Aldrich)) were used. On each 
set of blots, containing lysates of each of the empty vector, DAZL, and BOLL 
transfected cells, bands of the expected size (DAZL=36.8kDa, 33.2kDa of 
DAZL+3.6kDa of FLAG-Myc tag; BOLL=34.9kDa, 31.3kDa of BOLL+3.6kDA of 
FLAG-Myc tag) were detected by the appropriate antibodies (Figure 3.5), with no 
bands of the expected size in the control (empty vector-transfected) lanes, suggesting 
that the appropriate proteins were expressed, and could be specifically detected by 
the relevant antibodies without cross-reactivity between DAZL and BOLL. 
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Figure 3. 5 Western blotting for FLAG-tagged DAZL/ BOLL transfected HEK293 cells.  
DAZL, BOLL and FLAG antibodies were used as the primary antibodies. Each set of blots 
include proteins isolated from pCMV6-Entry (C), pCMV6-DAZL (D) or pCMV6-BOLL (B) 
transfected HEK293 cells. DAZL and BOLL antibodies detected a single band in DAZL/BOLL 
expressing samples, respectively; each band has the same size as the one detected by FLAG 
antibody in corresponding lanes. No similar signals were found in the empty vector 
(pCMV6-Entry) transfected cells, suggested that the corresponding proteins were only 
produced by and detected in the transfected cells and therefore the vectors are functional.  
anti-FLAG 
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3.2.4 Specificity of the DAZL and BOLL antibodies on human 
After testing the specificity of these antibodies in western blotting, we next test the 
specificity of these antibodies (mouse anti-DAZL (AbD Serotec)), mouse anti-BOLL 
(Abcam) and rabbit anti-DAZL (Cell Signaling Technologies)) for use in 
fluorescence immunocytochemistry on pCMV6-DAZL, pCMV6-BOLL or mock 
transfected HEK293 cells, to some antibodies may only be appropriate for western 
blotting or had not previously been reported to work in immunocytochemistry. Each 
antibody was applied to all three types of transfected cells, and as in the western 
blotting, both the anti-DAZL antibodies detected antigens in only DAZL-transfected 
cells, whilst the staining in BOLL-transfected cells only appears when using the 
anti-BOLL antibody (Figure 3.6). In addition, no signal was detected in mock 
transfected cells, suggesting that all the antibodies are also specific when applied 
with immunocytochemistry methods.  
Together, these results confirm that the anti-DAZL and anti-BOLL antibodies we 
used could effectively and specifically detect human DAZL or BOLL proteins using 
both western blotting and immunohistochemistry/immunocytochemistry.   
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Figure 3. 6 Specificity of DAZL and BOLL antibodies in fluorescence immunocytochemistry.  
Each image shows the HEK293 cells transfected with DAZL or BOLL vectors, or mock (only 
treated by transfection reagent) transfected cells. Both anti-DAZL antibodies detected DAZL+ve 
cells in only DAZL transfected cells, and similarly the anti-BOLL antibody detected BOLL+ve cells in 
only BOLL transfected cells. No signal was detected in mock transfected cells. Counter stained 
with DAPI, Scale bar=20μm 
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3.2.5 Establishing stably transfected TCam-2 cells expressing 
DAZL or BOLL 
TCam-2 cells are a cell line generated from human germ cell (male) tumor (Mizuno 
et al. , 1993). Previous studies have demonstrated that TCam-2 cells express several 
germ cell and meiosis markers at both the mRNA and protein levels, (de Jong et al. , 
2008a, de Jong et al. , 2008b, Eckert et al. , 2008, Nettersheim et al. , 2011) but do 
not express DAZL or BOLL protein (our unpublished work), and thus they might be 
a better model to study the functions of DAZL and BOLL than HEK293 cells.  
We first tried to transfect the TCam-2 cells with the same transient methods which 
were applied to HEK293 cells as described in previous sections (See Section 2.7). 
However, no protein was detected following western blotting (data not shown). This 
might be due to the low transfection ratio of TCam-2 cells of ~15% (which was 
confirmed by the experiments of other projects in our lab). Therefore, we decided to 
establish a stably transfected TCam-2 cell line using G418 selection as the vectors 
contained a neomycin resistance gene. TCam-2 cells were transfected with either 
pCMV6-DAZL, pCMV6-BOLL or pCMV6-Entry (empty) vectors and then cultured in 
media which contained G418 (see Section 2.6). After selection, RT-PCR was 
performed. Cells transfected with pCMV6-DAZL or pCMV6-BOLL showed a very 
strong band when using corresponding primers indicating that the vectors had been 
stably integrated and were expressing mRNA (Figure 3.7A). However, when we tried 
to detect the proteins by western blotting with both DAZL and FLAG primary 
antibodies, no specific bands were detected in the stably transfected samples (Figure 
3.7B). A strong band at the predicted size of DAZL appeared in the lanes of 
transfected HEK293 cells (the positive control) however, suggesting that the western 
blotting was effective (Figure 3.7B). Similar experiments were performed on the 
BOLL stably transfected cells and the results were similar (data not shown). 
Furthermore, we used immunocytochemistry to test the protein expression (Figure 
3.7C). However, no cytoplasmic staining was seen in the pCMV6-DAZL transfected 
cells and there was no difference between pCMV6-DAZL or empty vector stably 
transfected TCam-2 cells (Figure 3.7C). In addition, clear cytoplasmic staining 
occurred in the pCMV6-DAZL transfected HEK293 cells, indicated that the 
immunocytochemical method was also effective (Figure 3.7C), and although the 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
 
Chapter 3. Validation of Novel Methodologies 
117 
stably transfected TCam-2 cells were expressing the mRNA, no DAZL or BOLL 
protein was produced. 
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Figure 3. 7 Detection of mRNA and protein for stably transfected TCam-2 cells.  
A) RT-PCR for the stably transfected TCam-2 cells. When using the DAZL primers, a very 
strong band appeared in only the +RT of pCMV6-DAZL transfected sample, and so did the 
BOLL primers. A faint band occurred in the –RT of pCMV6-DAZL samples, possibly caused 
by residual plasmid contamination. RPL32 was used as the positive control for RT-PCR. B) 
Western blotting with DAZL or FLAG primary antibodies for stably transfected TCam-2 cells 
and transiently transfected HEK293 cells. C=Control (empty vector), D=DAZL. No specific 
band is detected in all the lanes of TCam-2 samples and empty vector transfected HEK293 
cells, and strong bands of DAZL appeared in the lanes of DAZL expressing HEK293 samples. 
C) Immunocytochemistry of stably transfected TCam-2 cells and transiently transfected 
HEK293 cells. The pCMV6-DAZL transfected TCam-2 cells only show very weak background 
nuclear staining and could not be distinguished from the empty vector transfected cells 
(unfilled arrows). In contrast, the DAZL expressing HEK293 cells (positive control) have very 
clear cytoplasm staining (arrows). Scale bar=20μm 
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3.2.6 pCMV-DAZL vector is successfully expressed in TCam-2 
cells 
After the unsuccessful attempt to make stably transfected TCam-2 cells, it appears 
that the translation of protein of pCMV6 vectors was blocked in TCam-2 cells, based 
on the fact that the pCMV6 vectors produced proteins in HEK293 cells, but only 
RNA in TCam-2 cells. We then sought other vectors and obtained a pCMV-DAZL 
vector (recombinant human DAZL tagged with T7, provided by Dr. Joao Pedro 
Sousa Martins from Prof. Nicola Gray’s group, MRC CRH).  
To test the vector, TCam-2 cells and HEK293 cells were transiently transfected with 
the pCMV-DAZL or pCMV6-DAZL vectors, and western blotting or 
immunocytochemistry with primary antibody against DAZL performed to test 
protein expression. By western blotting (Figure 3.8), a clear band was detected in the 
lane of pCMV-DAZL transfected TCam-2 cells (~34kDa) and also in the lane of 
pCMV6-DAZL transfected HEK293 cells (i.e. positive control, Figure 3.8A), No 
bands of the correct size were detected in the lane containing lysates from control 
vector (pCMV6-Entry) transfected TCam-2 cells. The small size difference may due 
to the different tags on the DAZL protein – the FLAG-Myc tagged DAZL is ~37kDa 
and the T7 tagged DAZL is 34.3kDa (33.2kDa of DAZL+1.1kDa of T7 tag). Similar 
results were also obtained by immunocytochemistry. Clear cytoplasmic staining was 
detected in the pCMV-DAZL transfected TCam-2 cells and also pCMV6-DAZL 
transfected HEK293 cells, but no such staining was found in the mock transfected 
(only treated with transfection reagent TransIT-LT1) TCam-2 cells. These 
experiments indicate that the pCMV-DAZL vector is effective at producing DAZL 
protein when transfected into TCam-2 cells. 
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Figure 3. 8 The pCMV-DAZL vector is expressed in TCam-2 cells.  
TCam-2 cells were transfected with pCMV-DAZL, and HEK293 cells transfected with pCMV6-DAZL 
vectors were used as the positive control. A) Western blotting for DAZL transfected cells. The 
bands of DAZL protein are detected in both DAZL expressing TCam-2 and HEK293 cells (positive 
control), and no bands at the size of DAZL are detected in empty vector transfected TCam-2 cells. 
The size difference of the DAZL bands between the TCam-2 and HEK293 is probably due to the 
different tags on DAZL protein (34kDa in TCam-2 transfected with T7 tagged pCMV vectors and 
37kDa in HEK293 transfected with FLAG+Myc tagged pCMV6 vectors. TC=TCam-2, 
HEK=HEK293, D=DAZL, C=Control (empty vector). B) Fluorescence immunocytochemistry for 
DAZL expressing cells. Green DAZL staining (arrows) is seen in both DAZL transfected TCam-2 
cells (left panel) and HEK293 cells (right panel) with pCMV and pCMV6 vectors respectively, 
however most TCam-2 cells are still DAZL-ve (unfilled arrows). No green staining is found in mock 
transfected TCam-2 cells (middle panel), suggesting that the DAZL staining is specific. Counter 
stained with DAPI, Scale bar=20μm 
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3.2.7 Establishment of the co-transfection/FACS system for 
TCam-2 cells 
Although we demonstrated that TCam-2 cells could express DAZL protein when 
transfected with the pCMV-DAZL vector, the transfection ratio of these cells was still 
very low, which made it very difficult to observe effects after transfection. Moreover, 
it was not possible to make a stable line with this vector as it does not contain an 
antibiotic resistance marker for selection in eukaryotic cells. To solve this problem, 
we developed a co-transfection/FACS system with a second, GFP-expressing vector, 
to separate the transfected/untransfected cells based on previous reports that cells 
co-transfected with two fluorescent reporters generally express both proteins (Susa et 
al. , 2008). The TCam-2 cells were transfected with both pCMV-DAZL and 
pEGFP-C1 vectors for 48h. Cells were then harvested and sorted by 
Fluorescence-Activated Cell Sorting (FACS) detecting the GFP fluorescence. DAPI 
was also added to mark the dead cells before FACS and the staining was detected by 
another gate to ensure the cells collected during FACS were live. 
To test this system, western blotting was first applied to the sorted cells. Three 
replicates were performed on different passages of cells. The blots were incubated 
with anti-DAZL, anti-GFP and anti-α-tubulin primary antibodies. α-tubulin was 
detected in all the lanes, demonstrating equivalent loading of protein. Bands 
corresponding to DAZL and GFP were detected in the lanes of transfected cell 
suspension before FACS (unsorted) and GFP+ve cells. No similar bands were seen in 
GFP-ve cells. Furthermore, both DAZL and GFP bands were much stronger in the 
lane of GFP+ve cells compared to the unsorted cells, implying that both GFP and 
DAZL proteins were enriched in the GFP+ve cells (Figure 3.9A). To semi-quantify the 
western blotting, the intensity of DAZL and GFP bands relative to α-tubulin was 
determined. Because of high background, the average value of GFP-ve cells became 
negative. The data were analysed using paired t-test. When compared to the mock 
transfection, the intensity of the DAZL band increased 3.66±0.79 fold in GFP+ve cells, 
and GFP increased for 3.54±0.62 fold, both were significant (p<0.05, n=3). In 
contrast, almost no DAZL or GFP protein was found in the GFP-ve samples (Figure 
3.9B). 
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qRT-PCR was also used to compare the mRNA levels of DAZL and GFP between 
GFP+ve and GFP-ve cells. The experiments were performed 5 times on different 
passages of cells and each sample was replicated for twice for qRT-PCR. The 
average Ct value was calculated and the results were related with RPL32. Data were 
analysed with paired t-test. Both DAZL and GFP mRNA levels in the GFP+ve cells 
were significantly higher than those in the GFP-ve cells (Figure 3.9C), suggesting that 
DAZL was enriched in GFP+ve cells at both mRNA and protein levels, and thus the 
co-transfection/FACS system effectively separates the GFP+ve/DAZL+ve and 
GFP-ve/DAZL-ve TCam-2 cells.  
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Figure 3. 9 The GFP and DAZL expression in co-transfected TCam-2 cells after FACS at 
both protein and mRNA levels.  
A) Western blotting for GFP+ve, GFP-ve and unsorted TCam-2 cells. Both the GFP+ve and 
unsorted samples show bands for DAZL and GFP proteins, and no bands at similar sizes are 
detected in GFP-ve cells. B) Quantification of the western blotting. DAZL increases 3.66±0.79 
and GFP increases 3.54±0.62 fold after sorting when compared to the unsorted cells, and the 
amount of DAZL or GFP protein is extremely low in the GFP-ve cells. n=3, *p<0.05, **p<0.01. C) 
qRT-PCR to quantify the mRNA expression of DAZL and GFP in GFP+ve and GFP-ve TCam-2 
cells. Both DAZL and GFP mRNA are expressed significantly higher in GFP+ve cells, all relative 
to RPL32. n=5, **p<0.01 
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3.2.8 Establishment of RNA immunoprecipitation experiments 
using human DAZL 
To investigate the interaction between DAZL protein and its mRNA targets, we also 
established RNA immunoprecipitation (RIP) experiments to immunoprecipitate 
DAZL and then isolate/determine the RNA which was co-precipitated with the 
DAZL protein. Despite this antibody has not been reported to be used for RIP in 
other studies, it is stated by the manufacturer that being suitable for RIP and the 
recommended concentration is given.   
HEK293 cells were co-transfected using the combination of Luciferase vectors (see 
Table 3.1) which were conjugated with GAPDH or TEX14 3’-UTR, together with 
pCMV6-Entry (empty) or pCMV6–DAZL vectors for 48h, and then DAZL protein 
was immunoprecipitated using the Millipore RIP kit (see Section 2.8). Western 
blotting was applied on the protein samples before (Input) and after 
immunoprecipitation (RIP) to find out whether the DAZL was expressed and 
precipitated successfully. The mouse anti-DAZL, rabbit anti-DAZL and also mouse 
anti-α-tubulin were used as primary antibodies. Emission spectra 680nm (red 
channel) anti-rabbit IgG and emission spectra 800nm (green channel) anti-mouse 
IgG antibodies were used as secondary antibodies.  










Figure 3.10A shows the western blot for Input samples. Two red DAZL bands 
detected by rabbit anti-DAZL antibody were seen only in the lanes from DAZL 
co-transfected samples. The mouse anti-DAZL antibody also detected DAZL-sized 
bands at the same size in these two lanes, suggesting that DAZL was expressed in the 
DAZL co-transfected cells before RIP. After RIP (Figure 3.10B), the rabbit 
anti-DAZL antibody detected not only the DAZL bands in DAZL-transfected 
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samples, but also the antibody heavy chain and light chain in all the lanes, because 
this antibody was also the one used to precipitate DAZL. In contrast, in channel 800 
(Green) only two DAZL bands appeared in the DAZL transfected samples and no 
band of α-tubulin or heavy/light chain was seen. Both the merged images of INPUT 
and RIP showed that the red and green bands of DAZL detected by different primary 
antibodies completely overlapped (yellow), indicating that DAZL is specifically 
expressed in the DAZL co-transfected cells and successfully precipitated in RIP 
experiments, without detectable contamination of other proteins such as α-tubulin. 
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 Figure 3. 10 DAZL protein is successfully precipitated in the RIP experiments.  
A) The western blotting for INPUT samples before RIP. Both mouse and rabbit anti-DAZL antibodies 
detect DAZL bands (~37kDa) only in the lanes of DAZL transfected samples, and the mouse 
anti-α-tubulin (loading control) detects the bands of α-tubulin (~50kDa) at the expected size in all the 
lanes. B) Western blotting for the RIP samples. The rabbit anti-DAZL antibody detects the bands of 
its own heavy (~50kDa) and light (~25kDa) chain in all the lanes and two DAZL bands in only DAZL 
transfected samples. The mouse anti-DAZL antibody also detects the same DAZL bands in DAZL 
transfections, and no α-tubulin is found in these blots, suggesting that DAZL is specifically 
precipitated in the experiments.  
CG=Entry+GAPDH-Luc, CT=Entry+TEX14-Luc, DG=DAZL+GAPDH-Luc, DT=DAZL+TEX14-Luc 
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3.3 Conclusion 
In this chapter, the results obtained in validation experiments are shown, to verify the 
novel materials and methods applied during this PhD project. 
For PCR, the quality of primers was strictly controlled from the step of design. The 
products of all the primers used show a band of predicted size in agarose 
electrophoresis following end-point PCR, as well as a single peak in melt curve 
during qRT-PCR, suggests that only single product was created from each primer pair. 
Therefore, all the primers should be specific. However this procedure could still be 
improved by cloning and sequencing the PCR products to further confirm the 
specification. 
For the validation of antibodies, the antibodies used are specific for both western 
blotting and immunohistochemistry on human protein. The mouse anti-DAZL 
antibody (AbD Serotec) and the mouse anti-BOLL antibody (Abcam) have not been 
previously reported on mouse tissue. However both Dazl and Boll show identical 
staining expression comparing to the previous studies (Ruggiu et al., 1997, 
VanGompel and Xu, 2010). Furthermore, data using the mouse anti-DAZL antibody 
in immunohistochemistry have been published by both our lab and another lab 
(Anderson et al., 2007, Conrad et al. , 2014). 
The novel methods, namely transfection/FACS and RIP, although never been applied 
by our lab, both work successfully as described in previous sections. In addition, the 
RIP had been successfully applied by Reynolds et al. (2005) and Jiao et al. (2002) to 
identify the mouse Dazl targets, suggested that it is an effective method for this 
purpose. Overall, the experiments described in this chapter confirmed the efficiency 
of the new materials and technologies, and these are all necessary for the aims of this 
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Chapter 4. DAZL and BOLL Expression during Human and 
Mouse Germ Cell Development in Fetal Ovary 
4.1 Introduction 
DAZL and BOLL are RNA-binding proteins from the DAZ family, of which all three 
members (DAZ, DAZL and BOLL) are expressed in germ cells (Eberhart et al., 1996, 
Reijo et al., 1995, Saxena et al., 1996) and can bind to, and regulate the translation of, 
their mRNA targets (Collier et al., 2005). DAZL is expressed only in vertebrates, 
whilst BOLL is expressed in almost all the metazoans. Both DAZL and BOLL are 
associated with infertility and subfertility phenotypes in both human and model 
animals (Eberhart et al., 1996, Karashima et al., 2000, Lin et al., 2009, Ruggiu et al., 
1997, Tung et al., 2006b, Tung et al., 2006c, VanGompel and Xu, 2010). 
Dazl-deficiency leads to sterility in both sexes of mice (Ruggiu et al., 1997)In 
humans, four DAZL mutations and seven SNPs have been identified that are 
associated with subfertility phenotypes in both sexes, such as azoospermia, sperm 
count, early menopause and ovarian failure (Tung et al., 2006b, Tung et al., 2006c).    
Compared to DAZL, BOLL has not been extensively studied, although several 
studies have suggested that Boll is required for the germ cell development in various 
species from flies and worms, to fish and mice (Eberhart et al., 1996, Karashima et 
al., 2000, VanGompel and Xu, 2010). In mice, Boll deficiency leads to infertility in 
males only, due to post-meiotic spermatogenic defects at elongating spermatid stage, 
whereas females are fertile (VanGompel and Xu, 2010). A similar sex-biased 
phenotype of azoospermia also occurs in bol-deficient Drosophila (in which bol 
expression is male specific as well) (Eberhart et al., 1996) and C.elegans (in which it 
causes sterility in hermaphrodites, affecting oogenesis) (Karashima et al., 2000), and 
both organisms show meiosis arrest phenotypes. There are fewer relevant studies on 
human BOLL compared to model animals. Kostova et al. (2006) demonstrated that 
reduced BOLL expression is associated with human spermatogenic failure, including 
Sertoli cell only syndrome and meiosis arrest, and higher levels of BOLL transcripts 
were detected in azoospermia patients with successful sperm retrieval when 
compared to patients in which it failed (Lin et al., 2005). However, no studies have 
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documented how BOLL functions during human oogenesis.  It has been suggested 
that Boll protein is not produced in the mammalian female germline, (as occurs in 
Drosophila) although low levels of transcripts have been detected in the mouse ovary 
(Eberhart et al., 1996, Shah et al., 2010, Xu et al., 2001). 
The macroscopic phenotypes caused by the loss of DAZL and BOLL reveal their 
microscopic functions during germ cell development. In Xenopus, dazl is necessary 
for early germ cell migration to the genital ridge and also the maintenance of a 
normal number of germ cells (Houston and King, 2000). The mouse Dazl-/- sterility 
phenotype arises from a meiotic arrest at early pachytene in females and at leptotene 
in males in mice with an outbred genetic background (Ruggiu et al., 1997, Saunders 
et al., 2003). On an inbred background, earlier defects are observed, with germ cell 
loss in males due to apoptosis by e15.5 (Lin and Page, 2005) and a failure to enter 
meiosis appropriately in female germ cells (Lin et al., 2008). Dazl is also reported to 
be required for sexual differentiation (Gill et al. , 2011), mRNA transport through 
interaction with the dynein motor complex in mouse germ cells (Lee et al., 2006), 
and epigenetic programming and maintaining the pluripotency of mouse PGCs 
(Haston et al., 2009). In contrast, the functions of BOLL are still unclear. It seems to 
promote G2/M transition in Drosophila meiosis by regulating its target twine 
(Eberhart et al., 1996), and is also has meiotic functions in C.elegans oogenesis 
based on the meiosis arrest phenotype in boll-deficient worms (Karashima et al., 
2000). Notably, both DAZL and BOLL are highly functionally conserved between 
species: human DAZL can partially rescue the mouse Dazl-/- phenotype (Vogel et al., 
2002), and human BOLL can rescue Drosophila boll-deficient phenotypes as well 
(Xu et al., 2002). This suggests that DAZL or BOLL functions might be highly 
conserved between human and model animals as well.  
Key to understanding the complicated functions of DAZL or BOLL during human 
germ cell development is establishing the expression period and patterns of DAZL 
and BOLL at particular stages of development. Several studies have revealed the 
expression of DAZL and BOLL in human testis (Anderson et al., 2007, Kostova et 
al., 2007, Lin et al., 2009, Luetjens et al., 2004, Reijo et al., 2000, Ruggiu et al., 
2000, Xu et al., 2001). In the testis, DAZL is extensively expressed at several stages 
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of spermatogenesis including spermatogonia, early and late spermatocytes, and 
post-meiotic cells (Reijo et al., 2000), whilst BOLL is mainly expressed in pachytene 
spermatocytes and persists through to germ cells forming early spermatids. The 
expression of DAZL and BOLL show minimal overlap (Lin et al., 2009, Luetjens et 
al., 2004, Xu et al., 2001), indicating they may have different functions at different 
stages of germ cell development (Xu et al., 2001). Furthermore, DAZL shows a 
dynamic pattern of translocation from nucleus to cytoplasm during human 
spermatogenesis (Reijo et al., 2000, Ruggiu et al., 2000), which may be an indicator 
of the activation of its RNA-binding function. 
Unlike the male, meiosis starts in human females during fetal life. To study 
oogenesis in humans, early ovarian development can be divided to three trimesters 
(see Section 1.2.1 and Figure 1.1). In humans, meiosis initiates at early second 
trimester and arrests as oocytes form primordial follicles in the late second trimester 
(Hartshorne et al. , 2009). In mice, meiosis initiates at e12.5 and arrests around 
postnatal day 0 (P0) (Borum, 1961). The figure below shows images of different 
developmental stages of human and mouse fetal ovaries, which were used in this 
study (Figure 4.1).   
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Figure 4. 1 Different stages of human and mouse fetal ovary development. 
A) Human fetal ovary development. In the first trimester, the primordial germ cells (arrows) and somatic cells (arrow heads) are not clearly distinguishable but 
germ cells have bigger, rounded nuclei. In the early second trimester, meiosis begins in the more mature germ cells (arrows) located in central area. The 
pre-granulosa cells (arrowheads) surround several germ cells to form nests (asterisk). In the late second trimester, nests in central area are broken-down by 
invading pre-granulosa cells (yellow arrowheads), which surround single growing germ cells (yellow arrows) to form primordial follicles. B) Mouse fetal ovary 
development. Meiosis initiates in mouse ovary at e12.5, therefore at e13.5 nests already formed (asterisk) and germ cells (arrow) are surrounded by 
pre-granulosa cells (arrowhead). At e15.5 meiosis reaches leptotene/pachytene, the size of germ cells (arrows) increases and they are still surrounded by 
pre-granulosa cells (arrowheads) in nests (asterisk). At P0 the nests also breakdown like in human, and single germ cells (yellow arrows) are surrounded by 
pre-granulosa (yellow arrowheads) cells to form the primordial follicles. Scale bar=20µm, human fetal ovary images by Dr Sharon Eddie 
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Previous work from our lab has demonstrated that the translocation of DAZL protein 
(as observed in human testis) also occurs during human oogenesis, and DAZL mRNA 
levels increase between the first and second trimester, co-incident with the entry of 
the first germ cells into meiosis in the human fetal ovary (Anderson et al., 2007). 
Another study suggested that DAZL is also expressed in the oocytes in human 
primordial follicles (Dorfman et al., 1999).  
Although Boll transcripts have been reported in the mammalian fetal ovary 
(Mandon-Pepin et al. , 2003, Shah et al., 2010, Vangompel and Xu, 2011), the 
existence of Boll protein in mammalian female germ cells has not yet been 
demonstrated. In this chapter, we will try to explore BOLL expression during human 
oogenesis, and also extend the existing knowledge on DAZL expression in the 
developing ovary by correlating it with specific meiotic stages. We will also compare 
the expression patterns of DAZL and BOLL in the developing ovaries of humans and 
mice, to find out whether the female mouse is an appropriate model in which to study 
the function of human BOLL.   
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4.2 Results 
4.2.1 DAZL and BOLL mRNA are expressed in human fetal ovary 
To find out whether DAZL and BOLL are expressed in human fetal ovary and how 
they associate with germ cell development, we first investigated the expression of 
DAZL and BOLL mRNA during human fetal ovary development, using qRT-PCR 
(Figure 4.2). 
Low levels of DAZL mRNA were expressed in first trimester ovaries, at 8 to 9 weeks 
gestation before meiosis when most germ cells are primordial germ cells. DAZL 
expression then increases significantly at 14 to 16 weeks gestation (p<0.001), i.e. 
early second trimester when meiosis starts, and remains at this level remains to late 
second trimester at 17 to 20 weeks gestation which represents the beginning of 
follicle formation (Figure 4.2A, n=5-6 samples per gestation group).  
There is almost no BOLL mRNA expression in first trimester, and its mRNA level 
also significantly increases at early second trimester (p<0.001). However, when 
compared to the early second trimester, the level of BOLL mRNA slightly decreases 
in late second trimester but not significantly (Figure 4.2B, n=5-6 samples per 
gestation group). Relative to RPL23, expression of BOLL was around half that of 
DAZL at 14-16 and 17-20 weeks gestation (0.017+/-0.005 vs 0.010+/-0.001). Both 
data of DAZL and BOLL were analysed using One-Way ANOVA with Tukey's 
multiple comparisons test; the normality of data was not able to be analysed due to 
the small sample number. 
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Figure 4. 2 Expression of DAZL and BOLL mRNA during human ovary development.  
A) DAZL significantly increases from 8-9 to 14-16 weeks, with no significant change 
thereafter. B) BOLL expression is not detectable at 8-9 weeks and also significantly 
increases at 14 to 16 weeks. There is no significant change between 14-16 and 17-20 
weeks (n=5-6, value=mean±s.e.m. ***p<0.001 vs 8-9 weeks for both DAZL and BOLL). 
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4.2.2 DAZL and BOLL proteins show dynamic changes during 
germ cell development in human fetal ovary 
After confirming the specificity of the DAZL and BOLL antibodies (see Section 
3.2.4), we used fluorescence immunohistochemistry on human fetal ovary sections to 
investigate DAZL and BOLL protein expression during germ cell development. All 
the experiments were performed on at least 2 sections from 2 different individuals. 
On day 65, before the germ cells enter into meiosis (Figure 4.1A, first panel), only 
DAZL was expressed, and was detected in these primordial germ cell nuclei and 
cytoplasm (Figure 4.3A). BOLL was not detected in either germ cells or somatic 
cells (Figure 4.3A). However, at 14 weeks of gestation, following the initiation of 
meiosis (Figure 4.1A, second panel), both DAZL and BOLL were found to be 
expressed in germ cells. Notably, DAZL translocated from the nucleus to cytoplasm 
at this stage, and BOLL appeared in a limited number of cells (Figure 4.3B). At 18 
weeks gestation, when germ cells began to enter into the later stages of meiosis, 
DAZL was still expressed extensively and BOLL expression became more abundant 
(Figure 4.3C). Finally at 19 weeks gestation, when germ cells were forming follicles 
together with pre-granulosa cells (Figure 4.1A, third panel), DAZL was expressed in 
the oocytes of primordial follicles whilst BOLL expression became less abundant, 
with no BOLL protein detectable in primordial follicles (Figure 4.3D). The dynamic 
changes of DAZL and BOLL protein expression in human fetal ovary are consistent 
with their mRNA expression described above (Section 4.2.1), i.e. DAZL showed a 
low expression in first trimester and then increased after meiosis initiation and stays 
at a high level through later stages, including in primordial follicles.  In contrast, 
BOLL is not expressed in first trimester, increases in the second early trimester but is 
not detected in primordial follicles. 
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  Figure 4. 3 (1/2) Dynamic changes in DAZL and BOLL protein expression during 
development of the human fetal ovary.  
Both proteins (green colouration) are germ cell specific. At 65 days, DAZL expression was 
both nuclear and cytoplasmic, whilst BOLL was not detected (A). At 14 week, both 
cytoplasmic DAZL and BOLL expression was detected in groups of germ cells, but the 
number of BOLL+ve was relatively small (B).  
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Figure 4. 3 (2/2) Dynamic changes in DAZL and BOLL protein expression during 
development of the human fetal ovary.  
At 18 week, DAZL was still abundantly expressed in germ cells and the abundance of 
BOLL+ve cells increased (C). At 19 week DAZL expressed in the oocytes within 
newly-formed primordial follicles (arrows) whilst the number of BOLL+ve cells decreased, 
and no primordial follicle was found BOLL+ve (D). 
Counter stained with DAPI (blue), Scale bar=20μm 
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4.2.3 DAZL and BOLL expression represents distinct groups of 
germ cells 
As DAZL and BOLL are both expressed in human fetal ovary and display dynamic 
changes during germ cell development, the next question we asked was whether 
these changes were associated with their functions, and whether these two proteins 
from the same family have similar or different functions during this process. To 
answer these questions, we further investigated the co-expression patterns of DAZL 
and BOLL using dual fluorescence immunohistochemistry. As BOLL is not 
expressed in the first trimester human fetal ovary, only early and late second 
trimester tissues were used.  
We first took the tiled images of the tissue to see their broad distribution at the tissue 
level. The images show that at 14 weeks gestation, DAZL is extensively expressed in 
both the peripheral and central areas of the ovary, whilst BOLL expression is 
restricted in small groups of germ cells in the central area (Figure 4.4A). At 18 weeks 
gestation, most cells that express DAZL are around the periphery of the ovary, with a 
few DAZL+ve cells localised in the central area. The number of BOLL+ve cells 
dramatically increased when compared with 14 week and they are all located in the 
central area (Figure 4.4B). Interestingly, only very few cells expressed both DAZL 
and BOLL at any gestation. 
To further investigate the degree of co-expression, we took high resolution images 
for DAZL and BOLL dual immunohistochemistry (Figure 4.5).  The 14 week tissue 
has both DAZL and BOLL expression: most cells are DAZL+ve, with several 
BOLL+ve cells. Few cells expressing both DAZL and BOLL are also found in this 
section. The 18 week tissue clearly shows a higher proportion of BOLL+ve cells, and 
while DAZL is also expressed in this section, there is little evidence of co-expression 
between DAZL and BOLL. The 20 week tissue shows two typical primordial 
follicles which were only DAZL+ve. Although BOLL is expressed near the follicles in 
the medulla of ovary, it appears to be less widely distributed than in the 18 week 
tissue.  
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Figure 4. 4 The overview of 
DAZL and BOLL distribution and 
co-localisation in human fetal 
ovary.  
A) Tiled image of 14 weeks human 
fetal ovary. DAZL (green) is 
extensively expressed in both 
periphery and medulla areas 
(arrows) and BOLL (red) is only 
expressed in medulla of ovary in 
small groups of germ cells 
(arrowhead). B) Tiled image of 18 
weeks ovary. DAZL is expressed in 
less mature germ cells in a more 
peripheral localisation (arrow), 
while BOLL is extensively 
expressed in more 
centrally-located germ cells 
(arrowhead). DAZL and BOLL 
showed minimal co-localisation in 
both sections (asterisk). 
Counter stained with DAPI (blue), 
Scale bar A)=100μm, B)=50μm, 
* 
* 
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Figure 4. 5 The co-localisation of DAZL and BOLL at different stages of germ cell 
development in human fetal ovary.  
Both proteins are expressed across14 to 20 weeks. To distinguish the different cell types of the 
ovary, see Figure 4.1A. Similar to the single staining (Figure 4.3), DAZL (green) is stably 
expressed across 14 to 20 weeks gestation. In contrast, BOLL (red) is detected in a few germ 
cells at 14weeks, then the number of BOLL+ve cells increases at 18 week, before decreasing at 
20 weeks. DAZL, but not BOLL, is expressed in oocytes of primordial follicles (arrows). Rare 
germ cells expressing both DAZL and BOLL are detectable (asterisk). Counter stained with DAPI 
(blue), Scale bar=20μm 
* 
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4.2.4 DAZL and BOLL expression represents distinct groups of 
germ cells 
The above data suggest that BOLL is expressed in germ cells at a later stage of 
development than DAZL. To further confirm this hypothesis, we measured the 
nuclear diameter of germ cells which are either DAZL+ve or BOLL+ve using the tiled 
images of DAZL and BOLL dual immunohistochemistry at both 14 and 18 weeks 
gestation, as this metric was reported as an indicator of germ cell maturation, 
increasing as germ cells progress through development (Hartley et al., 2002).  
We found that BOLL+ve cells had significantly larger nuclei when compared to 
DAZL+ve cells at both 14 (6.60+/-0.12μm vs 9.37+/-0.20μm) and 18 weeks gestation 
18 (6.87+/-0.12μm vs 9.23+/-0.19μm) (Figure 4.6A, both p<0.001, n=108-191 (cell 
number) per group, each gestation contains one sample). As the data of each group 
are not normally distributed according to D'Agostino & Pearson omnibus normality 
test, the significance were analysed with Mann Whitney test instead of unpaired t-test. 
This suggests that BOLL is mainly expressed in germ cells at later development 
stages. We also grouped the data by value ranges to show the distribution of 
DAZL+ve and BOLL+ve cells at both gestations, and found that DAZL+ve and 
BOLL+ve germ cells display distinct, although overlapping, nuclear diameter 
frequency distributions (Figure 4.6B & 4.6C). DAZL+ve cells have nuclei which are 
<4 to 12 μm (primordial follicles are excluded), compared to 4 to >14μm for 
BOLL+ve cells. Most DAZL+ve cells are distributed at 4 to 8 μm whilst BOLL+ve cells 
are at 8 to 12μm. No DAZL+ve germ cells had nuclei greater than 12μm, and no 
BOLL+ve cells has nuclei smaller than 4μm. Therefore, the data support that DAZL 
and BOLL are expressed in distinct groups of germ cells which are at different stages 
during development, with BOLL expressed by germ cells at a later stage of 
development than those expressing DAZL. 
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Figure 4. 6 Nuclear diameter of DAZL+ve /BOLL+ve cells (primordial follicles not included).  
A) BOLL+ve cells have larger nuclei than DAZL+ve cells at both 14 and 18 weeks gestation. B) and 
C) The nuclear diameter distribution of DAZL and BOLL+ cells at 14 and 18 weeks, respectively. 
DAZL+ve cell nuclei are mainly distributed at 4-8μm, while BOLL+ve cell nuclei are mainly 8-12μm 
in diameter. Only DAZL+ve cells have nuclei smaller than 4 μm, and only  BOLL +ve cells have 
nuclei larger than 12μm, and. (One sample for each gestation, cell number=108-191, ***p<0.001) 
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4.2.5 DAZL, but not BOLL, is expressed before meiosis 
After investigating the expression patterns of DAZL and BOLL, we tried to 
determine how they were associated with germ cell development in the human fetal 
ovary, by looking at their co-localisation with stage-specific markers. In the 
following results, all the immunofluorescence was performed on the sections from at 
least 2 different individuals each gestation to make sure the results were robust. 
LIN28 was identified as an early germ cell maker which is expressed in primordial 
and pre-meiotic germ cells in human fetal ovary (Childs et al., 2011), thus we first 
performed triple immunofluorescence for DAZL, BOLL and LIN28 on second 
trimester human fetal ovary. We found that in these tissues, germ cells expressing the 
three proteins formed three layers. Tiled images of 15 weeks gestation tissue were 
taken to show the distribution. LIN28 is expressed at the periphery of the ovary, 
BOLL is expressed mainly in the more central area, whilst DAZL is expressed in 
germ cells distributed between the LIN28+ve and BOLL+ve cells; however, there are 
also several BOLL+ve cells localised around the edge, along with some DAZL and/or 
LIN28+ve cells localised in the central area (Figure 4.7A).  
High resolution images were also taken to show the co-localisation between 
DAZL/LIN28 and BOLL/LIN28 (Figure 4.7B). DAZL and LIN28 are partially 
co-expressed in quite a few germ cells in both early (15 week, Figure 4.7B upper 
panels) and late second (18 week, Figure 4.7B lower panels) trimester tissues, 
especially in those cells which have nuclear DAZL expression. In contrast, although 
there appears to be a germ cell expressing very faint BOLL and LIN28 in the 15 
week gestation tissue, no other germ cell was found expressing both BOLL and 
LIN28 in either 15 or 18 weeks gestation tissue (Figure 4.7B). No cell was found to 
express all three proteins (DAZL/BOLL/LIN28) either, although some DAZL/BOLL 
co-localisation was observed as described in previous sections (Figure 4.4 and 4.5). 
Therefore, the cell position and partial co-expression of DAZL and LIN28 suggest 
that in the second trimester, DAZL is expressed in primordial and pre-meiotic germ 
cells but not in very early LIN28+ve primordial germ cells. The lack of LIN28 and 
BOLL co-expression demonstrates that BOLL is mostly expressed in germ cells at 
later stages of development, very likely after the initiation of meiosis. To conclude, 
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germ cells first express LIN28, then DAZL appears as LIN28 is down-regulated; 
DAZL expression then continues into meiosis, and is subsequently replaced by 
BOLL. 
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Figure 4. 7 DAZL but not BOLL is co-expressed with LIN28 in germ cells in the second 
trimester human fetal ovary.  
A) Tiled image of 15 weeks gestation ovary to show the distribution of DAZL (Green), BOLL 
(Blue) or LIN28 (Red) positive cells. LIN28+ve (arrow) cells are mainly located around the edge 
and BOLL+ve cells (asterisk) are in the centre, while DAZL+ve cells (arrowhead) are between them. 
B) In both 15 and 18 weeks gestation tissues, there are several cells are expressing both DAZL 
and LIN28 (arrows). Only one germ cell was found to express BOLL and LIN28 (arrowhead), and 
no cell was seen which expressed all three proteins. Scale bar A)=100μm, B)=20μm 
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4.2.6 DAZL and BOLL differentially associate with markers of 
meiosis  
Given the fact that the DAZL expression persists to later stages of germ cell 
development (after which the pre-meiotic marker LIN28 is down-regulated), then the 
switch between DAZL and BOLL expression during human fetal oogenesis may 
occur during meiosis. To establish if this timing occurs at a specific stage of the 
meiosis prophase I, we first performed triple immunofluorescence analysis for DAZL, 
BOLL and the meiosis marker SYCP3. This is a component of synaptonemal 
complex which is expressed from pre-meiosis to diplotene in human fetal ovarian 
germ cells (Roig et al., 2004). Again, we took tiled images of second trimester 
tissues to see the global distribution of DAZL, BOLL and SYCP3 (Figure 4.8). In 
both 15 and 17 weeks gestation tissues, SYCP3 is germ cell-specific and only 
distributed in the more central area of ovary (where BOLL+ve germ cells are mainly 
located). Most SYCP3+ve cells are also BOLL+ve, but a few single SYCP3+ve cells and 
SYCP3/DAZL double-positive cells were found on these sections as well (Figure 
4.9). 
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Figure 4. 8 BOLL is broadly co-expressed with SYCP3 in germ cells in the second 
trimester human fetal ovary.  
A)&B) SYCP3 is expressed in germ cells of both 15 and 17 weeks gestation ovaries. 
Although most SYCP3+ve cells are also BOLL+ve, several cells express both SYCP3 and DAZL 
(arrows), and there are also some SYCP3 single-positive cells (unfilled arrows). Counter 
stained with DAPI (yellow), Scale bar=100μm 
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To make it clearer, we also took high resolution images of the triple staining. The 
images show that almost all BOLL+ve germ cells are also SYCP3+ve, and there are 
relatively few SYCP3+ve germ cells that also express DAZL at 14, 15 and 17 weeks 
gestation (Figure 4.9A&B, sample of 15 weeks is not shown). Using randomly 
picked images from the tiled image, we calculated the ratios of all SYCP3 
co-localisation patterns. This confirmed the extensive overlap of BOLL and SYCP3 
expression (Figure 4.9C); nearly 70% SYCP3+ve germ cells also expressed BOLL, a 
fraction significantly higher than the 14% of SYCP3 and DAZL double-positive 
germ cells, 11% of SYCP3+ve germ cells which expressed both DAZL and BOLL, 
and the 6% of SYCP3+ve germ cells that express neither DAZL or BOLL (SYCP3+ve 
only; p<0.001, counted cell number=327-787, one sample from each gestation). Data 
was analysed using One-Way ANOVA with Tukey's multiple comparisons test. These 
data are also consistent with BOLL being expressed in germ cells that have reached a 
later stage of meiosis prophase I than those expressing DAZL. 
We also compared the extent of co-expression of DAZL and BOLL with another 
meiosis marker, the phosphorylated isoform of the Ataxia Telangiectasia Mutated 
(phospho-ATM) protein, which is expressed by germ cells from pre-leptotene to 
pachytene of meiotic prophase I (Hamer et al. , 2004). The tiled images of DAZL or 
BOLL/phospho-ATM double immunofluorescence stained human fetal ovary at 16 
weeks gestation show a pattern consistent with that of SYCP3. phospho-ATM is 
distributed in the nuclei of germ cells in the central area of ovary, and when 
co-stained with DAZL, most germ cells were found to be positive for either 
phospho-ATM or DAZL, with a few cells showing some co-expression of both 
markers (Figure 4.10A). In contrast, in the phospho-ATM/BOLL double stained 
tissue, almost all the phospho-ATM+ve cells were also BOLL+ve, with several BOLL 
single-positive cells and some very rare phospho-ATM single-positive cells (Figure 
4.10B). 
As we did with the SYCP3 co-localisation, high resolution images were also taken to 
show the details of co-localisation, and enable quantification of co-expression ratios 
were performed based on the tiled images. We found that the co-expression pattern 
was similar at 14and 16 weeks gestation, i.e. more phospho-ATM+ve cells also 
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express BOLL compared to the number of DAZL/phospho-ATM double-positive 
cells (Figure 4.11A). This was further confirmed by quantification – the data show 
that a significantly greater proportion of phospho-ATM+ve germ cells also express 
BOLL (78%) than express DAZL (37%; p<0.05) (Figure 4.11B). Data was analysed 
with unpaired t-test. As the sample number is too small and impossible for normality 
testing, it was assumed that both the data of SYCP3 and phospho-ATM were 
normally distributed and a parametric test was used. 
 
  
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
 
Chapter 4. DAZL and BOLL Expression during Human and Mouse Germ Cell 
Development in Fetal Ovary 
150 
  
Figure 4. 9 BOLL displays greater co-localisation with the meiosis marker SYCP3 than 
DAZL. 
A) Triple immunofluorescence analysis of DAZL (green), BOLL (blue) and SYCP3 (red) in 14 
and 17 week ovaries. All BOLL+ve germ cells also express SYCP3 (arrowheads), but only a few 
DAZL+ve germ cell express SYCP3 (arrows). Unfilled arrows indicate the SYCP3+ve cells that 
express neither DAZL nor BOLL. The asterisk indicates a germ cell nest containing 
BOLL/SYCP3+ve, DAZL/SYCP3+ve and DAZL single-positive germ cells in close proximity. B) 
Magnified image of germ cell nest marked with asterisk in A, showing neighbouring germ cells 
expressing different combinations of DAZL, BOLL and SYCP3 expression; arrow denotes a 
DAZL/SYCP3+ve germ cell, arrowhead denotes a BOLL/SYCP+ve germ cell. C) Quantification of 
DAZL, BOLL and SYCP3 co-expression. ~69% of SYCP3+ cells also express BOLL. This is 
significantly greater than the percentage of all the other co-expression patterns 
(value=mean±s.e.m., cell number=327-787, 14-17 week human fetal ovaries; one sample for 
each gestation, ***p<0.001). Scale bar A)=20μm, B)=10μm 
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Figure 4. 10 BOLL is widely co-expressed with phospho-ATM in second trimester 
human fetal ovary.  
A) The co-localisation of DAZL (green) and phospho-ATM (red) in 16 weeks gestation 
ovary. Very few phospho-ATM+ve cells are also DAZL+ve (arrow), and most cells express 
only DAZL or phospho-ATM. B) phospho-ATM (Red) is extensively co-expressed with 
BOLL (Green). Almost all the phospho-ATM germ cells also express BOLL (arrowhead), 
although some phospho-ATM single-positive cells can be seen (asterisk). Counter stained 
with DAPI (blue), Scale bar=100μm 
* 
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Figure 4. 11 Co-localisation of phospho-ATM with DAZL or BOLL.  
A) Immunofluorescent co-localisation of phospho-ATM (red) with DAZL or BOLL (green) in the 
human fetal ovary (14 weeks gestation). DAZL shows limited co-expression with phospho-ATM, 
whereas almost all the phospho-ATM+ve cells are also BOLL+ve. Arrows indicate germ cells 
co-expressing phospho-ATM of DAZL/BOLL, and arrowheads indicate phospho-ATM 
single-positive germ cells. B) Quantification of phospho-ATM co-localisation with DAZL and 
BOLL. BOLL is expressed in ~80% of phospho-ATM+ve cells, which is significantly higher than 
the proportion of DAZL/phospho-ATM double-positive cells (37%; value=mean±s.e.m., cell 
number=79-374, 14-16 week human fetal ovaries, one sample for each gestation, *p<0.05). 
Counterstained with DAPI (blue), Scale bar=20μm 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
 
Chapter 4. DAZL and BOLL Expression during Human and Mouse Germ Cell 
Development in Fetal Ovary 
153 
4.2.7 Dazl and Boll show different expression patterns in mouse 
fetal ovary and adult testis 
After confirming the specificity of the anti-Dazl and anti-Boll antibodies on mouse 
tissue in immunohistochemistry (see Section 3.2.2), we performed single 
immunofluorescence to detect either Dazl or Boll on fetal mouse ovaries at e13.5, 
e15.5, e18.5 and postnatal day 0 (P0). Experiments were performed on sections from 
2 different individuals per development stage. Unlike the human, germ cell 
development is relatively synchronized in the fetal mouse ovary. Therefore, most of 
the germ cells in one section of a fetal mouse ovary are at the same approximate 
stage of development. The ages of the ovaries we used correspond to meiosis 
initiation (e13.5, Figure 4.1B, first panel), leptotene/zygotene (e15.5, Figure 4.1B, 
second panel), pachytene (e18.5) and diplotene/ follicle formation (P0, Figure 4.1B, 
third panel).  
Consistent with previous studies, germ cells in the fetal mouse ovary expressed Dazl 
in the cytoplasm at all stages examined (Figure 4.12A). At e13.5 when meiosis has 
just started, small groups of Dazl+ve germ cells are readily detectable in the fetal 
mouse ovary. Their number subsequently increases and they become more 
homogeneously distributed throughout the ovary by e15.5. At e18.5, when most cells 
are entering into pachytene, Dazl+ve germ cells are clearly larger than at previous 
stages, but the number of cells appears to have decreased slightly, and they are 
predominantly localised towards the periphery of the ovary. At P0, Dazl is expressed 
in the primordial follicles and the cells maintain the peripheral distribution.  
In contrast, no Boll+ve germ cells were detected at e13.5, 18.5 and P0, but Boll was 
extensively detectable in large numbers of germ cells at e15.5, with a distribution 
similar to that of Dazl (Figure 4.12A). The same experiments were also performed on 
adult mouse testis using same conditions as the positive control (Figure 4.12B). 
Consistent with the DAB staining, Dazl was mainly expressed in germ cells at earlier 
stages of development (from spermatogonia to pachytene) and Boll was only found 
in germ cells at later stages of meiosis (especially pachytene) suggesting that the 
fluorescence technique we used is as specific and effective as the DAB methods.  
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Figure 4. 12 Dazl and Boll proteins display distinct patterns of expression during mouse 
fetal ovary development.  
A) Single immunostaining for Dazl or Boll (both green) in e13.5, e15.5, e18.5 and P0 mouse 
ovary. For different cell types in the ovary, see Figure 4.1B. Dazl is highly expressed in germ 
cells through all stages of development, whilst Boll is widely expressed in germ cells at e15.5 but 
not detectable at earlier or later gestations. B) Single immunostaining in adult mouse testis as 
positive control. The distribution of Dazl and Boll staining is similar to the DAB staining described 
in previous section and confirmed the effectiveness of the fluorescence methods. Counter 
stained with DAPI (blue), Scale bar=20μm 
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4.2.8 Dazl and Boll co-expression in mouse fetal ovary 
The distribution of Dazl and Boll in the germ cells of the fetal mouse ovary at e15.5 
suggests that Dazl and Boll may be extensively co-expressed in the same germ cells 
during fetal mouse oogenesis. We therefore performed double immunofluorescence 
to detect Dazl and Boll on sections of e15.5 fetal mouse ovaries (Figure 4.13A). The 
split channels of this image show that both Dazl and Boll are widely expressed in 
germ cells as detected by single staining. In contrast to our findings in the human 
fetal ovary, we confirmed that Dazl and Boll proteins are extensively co-expressed in 
the germ cells of the e15.5 fetal mouse ovary. Dual-immunofluorescence for both 
proteins was also performed on the adult mouse testis, in which both proteins are 
known to be expressed, revealing distinct but with some incomplete co-expression 
patterns of Dazl and Boll. Consistent with the single staining, Boll is expressed in 
germ cells at a later stage of development than those expressing Dazl (Figure 4.13B, 
VanGampel and Xu 2010; Xu et al., 2001).  
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  Figure 4. 13 Dazl and Boll are extensively co-expressed in fetal mouse ovary at e15.5.  
A) Double immunostaining for Dazl and Boll in e15.5 mouse fetal ovary: Dazl (green) and Boll 
(red) show extensive co-expression in germ cells at this gestation. B) Control showing mainly 
distinct expression and partial co-localisation of Dazl and Boll in germ cells in the adult mouse 
testis (arrows). Counter stained with DAPI (blue), Scale bar=20μm 
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4.3 Discussion 
In this chapter, we investigated the expression and distribution of DAZL and BOLL 
during early oogenesis in the human and mouse ovary.  
The difference in mRNA expression between DAZL and BOLL indicates that they 
may have different functions during germ cell development. The significantly 
increased levels of both mRNAs in the early second trimester suggest that these two 
genes may associate with meiosis. However the decrease in BOLL expression in late 
second trimester indicates that BOLL might be down regulated when germ cells 
become more mature and thus its expression is relatively transient when compared 
with DAZL in human fetal ovary. However, it is also necessary to recognise that the 
method used to calculate expression from the qRT-PCR data may be imperfect. The 
levels of DAZL/BOLL mRNAs were calculated relative to RPL32 which is expressed 
by all cells in the sample, rather than just the germ cells. Therefore it is difficult to 
tell that whether the change in expression between gestations is caused by increased 
gene expression or changes in somatic or germ cell numbers. This could be corrected 
for by relating the values of DAZL/BOLL expression to a germ cell specific marker 
such as VASA instead of RPL32. This method has been utilised in another study 
(Bowles et al., 2006) and therefore is accurate. Alternatively, expression could be 
calculated relative to counted germ cell numbers. Unfortunately, in this study, only 
the germ cell numbers in second trimester were counted (see Section 4.2.4), and data 
on first trimester numbers was unavailable.  It was therefore impossible to correct 
the qRT-PCR results with this method. Modifications like this should be made if this 
experiment could be repeated and similar attention is necessary in the future studies.    
Although both human DAZL and BOLL mRNA are expressed during the second 
trimester, their proteins are distributed in germ cells at different stages of 
development. DAZL expression is abundant after meiosis initiation in the early 
second trimester, but is mainly restricted to germ cells around the cortex of ovary, i.e. 
in the less mature germ cells. After that, it soon down-regulated and replaced by 
BOLL. Despite DAZL and BOLL possibly regulate some common mRNA targets, 
this pattern of sequential expression suggests that they may have distinct, 
non-overlapping functions. Indeed, this view is supported by Kee et al. (2009)’s 
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study, which suggests that DAZL is important for the differentiation of primordial 
germ cells whilst BOLL is promoting the later stages of meiosis. However, further 
investigation is still needed, potentially by isolating their specific mRNA targets. 
BOLL expression begins at the second trimester, i.e. after meiosis has initiated in the 
human fetal ovary. Its expression increases with germ cell development and reaches a 
very high level in maturing germ cells in late second trimester before primordial 
follicle formation. The central localisation of BOLL-expressing germ cells also 
indicates that BOLL is only expressed in more mature germ cells. BOLL is then also 
down-regulated and DAZL is re-expressed when germ cells form primordial 
follicles.  
Indeed, the small fraction of germ cells expressing DAZL and a meiosis marker and 
high ratio of BOLL/meiosis marker co-expressing germ cells, suggest that the DAZL 
expression persists from pre- to early stage of meiosis, and the switch between 
DAZL and BOLL expression happens during the early stage of meiosis prophase I. 
Thereafter, BOLL continues to be expressed during meiosis. DAZL is expressed 
before, and persists into, early meiotic prophase I, but is soon down-regulated around 
the leptotene/zygotene stage and replaced by BOLL. When meiosis arrests at 
diplotene and follicle formation is initiated, BOLL expression is extinguished and 
DAZL expression reactivated. This suggests a DAZL→BOLL→DAZL expression 
pattern during the development of a single germ cell in the human fetal ovary. 
We then tried to find out whether the switch in expression from DAZL to BOLL that 
we observe during human fetal oogenesis also occurs during germ cell development 
in the fetal mouse ovary. However, in fetal mouse ovary, we found Dazl to be 
expressed at all the time points examined, from meiosis initiation to follicle 
formation. Boll is expressed in a limited window during meiosis prophase I (in 
human), and in mice we found Boll is also expressed in a narrow window around 
e15.5 (which corresponds with early meiosis at the leptotene/zygotene stages).  
Furthermore, we found Boll to be expressed in the same germ cells as Dazl in the 
fetal mouse ovary, in contrast to the pattern seen in the human. Moreover, the pattern 
in mouse fetal ovary is also different from adult mouse testis, in which the Boll starts 
to be expressed around the pachytene stage (VanGompel and Xu, 2010, 2011). Thus, 
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in the mouse there is continuous expression of Dazl throughout fetal germ cell 
development with coincident, brief, expression of Boll. This is in contrast to the two 
distinct windows of DAZL expression (separated by the expression of BOLL) and 
rare DAZL/BOLL co-expressing germ cells in the human fetal ovary. The relative 
timing of expression suggests there may be different functions for DAZL and BOLL 
proteins.  The different expression patterns between human and mouse ovaries, or 
between mouse ovaries and testes imply the lack of conservation and therefore the 
mouse model might not perfectly represent Boll function in human.  
Human ovarian development during the second trimester encompasses two key 
developmental stages; the formation of germ cell nests and entry into and 
progression through meiotic prophase I (approximately 12-16 weeks gestation) and 
the breakdown of germ cell nests and the assembly of individual oocytes into 
primordial follicles (approximately 17 weeks gestation onwards) (Hartshorne et al., 
2009). Consistent with the previous work from our laboratory which indicated that 
DAZL mRNA significantly increases between first and second trimester (Anderson et 
al., 2007), our work more precisely positions this increase occurs between first and 
early second trimester. The increase of DAZL expression between first and second 
trimester is coincident with the onset of meiosis in the human fetal ovary (Anderson 
et al., 2007). Lin et al. (2008) reported that mouse Dazl is necessary for the entry of 
meiosis together with retinoic acid, and that in Dazl-/- mice there is no initiation of 
meiosis, and the expression of Stra8 RNA is nearly undetectable. Furthermore, Dazl 
also regulates the translation of some meiosis associated proteins such as Sycp3 in 
mouse (Reynolds et al., 2007). In our study, we also tried STRA8 staining in human 
fetal ovary (data not shown) but the antibodies were not specific enough and we are 
not able to tell whether STRA8 is co-expressed with, and possibly regulated by, 
DAZL in the human fetal ovary. However, the significantly increased level of DAZL 
transcripts in pre-meiotic and early meiotic germ cells, and the protein translocation 
from nucleus (Figure 4.3) to cytoplasm, both support a conserved role for this protein 
in regulating the entry into meiosis in humans, consistent with the requirement for 
Dazl in fetal mouse ovarian germ cells to enable them to respond appropriately to the 
meiosis-inducing signal retinoic acid (Lin et al., 2008). 
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In the human fetal ovary, we found that BOLL RNA is not detectable in first trimester, 
but is significantly up-regulated in early second trimester. The pattern of overlapping 
DAZL and BOLL expression, with the onset of BOLL expression occurring slightly 
later than that of DAZL, is comparable to that reported previously in the fetal sheep 
ovary (Mandon-Pepin et al., 2003). In that model, although both DAZL and BOLL 
begin to express at 38 days post coitum (dpc), the level of DAZL RNA was found to 
be higher than that of BOLL at 49dpc (just prior of meiosis), and then they both 
dramatically increased at 56dpc (i.e. around the time of the initiation of meiosis). 
Interestingly, in our study, the level of BOLL slightly reduced (but not with statistical 
significance) at late second trimester in human fetal ovary. This may represent the 
down-regulation of BOLL during follicle formation, although this may also result 
from a dilution of BOLL mRNA due to the emergence of additional BOLL-negative 
germ cells at this stage. 
Although the expression patterns of DAZL and BOLL mRNAs overlap in the second 
trimester, our immunohistochemistry data show that DAZL and BOLL protein are 
actually distributed in different groups of germ cells, with DAZL-expressing germ 
cells towards the periphery of the human fetal ovary, and BOLL-expressing germ 
cells towards the centre. The greater nuclear diameter of BOLL+ve cells compared to 
those of DAZL+ve cells suggests that BOLL is expressed in more mature germ cells 
(Fulton et al. , 2005). The co-localisation of the two proteins with meiosis-specific 
proteins further demonstrates that BOLL is expressed by germ cells at later stages of 
development, as both SYCP3 and phospho-ATM show a higher co-localisation ratio 
with BOLL than they do with DAZL. The expression pattern reveals different roles 
of DAZL and BOLL during germ cell development. The expression at pre-, early and 
arrested meiosis of DAZL suggests that DAZL is not only regulating the entry of 
meiosis, but also has some meiosis-independent functions such as germ cell 
differentiation. Indeed, this is supported by several studies which reported that the 
expression of pluripotency (e.g. Oct4) or germ cell markers (e.g. Mvh) were reduced 
in the germ cells of Dazl-/- mice on an inbred background at e14.5 (Lin and Page, 
2005), and that Dazl might be necessary to maintain the number of pre-meiosis germ 
cells in vivo (Lin and Page, 2005) or the pluripotency of mouse primordial germ cells 
in vitro (Haston et al., 2009). In contrast, BOLL has not been studied as extensively 
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as DAZL. Several studies suggest that the loss of Boll causes subfertility phenotypes 
across many species from flies, worms to mice, and it has been also reported to be 
associated with male subfertility phenotypes in human (Eberhart et al., 1996; 
Karashima et al., 2000; VanGompel and Xu, 2010; Kostova et al., 2007). However, 
although the studies in model animals revealed that BOLL expression is associated 
with meiosis (Eberhart et al., 1996, Karashima et al., 2000), it is still unclear how 
BOLL is associated with oogenesis in humans. Our study indicates that in the human 
fetal ovary, BOLL is more tightly associated with meiosis than DAZL, and it is only 
expressed in a narrow window between meiosis initiation and meiosis arrest. The 
data presented here reveal a complex relationship between DAZL, BOLL and 
meiosis during human fetal ovarian development, and suggests that DAZL may have 
meiosis-dependent and meiosis-independent roles during human fetal germ cell 
development, the former being restricted to the fetal ovary and the latter shared with 
the germ cells of the human fetal testis. 
In mice, deficiency of Boll causes subfertility phenotypes in males only (VanGompel 
and Xu, 2010), despite Boll mRNA being detectable in the mouse ovary from e10.5 
to adult life (Shah et al., 2010). We therefore studied the expression pattern of Dazl 
and Boll during mouse meiotic prophase I. To our surprise, Boll was only expressed 
at e15.5 (leptotene/zygotene) in fetal mouse ovary, and co-expressed in the same 
germ cells as Dazl; a very different pattern to that which we found in the human fetal 
ovary. This is not due to the synchronised germ cell development in fetal mouse 
ovary, as Boll-expressing germ cells are abundant at pachytene in both the human 
fetal ovary and mouse testis, whilst there is no Boll expression at e18.5 (pachytene) 
in fetal mouse ovary. This suggests that there is a genuine lack of conservation of the 
expression pattern of BOLL between human and mouse ovaries, and between female 
and male mouse meiosis. 
The data presented here raise important questions about the validity of the 
Boll-knockout mouse as a model for understanding BOLL function during human 
female oogenesis. As RNA-binding proteins from the same family, the DAZ family 
proteins are highly conserved (Collier et al., 2005) and may have partly overlapping 
targets such as CDC25A (Jiao et al., 2002, Lin et al., 2009). This is supported by 
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several studies, such as using Xenopus dazl to rescue the Drosophila boule 
phenotype (Houston et al.,1998), or using human DAZ to rescue the mouse Dazl 
knockout (Vogel et al., 2002). Therefore, the complete co-expression of Dazl and 
Boll within the same germ cells in the fetal mouse ovary implies that Dazl may 
compensate for the loss of Boll in Boll-/- fetal ovarian germ cells, by binding and 
regulating some Boll target mRNAs.  Because of the lack of overlap between 
DAZL and BOLL in the human fetal ovary (and to a less extent the adult mouse 
testis), such compensation is unlikely to happen. This probably explains the 
male-specific infertility phenotypes in Boll-/- mice, and also indicates that the Boll-/- 
mice may not accurately represent what happens during oogenesis in the fetal human 
ovary. Together, these data indicate that BOLL may have specific and important 
functions in regulating oogenesis in humans - distinct from those of DAZL - in 
contrast to its dispensability in mice.  
Before concluding, it is still necessary to point out some weaknesses in the data. First, 
for all immunohistochemistry experiments, no peptide-block controls were applied. 
Only no-primary control (e.g. applying serum block without primary antibody) was 
used. To make sure the antibodies were specific, the peptides which were used to 
raise these antibodies should be applied together with the primary antibodies on the 
sections. However, since the peptides were not commercially available, this step was 
skipped. It also would be ideal to use isotype control, such as IgGs which are from 
the same species that the primary antibodies were raised against. And if no staining 
was observed, then it could be concluded that the staining on other sections was 
specific. And despite all the immunohistochemistry experiments being performed 
with no-primary control, some of them were only directly observed under 
microscope and images were not taken due to an underestimation of the importance 
of these controls. Failure to do the latter is a weakness of these studies and special 
attention to these is necessary in future work. 
Another problem is that the sample size were quite small. For the datasets with this 
problem, the analysis of normal distribution was impossible and this could lead to 
type II error, which means the null hypothesis is not correctly rejected. Thus we 
could only assume that they were normally distributed and chose the corresponding 
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methods. The small sample size was caused by the limited resource of human tissue 
– the human tissue is very precious, and it is even more difficult to obtain the fetal 
ovary. Although all the immunohistochemistry was applied on sections from different 
individuals to make sure the results were convincing, the images showed here, and 
all the immunohistochemistry-dependent data collection and analyses were only 
based on one sample per gestation. This one sample basis was a big flaw and made 
the data less convincing than it should be. Unfortunately there was no time to redo all 
these work and increase the sample number, but it should be avoided in future work. 
In conclusion, these data reveal that human DAZL and BOLL expression 
dynamically changes during fetal ovary development, and follows a 
DAZL→BOLL→DAZL pattern in a single germ cell. Further investigation strongly 
suggest that both proteins are associated with different stages of meiosis. The 
existence of a conserved and transient window of BOLL expression during fetal 
oogenesis in both humans and mice was observed, which probably corresponds to a 
specific stage of meiotic prophase I. However, the striking switch from DAZL 
expression to BOLL expression during germ cell maturation in the human fetal ovary 
does not occur in mice, suggest a non-conserved pattern of Dazl and Boll expression 
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Chapter 5. Identification of Human mRNA Targets of DAZL 
and BOLL 
5.1 Introduction 
DAZ family proteins bind mRNA targets and promote their translation (Collier et al., 
2005), and possibly enhance their stabilization (Takeda et al., 2009, Wiszniak et al., 
2011). Although some target mRNAs have been reported in model animals, no 
definitive human DAZL targets have been identified so far.  
It has been suggested that mouse Dazl recognises a U(2-10)G/CU(2-10) motif in the 
3’-UTR of its mRNA targets (Reynolds et al., 2005, Venables et al., 2001), whilst 
zebrafish dazl binds to GUUC motifs (Maegawa et al., 2002). Research on the 
crystal structure of DAZL RNA recognise motif (RRM) indicates that GUU might be 
sufficient for DAZL to bind, and suggests that BOLL may share some binding 
features with DAZL, but has its own binding motif (Jenkins et al., 2011).  
The putative dazl targets identified in zebrafish are tdrd7, HuB and dazl itself, and 
they are all protected by dazl protein from miRNA-mediated degradation, and 
possibly also show enhanced translation under this regulation; the stabilisation effect 
may play a role in germline-specific expression of these mRNA (Takeda et al., 2009, 
Wiszniak et al., 2011).  
Most Dazl targets have been identified in mouse. Amongst these targets, Mvh and 
Sycp3 are the only definitively proven ones (Reynolds et al., 2007, Reynolds et al., 
2005). Putative Dazl binding sites are found in the 3’-UTR of both target mRNAs, 
and direct binding between Dazl and these two mRNA has been confirmed at the 
molecular level (Jenkins et al., 2011). The activity of luciferase vectors conjugated 
with the Mvh or Sycp3 3’-UTRs could be stimulated by co-injecting Dazl into mouse 
oocytes (Reynolds et al., 2007, Reynolds et al., 2005). Moreover, the 
null-phenotypes of Dazl include reduced Mvh and Sycp3 protein levels in the testis, 
and the meiotic arrest phenotypes observed in Dazl or Mvh-null mutant mice are very 
similar (Reynolds et al., 2007, Reynolds et al., 2005). Some other targets have also 
been identified: Zeng et al. (2007, 2009) reported that Dazl could interact with 
Tex19.1, Tssk1, 2 and 4 (which all contain the DAZL binding sites in their 3’-UTRs), 
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and the translation of Tex19.1 seems to be repressed by Dazl in single-cell zebrafish 
embryo. Research performed on mouse oocytes revealed similar RNA-protein 
interactions between Dazl and Tpx2, with the activity of luciferase conjugated to 
Tpx2 3’-UTR being down-regulated when Dazl is knocked down (Chen et al., 2011). 
This work also confirmed that Dazl binds and promotes the translation of its own 
mRNA (Chen et al., 2011).  
The expression of a range of other mRNA targets has been reported to be affected by 
Dazl knockout, but their direct regulation by Dazl protein has not been proven yet. 
One of the most important candidates is Stra8, which is essential for the entry of 
meiosis, and which almost completely disappears in the Dazl-/- mouse fetal ovary, 
along with the several other meiosis-associated mRNA including Dmc1, Spo11, 
Sycp3 and Rec8 (Lin et al., 2008). Like Tex19.1, Dazl also represses the translation 
of Caspase 2, 7 and 9 mRNAs (Chen et al., 2014).  A mouse Dazl variant which 
does not contain exon 8 seems be act as a repressor of its potential targets including 
Mvh, Oct3/4 and Sox2, but again no evidence of direct binding has been reported (Xu 
et al., 2013). 
Some additional mRNAs have been reported to co-precipitate with Dazl but no 
further investigation has been performed so far. These include Tpx1, Pam, Trf2, 
Grsf1, D2, Cappβ1, Pα7/C8, H47 (Jiao et al., 2002), Odc1, Tex14, Fthl17, Calm2 
(Reynolds et al., 2005), Rap2c, Nbn, Ercc1, Spnr, Dnmt3l and Sox17 (Zeng et al., 
2008), which all co-precipitate with Dazl from mouse testis extracts. Using RNA 
immunoprecipitation (RIP) and microarray, several additional mRNA that directly 
bind with and repressed by Dazl has been identified, namely Sox2, Sall4, Suz12, 
Zfp42 and Zic3 (Chen et al., 2014). 
The only BOLL mRNA target identified so far is twine/CDC25A homologue. twine is 
expressed in Drosophila, and twine mutants show similar phenotypes to boll mutants 
(Eberhart et al., 1996). Further investigation revealed that loss of one copy of bol in 
twine mutants increased the severity of the phenotype, from meiosis arrest to no 
entry into meiosis, and this could be rescued by twine expression that was 
independent of translation-regulation by bol (Maines and Wasserman, 1999). In 
humans, CDC25A is a strong putative BOLL target, as it is co-precipitated with 
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BOLL, through a 21-nucleotide sequence (AGGUGUAGGUGGGUUUUUCUU) on 
its 3’-UTR, the mutation of which (UUUUU to CCCCC) strongly reduces the 
strength of interaction (Lin et al., 2009). Mouse Cdc25a has also been reported as a 
potential Dazl target, however only binding in vitro has been confirmed (Jiao et al., 
2002). Moreover, as DAZL and BOLL are from the same family and have highly 
conserved RNA-recognition motif (RRM) (Eberhart et al., 1996), it is possible that 
they could recognise/bind to similar motifs in their mRNA targets, and cross-species 
rescue studies indicate that these proteins may regulate the same targets (Houston et 
al., 1998). However, the investigation on the molecular structure of DAZL and 
BOLL proteins suggested that a crucial residue of amino acid in DAZL for the GUU 
triplet recognition is mutated in BOLL RRM, and it is not certain that BOLL could 
bind to GUU with the same way as DAZL (Jenkins et al., 2011). Therefore, during 
further investigation we assumed that some of the DAZL targets listed in Table 5.1 
may also be BOLL targets. 
For human DAZL however, no definitive targets have been identified. One candidate 
is SDAD1, which is interacts with both DAZL and its co-factor PUM2 through its 
3’-UTR in a yeast three-hybrid-assay (Fox et al., 2005). Similarly, human TSSK1, 2, 
4 and 5 are also bound by DAZL (Zeng et al., 2008).  In addition, both expression 
of DAZL and BOLL seem to increase the percentage of VASA-GFP+ve human ES 
cells, as well as the number of cells with SYCP3 protein loaded properly on 
chromosomes, suggesting that they may regulates these two proteins as well (Kee et 
al., 2009).  
To summarize, despite the identification of many potential targets of DAZL and 
BOLL, very few of them have been confirmed and most have only been investigated 
in a single respect – either direct binding or translation regulation. The known targets 
of human DAZL or BOLL are limited, and this has become a bottleneck to 
understanding the functions of DAZL and BOLL during germ cell development. This 
chapter will focus on identifying these mRNA targets and try to co-relate them to 
human oogenesis. 
To identify putative DAZL targets, we searched on PubMed and established a list of 
potential mRNA targets identified previously in human or model animals. We 
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selected the human homologues of Tex19, Tex14, Stk31 (Reynolds et al., 2005), Pam, 
Grdf1, Trf2 (Jiao et al., 2002), Tpx1, Ercc1, Tssk2, Spnr, Dnmt3l, Sox17 (Zeng et al., 
2008) to investigate further. By looking at the literature, we made Table 5.1 to show 
the expression and functions of each mRNA/protein, especially whether they were 
expressed in gonads and associated with infertility phenotypes. For the targets which 
only have been studied in non-human animals, we also found that all of them or their 
homologues were reported to be expressed in human. Almost all of the targets are 
related to subfertility/infertility phenotypes, but mostly only in mouse knockout 
models (Table 5.1). Based on the findings of this literature search, we selected 
TEX19, TEX14, STK31, GRSF1, TRF2, TPX1, ERCC1, TSSK2, DNMT3L and SOX17 
as the targets we investigated further.
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Table 5. 1 Literature review of potential DAZL mRNA targets 
The following aspects of these mRNA targets were checked: expression in human, whether they were expressed in germ cell/ovary/testis, their function 





Ovary Testis Function/Phenotype References 





Impaired spermatogenesis (in mouse) 
Kuntz et al. (2008) Stem Cells;26(3):734-44 
Ollinger et al. (2008) PLoS Genet;4(9):e1000199. 
Tarabay et al. (2013) Hum Reprod.;28(8):2201-14  
STK31 X X mouse X 
Meiosis 
Dynamic change during mouse testis 
development 
Decreased in human testis of germ 
cell absent patients * 
Wang et al. (2001) Nat Genet.;27(4):422-6 
Olesen et al. (2007) Cell Tissue Res 328:207–221 
Bao et al. (2012) Histochem Cell Biol.;137(3):377-89 
TEX14 X X X X 
Meiosis 
Cell cycle 
Intercellular bridges absent, male 
infertility and oocyte decrease (in 
mouse) 
Wang et al. (2001) Nature Genet 2001;27:422-426 
Houmard et al. (2009) Biol Reprod.;81(2):438-43 
Greenbaum et al. (2009) Biol Reprod.;80:449–457 
Mondal et al. (2012) Mol Cell;45(5):680-95 




Breakpoint may cause male infertility 
Olesen et al. (2001) Mol Hum Reprod.;7(1):11-20  
Maeda et al. (1998) Biochem Biophys Res 
Commun.;248(1):140-6 
Maeda et al. (1999) Dev Growth Differ;41(6):715-22. 
Nimlamool et al. (2013) Mol Reprod Dev;80(6):488-502 
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may be required in chromatin 
function 
Guo et al. (1998) Proc. Natl. Acad. Sci. USA;95:9172–9177 
Braas et al. (1992) Endocrinology;130(5):2778-88 abstract 
GRSF1 X ? ? X(mouse) 
5’-UTR mRNA-binding translational 
regulator 
Cleavage of primary mitochondrial 
RNA transcripts 
A target of the Wnt/β-catenin pathway 
which is necessary for mesoderm 
formation 
Sampath et al. (2008) Cell Stem Cell;2:448–460 
Lickert et al. (2005) Development;132:2599-2609 
Jourdain et al. (2013) Cell Metab.;17(3):399-410 
Antonicka et al. (2013) Cell Metab.;17(3):386-98 
TRF2 X X X(mouse) X 
Negative regulator of telomere length 
and keep telomere stable 
Defect in spermiogenesis (mouse) 
Smogorzewska et al. (2000) Mol Cell Biol.;20(5):1659-68 
Zhang et al. (2001) Science;292 (5519):1153-1155 
Xiao et al. (2006) Gene Expression Patterns;6:409–419 
ERCC1 X X X X 
Essential for nucleotide excision 
repair 
Infertility of both male and female 
mouse 
Hsia et al. (2003) Development;130:369-378 
Cheng et al. (1999) Cancer Epidemiol Biomarkers 
Prev.;8(9):801-7 
Koberle et al. (2010) Oncol Rep.;23(1):223-7 
TSSK2 X X N X 
Testis specific serine/threonine kinase 
Transformation of chromatoid body in 
elongating spermatids 
SNPs related to impaired human 
spermatogenesis 
Xu et al. (2008) Dev Biol.;319(2):211–222 
Zhang et al. (2010) J Androl.;31(4):388-92 
Hao et al. (2004) Mol Hum Reprod.;10(6):433-444 
Li et al. (2011b) Mol Hum Reprod.;17(1):42-56 
Shang et al. (2010) J Cell Sci.;123(Pt 3):331-9 
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Spermatid perinuclear RNA binding 
protein 
Sperm defects in the flagellum 
(mouse) 
Pires-daSilva et al. (2001) Dev Biol.;233(2):319-28 
Schumacher et al. (1995) J Cell Biol. 1995;129(4):1023-32. 
Salemi et al. (2012) J Endocrinol Invest.;35(1):5-7  
DNMT3L X X Low mRNA X 
Promote DNA methylation 
Required for imprints 
Variations associated with 
oligospermia. 
Aapola et al. (2000) Genomics;65(3):293-298 
Bourc'his et al. (2001) Science;294(5551):2536-9 






DNA-binding protein  
A transcriptional factor in premeiotic 
germ cells 
Promote germ cell differentiation 
Katoh (2002) Int J Mol Med;9(2):153-7 abstract 
de Jong et al. (2008b) J Pathol.;215(1):21-30 
Kanai et al. (1996) J Cell Biol. ;133(3):667-81 




X (low in 
adult mouse) 
X 
Regulate meiosis I-II transition and 
MII arrest in female 
mRNA level decreased in infertile 
human male 
Wickramasinghe et al. (1995) 
Development;121(7):2047-56. 
Solc et al. (2008) Dev Biol.;317(1):260-9 
Oh et al. (2013) J Cell Sci;126(Pt 5):1081-5 
Lin et al. (2006) Hum Reprod.;21(1):138-44 
 
Updated from Msc thesis, J. He 2010 
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In this study, we used HEK293 cells and TCam-2 cells as models to study DAZL 
function. TCam-2 cells was used as a germ cell model in this study. The studies on 
this cell line are very limited and it is very difficult to explain why it do not 
endogenously express DAZL or BOLL. However, the karyotype analysis indicates 
that TCam-2 cells seem to be tetraploid (Mizuno et al., 1993). The gene expression 
analysis shows that it expresses several protein markers of primordial germ cells 
such as OCT4, NANOG and c-Kit (de Jong et al., 2008; Eckert et al., 2008). 
Together, these data imply that the TCam-2 cells are possibly similar to the 
differentiating primordial germ cells which has finished the pre-meiosis chromosome 
replication, but the meiosis is arrested, possibly because of carcinogenesis. Therefore 
the expression of DAZL and BOLL, which are potentially required for human 
primordial germ cell differentiation and/or meiosis (Kee et al., 2009) might be 
stopped by the same cause of carcinogenesis. 
As transfection of the germ cell tumor derived TCam-2 cells was difficult (see 
Section 3.2.5), HEK293 cells were used instead before this problem was solved.  
We performed RT-PCR to find out the expression of potential DAZL targets in these 
two cell lines (MSc thesis, 2010). Figure 5.1 shows the expression of the putative 
mRNA targets of DAZL in 16 week gestation human fetal ovary, TCam-2 cells and 
HEK293 cells. All the targets are expressed in both fetal ovary and TCam-2 cells, 
although STK31 and TPX1 are very weak in TCam-2 cells.  
HEK293 cells originate from human embryonic kidney and therefore are not an ideal 
model to study DAZL function in germ cells. Indeed, no bands of DNMT3L, SOX17 
or TPX1 are detected in HEK293 cells and STK31 is extremely weak as well. 
However, the remaining seven mRNA targets are all expressed at a relatively high 
levels in HEK293 cells. RPL32 is also detected as positive control, suggesting that 
the PCR is effective. The expression of multiple potential DAZL/BOLL targets in 
HEK293 cells demonstrates that this cell line also could be used to study the effect of 
DAZL/BOLL on their endogenous mRNA targets. 
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Figure 5. 1 Expression of potential DAZL targets/germ cell markers in 16 week gestation 
human fetal ovary, TCam-2 cells and HEK293 cells.  
All the targets are expressed in fetal ovary and TCam-2 cells, although STK31 and TPX1 are very 
weak in TCam-2 cells. The non-germline cell line HEK293 also expresses most of the targets 
except DNMT3L, SOX17 and TPX1, and STK31 is very weak. The house keeping gene RPL32 is 
also detected as positive control, and no band is seen in the –RT reactions, suggests that the PCR 
is effective and has no genomic DNA contamination. 
MSc Thesis, J.He 2010 
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5.2 Results 
5.2.1 Introducing DAZL or BOLL could increase the level of their 
potential mRNA targets in HEK293 cells 
After successful transfection with pCMV6-DAZL or pCMV6-BOLL vectors in 
HEK293 cells was confirmed (see Section 3.2.3), mRNA was isolated from 
transfected cells, and expression of putative target mRNAs was analysed by 
qRT-PCR. Seven of the potential targets expressed in HEK293 cells, namely TEX19, 
TEX14, CDC25A, TSSK2, GRSF1, ERCC1 and TRF2 were previously tested between 
DAZL and Empty transfections (MSc thesis, J He 2010). The changes in mRNA 
levels were detected for TEX19, TEX14 and CDC25A, therefore, these targets were 
selected for further investigation in pCMV6-DAZL or pCMV6-BOLL transfected cells 
(Figure 5.2). Each transfection contained one technical replicate during every 
experiment, and the experiment repeated for four times (four biological replicates). 
When doing the qRT-PCR, each sample is replicated for twice and the average Ct 
value was calculated for further analysis. 
Since the samples were matched in each group, the data were analysed using 
(Repeated-measures) RM One-Way ANOVA with Geisser-Greenhouse's correction, 
followed by Tukey's multiple comparisons test. In pCMV6-DAZL transfected cells, 
the transcripts of TEX19 and TEX14 increased 1.68±0.09 (n=4) and 2.60±0.18 (n=4) 
fold relative to empty-vector transfected cells respectively (Figure 5.2, both p<0.001). 
The levels of these mRNAs also increased in pCMV6-BOLL transfected cells when 
compared to the empty vector transfections (both p<0.05), but were still significantly 
lower than those in DAZL expressing cells (p<0.005 for TEX19 and p<0.001 for 
TEX14).  
Besides TEX19 and TEX14, CDC25A expression was also analysed as it has been 
reported to be a potential target of both DAZL and BOLL (Lin et al., 2009, Pan et al., 
2009). CDC25A expression only increased very slightly in pCMV6-DAZL 
transfections (but not significant) and showed almost no change in pCMV6-BOLL 
transfection. Cadherin-associated protein beta 1 (beta-catenin) (CTNNB1) was 
chosen as the non-DAZL target control because it is highly expressed in HEK293 
cells and no evidence so far demonstrates that it could be bound directly by DAZL, 
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although its 3’-UTR does contain some potential DAZL recognition sites. Results 
showed that the levels of CTNNB1 remained unchanged in all transfections (Figure 
5.2).   
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Figure 5. 2 qRT-PCR for potential DAZL targets after expressing DAZL/BOLL in HEK293 
cells.  
TEX19 increases 1.68±0.09 fold and TEX14 increases 2.60±0.18 fold after pCMV6-DAZL 
transfection. Introducing BOLL also has some effects on both the targets (1.28±0.02 fold for 
TEX19 and 1.47±0.07 fold for TEX14) but the increases are still significantly lower than those 
with DAZL. CDC25A increases 1.09±0.02 fold in DAZL expressing cells but not significant, and 
BOLL has no effect on this mRNA. No significant change was detected in non-DAZL/BOLL 
target CTNNB1. n=4 per group, * relative to Control, +relative to DAZL, ***p<0.001, **p<0.01, 
*p<0.05, value=mean±s.e.m. 
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5.2.2 The increase in TEX19 and TEX14 mRNA levels may be due 
to DAZL-mediated mRNA stability 
We already found that TEX19 and TEX14 mRNA levels increased after 
pCMV6-DAZL transfection. This could arise from increased transcription or 
increased mRNA stability. As RNA-binding proteins, DAZL and BOLL cannot 
promote the transcription of TEX14 and TEX19 directly, but are more likely to 
regulate their mRNA targets at a post-transcriptional level. 
To find out whether overexpression of DAZL increased target mRNA stability in 
vitro, we transfected HEK293 cells with pCMV6-DAZL or empty vector, followed by 
5μg/ml Actinomycin D (ActD) treatment to block transcription. This dose and 
treatment time was based on previously published studies (Basu et al. , 2010, Ren et 
al. , 2005). Each treatment contained one sample and 5 groups of treatment were 
carried out on different passages of cells in total. After 24h ActD treatment, levels of 
TEX19 and TEX14 mRNA decreased to 7.69±1.52% (n=5) and 90.06±11.11% (n=5) 
of their Time 0 levels in empty-vector transfected cells, respectively. In contrast, 
21.40±2.64% of TEX19 mRNA remained after 24h in pCMV6-DAZL transfected 
cells and TEX14 slightly increased to 104±10.35% when compare to time 0 level 
(Figure 5.3), both of which were significantly higher than the levels in empty-vector 
transfected cells after treatment (p<0.005). The non-DAZL target CTNNB1 was 
investigated as a negative control but its level did not decline over the time window 
examined in empty-vector transfected cells. 
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  Figure 5. 3 The mRNA levels of TEX19 and TEX14 in pCMV6-DAZL transfected 
HEK293 cells are rescued after 24h ActD treatment (transcription blocking)  
7.69±1.52% TEX19 mRNA and 90.06±11.11% TEX14 mRNA is left in the control 
transfected cells 24h after ActD treatment. In contrast, 21.40±2.64% TEX19 mRNA 
survived in DAZL expressing cells and TEX14 mRNA levels increase to 104±10.35% 
when compare to time 0. No change was observed in non-DAZL/BOLL target CTNNB1. 
n=5 cultures per group, **p<0.01, value=mean±s.e.m.  
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5.2.3 Quantification of DAZL and BOLL protein expression in 
HEK293 cells at different time point after transfection 
The differential increases in the level of target mRNAs between DAZL and 
BOLL-transfected cells may be due to the selective binding of the mRNA targets, but 
also could be caused by different levels of DAZL or BOLL protein expression at the 
same time point when the mRNA was isolated (i.e. variation in efficiency of 
transfection or kinetics of protein production). Therefore, to find out when the peak 
of DAZL and BOLL protein expression occurred after transfection and to compare 
their levels at the same time point, we transfected HEK293 cells with pCMV6-DAZL 
or -BOLL vectors, harvested the cells and extracted the protein every 12h from 0h to 
72h after transfection. Western blotting was performed to quantify the amount of 
DAZL or BOLL protein, relative to the loading control α-tubulin (Figure 5.4). 
By Western blotting, both the anti-FLAG and α-tubulin antibodies detected 
corresponding bands at the right size (DAZL-FLAG=~37kDa, 
BOLL-FLAG=~35kDa, α-tubulin=~50kDa) in the lanes of 12 to 72h transfected 
samples. Only α-tubulin (no or very faint DAZL/BOLL bands) was detected in the 
lanes of 0h or untransfected cells, suggesting that the FLAG-tagged DAZL or BOLL 
bands were specific (Figure 5.4A). Quantification (Figure 5.4B) based on Western 
blotting was performed, using the LiCor Odyssey system to calculate the colour 
intensity of each band, and demonstrated that almost no FLAG-tagged DAZL or 
BOLL protein was expressed at time 0, but after 12h both proteins appeared. It then 
took 36h for DAZL protein to reach its peak amount, whilst for BOLL the peak was 
at 48h. After these time points the amount of both proteins began to reduce slightly, 
but still remained easily detectable until 72h. The average relative expression levels 
of FLAG-tagged DAZL protein were higher than BOLL at all the tested time points 
include 48h, but not significantly so (n=4).  
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Figure 5. 4 Time course of DAZL or BOLL protein in transfected HEK293 cells.  
A) Western blotting for pCMV6-DAZL or -BOLL transfected HEK293 cells at different time 
points. The left set of samples were transfected with pCMV6-DAZL vector whilst the right set 
were transfected with pCMV6-BOLL vector, and both were detected using FLAG and 
α-tubulin primary antibodies. DAZL and BOLL bands appear in all the lanes except very faint 
DAZL or BOLL bands are detected in the lanes of 0h transfection and no band in the 
untransfected samples. α-tubulin is detected in all the lanes. B) Quantification of DAZL and 
BOLL proteins in the transfected HEK293 cells at different time point, relative to α-tubulin. 
Both the proteins begin to express at 12h and the levels of DAZL are higher than BOLL at all 
the time points but not significant. The peak of DAZL expression appears at 36h (0.27±0.11 
relative to α-tubulin, whilst the peak of BOLL is at 48h (0.15±0.04 relative to α-tubulin). n=4, 
value=mean±s.e.m., UN=untransfected cells 
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5.2.4 The levels of putative DAZL mRNA targets change 
significantly in GFP-sorted, pCMV-DAZL transfected TCam-2 
cells 
The pCMV6 vectors could be transcripted in TCam-2 cells and the stable transfected 
cells lines were generated, however no protein was translated (see Section 3.2.5). 
Moreover, the TCam-2 cells have an extremely low transfection ratio. To solve the 
problem of these non-working vectors on TCam-2 cells and the low transfection ratio, 
a co-transfection/FACS system was established (see Section 3.2.6-3.2.7), and used 
this to look at how DAZL expression affected the expression of its mRNA targets in 
TCam-2 cells by qRT-PCR (Figure 5.5). Each treatment contained one sample, and 5 
groups were generated in total. For qRT-PCR, every sample was repeated once and 
the average of Ct value was calculated. 
We compared the levels of putative mRNA targets of DAZL between the GFP+ve 
(DAZL+ve ) and GFP-ve (DAZL-ve) cells. Both SYCP3 (p<0.005) and TEX14 (p<0.05) 
mRNA levels increased significantly in GFP+ve cells, 2.05±0.22 (n=5) and 1.37±0.14 
(n=5) fold respectively relative to GFP-ve cells. Surprisingly, the mRNA levels of 
DNMT3L (p<0.05) and SOX17 (p<0.005) both significantly decreased in the GFP+ve 
cells; DNMT3L to 58±0.05% (n=5) and SOX17 to 57±0.04% (n=5) compared to their 
levels in GFP-ve cells, indicating that the DAZL protein may have a novel repression 
effect on some mRNA targets in human. A 1.44±0.19 fold increase of the mRNA 
level of VASA in GFP+ve cells was not significant (although VASA protein levels 
increased when DAZL overexpressed in human ES cells, and thus is a potential 
DAZL target in human (Kee et al., 2009)) The mRNA level of another putative 
DAZL target TRF2 remained unchanged (1.01±0.02 (n=5) fold relative to levels in 
GFP-ve cells).  
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Figure 5. 5 The mRNA levels of potential DAZL targets show significant difference after 
DAZL/GFP co-transfection and GFP sorting.  
SYCP3 and TEX14 mRNA levels both significantly increase in GFP+ve/DAZL+ve TCam-2 cells 
(2.05±0.22 fold for SYCP3 and 1.37±0.14 fold for TEX14) relative to GFP-ve/DAZL-ve cells. 
DNMT3L and SOX17 mRNA levels were significantly reduced to ~57% of their levels in the 
GFP-ve/DAZL-ve cells. The human DAZL target VASA also slightly increased in GFP+ve/DAZL+ve 
cells (1.44±0.19 fold) but not significant, and another putative DAZL target TRF2 did not show 
any change (1.01±0.02 fold). n=5, *p<0.05, **p<0.01, value=mean±s.e.m. 
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5.2.5 DAZL promotes the translation of Luciferase mRNA 
conjugated with TEX14-3’UTR in HEK293 cells 
After identifying the effect on the mRNA levels of putative DAZL mRNA targets, we 
next sought to investigate whether DAZL regulates the protein levels of these 
mRNAs. For this purpose, a 3’-UTR luciferase assay was designed. As DAZL 
usually functions by binding to the 3’-UTR of its mRNA targets (Collier et al., 2005), 
optimized Renilla Luciferase vectors with either no 3’-UTR, or conjugated to the 
human GAPDH 3’-UTR or TEX14 3’-UTR were used as the reporter and 
co-transfected with pCMV6-Entry (empty) or pCMV6-DAZL vectors into HEK293 
cells for 48h (Table 5.2). If DAZL promotes the translation of these mRNAs through 
their 3’UTRs, then the translation of luciferase will be enhanced and thus the 
luminescence will be stronger (Figure 5.6). The Luciferase vectors with no 3’-UTR 
or GAPDH 3’-UTR cannot be regulated by DAZL and are therefore used as control 
and also for normalisation. Each experiment contained 3 technical replicates, and the 
experiment was performed 4 times on different passages of cells. After transfection, 
cell lysis and the luminesce reaction were both triggered by adding the assay solution 
which contained the specific substrate of Renilla luciferase directly to the wells. 
After 30min incubation, the luminescence values which represented the activity and 
thus the protein level of luciferase were read by FLUOstar OPTIMA. The average 
reading was calculated for the 3 replicates in each round of the experiment and the 
original data were normalised following the manufacture’s protocol (see Section 
2.10.2).   















After normalisation following manufacturer’s protocol, the data were analysed using 
paired t-tests as the treatment was matched in each experiment. We found that the 
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activity of luciferase with TEX14 3’-UTR was significantly (p<0.05) increased about 
1.92±0.18 fold (n=4) in the DAZL co-transfected cells, when compared to the empty 







Figure 5. 6 Luciferase activity increases in pCMV6-DAZL/Luc-TEX14 3’-UTR 
co-transfected HEK293 cells.  
HEK293 cells were transfected with either pCMV6-Entry (empty) or pCMV6-DAZL vectors 
combined with Luciferase vectors which were conjugated with no 3’-UTR, GAPDH 3’-UTR or 
TEX14 3’-UTR. Whilst no difference was detected in no UTR or GAPDH 3’-UTR 
co-transfections, the activity of luciferase increased in pCMV6-DAZL and Luc-TEX14 3’-UTR 
co-transfected cells when compared to the empty vector transfection. n=4, *p<0.05, 
value=mean±s.e.m. 
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5.2.6 DAZL represses the translation of Luciferase mRNA 
conjugated to SOX17-3’UTR in TCam-2 cells 
A similar approach was applied to testing the regulation of the SOX17 3’-UTR 
regulation by DAZL, but 3 replicates of experiments on different passages of cells 
were carried out. The experimental design was similar to the one of the TEX14 
3’-UTR (see Table 5.3 for the combination of vectors), but using the pCMV-DAZL 
vector instead of the pCMV6-DAZL vector and TCam-2 cells were used as the in 
vitro model, because the HEK293 cells might lack some key factors which involved 
in regulating SOX17. 
 















These data were also analysed using a paired t-test. The activity of SOX17 3’-UTR 
significantly (p<0.01) decreased in the pCMV-DAZL co-transfected TCam-2 cells 
(Figure 5.7), to about 68.81±0.04% (n=3) when compared to the cells co-transfected 
with empty vector.  
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Figure 5. 7 SOX17 Luciferase activity decreases in pCMV-DAZL/Luc-SOX17-3’UTR 
co-transfected TCam-2 cells.  
Similar transfections were applied on TCam-2 as listed in Figure 5.6 but with the 
pCMV-DAZL vector, and Luciferase vector is conjugated with SOX17 3’-UTR. Whilst no 
difference was detected in non- or GAPDH 3’-UTR co-transfections, the activity of 
luciferase decreased to 68.81±0.04% in pCMV-DAZL and SOX17 3’-UTR co-transfected 
cells when compare to the empty vector transfection. n=3, **p<0.01, value=mean±s.e.m. 
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5.2.7 Luciferase mRNA with TEX14 3’-UTR co-precipitates with 
human DAZL protein 
Once the immunoprecipitation of human DAZL after co-transfection was 
successfully confirmed (see Section 3.2.8), we performed RNA extraction and 
RT-PCR to isolate and detect the luciferase mRNA co-precipitated with DAZL. The 
methods of transfection, RIP and combination of vectors were the same as those 
described in previous section (see Section 5.2.5 and 5.2.6). After RIP, the RNA of 
both INPUT and RIP samples were isolated and converted to cDNA, and then 
end-point PCR was performed to detect the luciferase mRNA using the primers 
designed against the sequence of luciferase gene provided by manufacturer (not 
relative to the sequence of 3’-UTR).  
Agarose electrophoresis for the PCR product (Figure 5.8) showed that the luciferase 
mRNA was appropriately expressed in all the INPUT samples whether they 
contained GAPDH or TEX14 3’-UTR, or were co-transfected with empty or DAZL 
vectors. After RIP, there was no detectable luciferase mRNA in the lanes of empty 
vector or DAZL/GAPDH 3’-UTR co-transfected samples, and the only band was seen 
in the lane of DAZL/TEX14 3’-UTR co-transfected cells. The electrophoresis for –RT 
was clear without any band, suggested that the bands in +RT reactions were not 
primer-dimer or because of any contamination. This experiment was repeated twice 
more with the same results. 
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Figure 5. 8 Luciferase mRNA is co-precipitated with DAZL protein in only 
pCMV6-DAZL/Luc-TEX14 3’-UTR co-transfected HEK293 cells.  
The samples of INPUT and RIP were separated by the white dashed line. The bands of Luciferase 
mRNA were detected in all the INPUT lanes, suggesting that it was expressed normally in all the 
co-transfections before RIP. However after RIP, the mRNA was only detected in 
pCMV6-DAZL/Luc-TEX14 3’-UTR co-transfected cells. No bands were seen in –RT samples, 
indicating there was no contamination in the PCR system. 
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5.2.8 The level of Luciferase mRNA is significantly higher in 
pCMV6-DAZL/Luc-TEX14 3’-UTR co-transfected HEK293 
cells after RIP 
To further test the results obtained from RIP, luciferase mRNA was quantified using 
qRT-PCR to find out the enrichment of luciferase mRNA. Three sets of transfections 
was performed on different passages of cells. Since a huge amount of input RNA is 
necessary for RIP, each treatment contained 3 3×10cm dishes of cells that were 
mixed together once the cells were lysed. For qRT-PCR, each sample was repeated 
once and the average Ct value was calculated for further analysis. As it could not 
guarantee that the level of housekeeping gene was stable after the RIP for 
normalisation, the amount of luciferase mRNA was determined relative to the 
concentration of isolated mRNA from corresponding INPUT samples, and then 
calculated as fold change between INPUT and RIP. The data seemed to show a 
skewed distribution after RIP (1.97 vs 26.43 for GAPDH and 140.88 vs 780.88 for 
TEX14), but due to the small sample size the normalisation test could not be 
performed. Therefore the results were assumed not normally distributed and were 
logged before analysis. Significance was analysed using a paired t-test and the results 
are shown in Figure 5.9. 
The data suggest that in the INPUT samples before RIP, the levels of luciferase 
mRNA conjugated with GAPDH or TEX14 3’-UTR did not show any significant 
difference in DAZL co-transfection samples when compare to pCVM6-Entry vector 
transfections (1.09±0.18 fold for GAPDH and 1.09±0.24 fold for TEX14). After RIP, 
there was a low level of GAPDH 3’-UTR luciferase mRNA still remaining in the 
samples, with no significant difference between pCVM6-Entry and DAZL transfected 
samples (10.24±8 fold in DAZL transfections). In contrast, the Luc-TEX14 3’-UTR 
mRNA significantly increased in the pCMV6-DAZL co-transfected samples (p<0.01), 
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Figure 5. 9 TEX14 3’-UTR conjugated Luciferase mRNA significantly enriches in DAZL 
co-transfected samples after RIP.  
A) The levels of both GAPDH and TEX14 3’-UTR conjugated luciferase mRNA did not show 
any significant difference between empty and pCMV6-DAZL transfections before RIP. B) In 
contrast, luciferase mRNA enriched 359±210 fold in pCMV6-DAZL/Luc-TEX14 3’-UTR 
co-transfections when compared to the pCMV6-Entry/Luc-TEX14 3’-UTR transfected sample 
after RIP. No significant difference is detected between the Luc-GAPDH transfections, 
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5.2.9 Human DAZL directly binds to its endogenous potential 
mRNA target in TCam-2 cells 
Although the above experiments demonstrate that DAZL can bind to the 3’-UTR of 
TEX14 and regulate the translation of a luciferase vector conjugated to this 3’-UTR, 
this was based on transfections of HEK293 cells, which was not an ideal model to 
study germ cells, and the luciferase mRNA was also artificial (exogenous vector 
rather than an endogenously-expressed transcript). Hence, it was still unclear that 
whether the same regulatory relationship also exists in germ cells, between DAZL 
and endogenous mRNAs. In order to determine whether DAZL can also bind to its 
endogenous mRNA targets in human germ cells, we again performed RIP on TCam-2 
cells. The cells were transfected with pCMV6-Entry (empty) or pCMV-DAZL vectors 
and no luciferase or other vectors were added. The rest of methods were the same as 
the ones we applied on HEK293 cells and 3 sets of experiments were performed. To 
perform RIP requires large amount of input RNA, therefore, considering the 
transfection ratio and extremely low yield of transfected cells after FACS, the 
co-transfection/FACS system was not applied. 
After RIP, RT-PCR was utilised to detect the precipitated potential DAZL targets. In 
previous co-transfection/FACS experiments on TCam-2 cells (see Section 5.2.4) 
TEX19, TEX14, SYCP3, DNMT3L and SOX17 had been investigated as potential 
human DAZL targets and the binding between TEX14 3’-UTR and DAZL had been 
already confirmed, so primers against these genes were used to detect the presence of 
their mRNA in both the INPUT and RIP products. The non-DAZL target GAPDH 
was also examined to identify the specificity of RIP, and besides the ±RT, another 
reaction for each gene using dH2O as the blank template was set up as a negative 
control (Figure 5.10, (1)&(2)). 
Although some primer-dimers formed, no major bands were detected in the –RT or 
dH2O samples, demonstrating that the bands in +RT reactions were not produced by 
non-specific reactions. As anticipated, all tested mRNAs were expressed 
endogenously in the INPUT samples before RIP, and the strength of bands did not 
show major differences between empty vector and DAZL transfected samples 
(Figure 5.10, (1)&(2)). After RIP, the bands for GAPDH, DNMT3L, SOX17 and 
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SYCP3 were still detectable in both empty vector and DAZL-transfected samples. 
GAPDH did not show any difference between the two samples. The bands 
forDNMT3L and SYCP3 were very weak, and only slightly brighter in the 
pCMV-DAZL transfections than in the empty vector samples.  In contrast, the band 
for SOX17 mRNA in the RIP sample from DAZL-expressing TCam-2 cells was 
much stronger than that for empty vector transfected cells, and TEX19 was only 
detectable in the RIP from pCMV-DAZL transfected cells. Together, the data suggest 
that SOX17 and TEX19 mRNA are directly bound by DAZL protein, and DNMT3L 
and SYCP3 were likely to be co-precipitated as well. The similar levels of GAPDH 
between pCMV-DAZL and empty vector transfections indicate that the DAZL 
binding was specific. 
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Figure 5. 10 (1/2) RT-PCR for the endogenous potential DAZL targets before/after RIP in 
TCam-2 cells.  
Blots are sorted by gene names with long dashed lines, and also by INPUT/RIP with short dashed 
lines. GAPDH, DNMT3L and SOX17 are expressed normally in both pCMV-DAZL and empty 
vector transfections before RIP. After the RIP, SOX17 shows a stronger band in DAZL expressing 
samples, whilst DNMT3L is only very slightly stronger and GAPDH is similar. Although some 
primer-dimer formed, no similar band as in the +RT is detected in –RT or dH2O template negative 
controls, suggests that the bands in +RT are specific. 
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  Figure 5.10 (2/2) RT-PCR for the endogenous potential DAZL targets before/after RIP in 
TCam-2 cells.  
Blots are sorted by gene names with long dashed lines, and also by INPUT/RIP with short dashed 
lines. SYCP3 and TEX19 are also expressed normally in the INPUT samples before the RIP. After 
the RIP, although still detectable in the empty vector transfection, SYCP3 shows a slightly stronger 
band in the pCMV-DAZL transfection, whilst TEX19 only appears in the DAZL expressing sample. 
The –RT and dH2O negative controls were also clean, indicating contamination was avoided in the 
PCR system. 
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5.2.10 Quantification of DAZL co-precipitated endogenous mRNA 
targets 
After RIP in TCam-2 cells for endogenous DAZL targets, these experiments were 
repeated to quantify the amounts of target mRNA isolated from both INPUT and RIP 
samples by qRT-PCR. The significance of data was analysed using paired t-test as 
only two kinds of treatments (i.e. transfected with DAZL or empty vector) were 
performed and they were matched in each experiments. 
In Figure 5.11, in all of the INPUT samples, almost no difference was detected 
between the empty and pCMV-DAZL transfected samples. This was unexpected, as 
previous experiments had demonstrated that DAZL transfection could affect the level 
of its mRNA targets, but may be explained by the very low transfection ratio of 
TCam-2 cells – any change in a small percentage of cells might be masked by the 
presence of many untransfected cells. In the RIP samples, TEX19, TEX14 and SOX17 
all showed a significantly higher amount of mRNA in the DAZL transfected cells. To 
specify, TEX19 was 7.11±1.65 (n=3) fold (p<0.05) higher and TEX14 (p<0.01) had 
2.7 fold enrichment in one set of samples (but its overall fold change was unable to 
be calculated as it was undetectable in two other sets of empty vector transfected 
samples after RIP). SOX17 was 22.84±4.51 (n=3) fold (p<0.01) higher when 
compared to the empty vector transfected cells. DNMT3L also showed enrichment 
(2.48±0.85 (n=3) fold on average) in the pCMV-DAZL transfections after RIP in 
every experiment we performed but this difference was not significant. Although 
GAPDH was also slightly enriched in the pCMV-DAZL transfections (1.48±0.61 (n=3) 
fold on average), it was very variable in the RIP and not statistically significant. To 
conclude, TEX19, TEX14 and SOX17 are all significantly enriched in DAZL RIP 
suggesting that they can be directly bound by to DAZL protein in human germ cells. 
The validity of DNMT3L as a possible DAZL target is still unclear, and the variable 
but not consistently changed level of the non-DAZL target GAPDH confirms that the 
binding between DAZL and its mRNA targets are specific. 
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Figure 5. 11 The putative mRNA targets of DAZL enrich in pCMV-DAZL transfected TCam-2 
cells after RIP.  
None of the mRNAs we examined showed significant change between pCMV-DAZL and empty 
vector transfections in the INPUT samples. After the RIP, TEX19, TEX14 and SOX17 were 
significantly enriched in DAZL expressing cells when compare to the empty vector transfected 
cells. Since TEX14 was undetectable after RIP in two empty vector transfected samples, the fold 
change of it after RIP in the figure was calculated based on only one sample and the significance 
was analysed based on the raw PCR data rather than fold change. DNMT3L was also enriched 
but not significant, and GAPDH remained unchanged between pCMV-DAZL or empty 
transfections.  n=3, *p<0.05, **p<0.01, value=mean±s.e.m. 
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5.3 Discussion 
In this chapter, we identified several putative human DAZL targets, namely TEX19, 
TEX14, CDC25A, SOX17, SYCP3 and DNMT3L, and the interactions between DAZL 
and TEX14/SOX17 mRNAs were studied in detail.  
Although several mRNA targets of mouse Dazl have been identified (Chen et al., 
2014, Chen et al., 2011, Jiao et al., 2002, Reynolds et al., 2007, Reynolds et al., 2005, 
Zeng et al., 2008, Zeng et al., 2009), and DAZL silencing/overexpression can affect 
the expression or distribution of some proteins in human ES cells (Kee et al., 2009), 
the only mRNA target that has been proven to interact with human DAZL is SDAD1, 
and this was only shown using a yeast three-hybrid-assay in vitro (Fox et al., 2005) 
so may not represent a physiological interaction. In our research, we not only showed 
that human DAZL could regulate some putative targets at mRNA and/or 
corresponding protein levels, but also confirmed that this regulation is due to the 
direct binding between DAZL and 3’-UTR of these targets.  
Significantly increased levels of endogenously-expressed mRNAs were seen in 
HEK293 cells after DAZL or BOLL was introduced, suggesting that TEX19, TEX14 
and CDC25A could be potential DAZL/BOLL targets. That there was no significant 
change in CTNNB1 expression indicates that that the effect on theses transcripts is 
specific, and not caused by a global increase in mRNA levels in response to 
DAZL/BOLL expression. The time course analysis of DAZL and BOLL protein 
expression suggests that pCMV6-DAZL vector reached peak production of DAZL 
protein at 24h (when the mRNA was isolated at 24h) in contrast to the pCMV6-BOLL 
vector (which peaked later at 36h), this difference might not be the most important 
factor to explain the stronger effect on target mRNA levels caused by DAZL than by 
BOLL. The different regulation effect may be due to the different binding capacity 
and/or recognise motif between DAZL and BOLL, because a substitution of a crucial 
amino acid residue was found on the RRM of BOLL when compare with DAZL 
(Jenkins et al., 2011). In addition, despite both DAZL and BOLL share some similar 
co-factors such as PABPs (Collier et al., 2005) and PUM2 (Urano et al., 2005), the 
binding mechanisms can be different and their protein complexes indeed recognise 
different mRNA targets (Urano et al., 2005). However, no further investigation of the 
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BOLL regulation on TEX19 and TEX14 has been performed and therefore it is still 
difficult to tell whether these mRNAs are directly modulated by BOLL, or how 
effective the regulation is.  
After that, our experiments using TCam-2 cells added SYCP3, SOX17 and DNMT3L 
as potential DAZL targets. They had been originally identified as potential Dazl 
targets by previous research in mouse (Reynolds et al., 2007, Reynolds et al., 2005, 
Zeng et al., 2008, Zeng et al., 2009), although this is the first time they have been 
demonstrated to be targets of human DAZL. The luciferase assay demonstrates that 
the translation of a luciferase reported conjugated to the TEX14 or SOX17 3’UTR of 
DAZL target mRNAs is specifically promoted by DAZL (relative to control 3’UTRs), 
and therefore DAZL may regulate the translation of these targets in germ cells via 
this mechanism. Furthermore, by RIP, it was shown that only the luciferase mRNA 
conjugated with TEX14 3’-UTR could be co-precipitated with DAZL protein, 
indicating that there is direct binding between DAZL and the TEX14 3’-UTR. 
Furthermore, the RIP performed on TCam-2 cells also demonstrated direct binding 
between DAZL protein and its targets, i.e. TEX14, TEX19, SOX17 and potentially 
DNMT3L. 
Although the mouse Dazl homologue targets Tex19.1 and Sycp3 have been 
investigated in detail (Reynolds et al., 2007, Zeng et al., 2009), no previous studies 
have described how Dazl regulates these targets at mRNA level. In addition, Tex14, 
Sox17 and Dnmt3l mRNA in mouse were only co-precipitated with Dazl protein and 
no further effect of regulation was described in these studies. The data presented here 
is therefore the first demonstration of DAZL regulation of these targets, and of the 
regulation of target mRNA levels by DAZL.  
Mouse has two Tex19 homologues, Tex19.1 and Tex19.2, of which Tex19.1 is more 
conserved with the one human TEX19 gene (Kuntz et al., 2008). In our experiments, 
human TEX19 mRNA levels increased in both HEK293 and TCam-2 cells after 
DAZL transfection. In addition, endogenous TEX19 mRNA in TCam-2 cells could be 
co-precipitated with DAZL protein, which confirms a direct binding of human DAZL 
to TEX19 mRNA, as occurs in mice. However, previous research suggests that the 
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translation of a luciferase vector conjugated to 3’UTR of mouse Tex19.1 is 
down-regulated when co-transfected with mouse Dazl into zebrafish oocytes (Zeng 
et al., 2009), which is in conflict with our experiments. This may be due to the 
presence of different Dazl co-factors between zebrafish and mammals, and thus the 
zebrafish model may not represent the Dazl regulation of Tex19.1 in vivo accurately. 
Another possibility is that mouse has two Tex19 genes whilst humans have only one 
TEX19 homologue (Kuntz et al., 2008), and therefore their functions – and regulation 
- may not be exactly conserved. 
Tex14 mRNA can be co-precipitated with Dazl from testis extracts (Reynolds et al., 
2005). Here we have shown that TEX14 mRNA levels increase after DAZL 
transfection in both HEK293 and TCam-2 cells, the activity of luciferase conjugated 
with TEX14 3’-UTR increases when it is co-transfected with DAZL, and we have 
demonstrated direct binding between DAZL and the TEX14 3’-UTR. This provides 
very strong evidence that TEX14 is an mRNA target of human DAZL. Although 
human studies are lacking, mouse Tex14, which is 64% conserved with its human 
homologue (Wu et al. , 2003) has been investigated in detail, especially during germ 
cell development. In mouse, Tex14 is essential for the formation of germ cell 
intercellular bridges (Greenbaum et al., 2006), and male Tex14-/- mice display 
meiosis arrest and sterility.  Females are fertile, but have fewer follicles and 
significantly smaller litter sizes (Greenbaum et al., 2009, Greenbaum et al., 2006). 
Tex14 protein is expressed by spermatogonia and spermatocytes in testis 
(Greenbaum et al., 2006), and is therefore at least partly co-expressed with Dazl, 
meaning that this regulation might occur in vivo as well. The expression pattern of 
TEX14 is therefore likely to be conserved between human and mouse, and suggests 
that TEX14 mRNA could interact with DAZL protein during human fetal oogenesis 
in vivo. 
Another target we identified is SOX17. Although the functions of SOX17 and its 
relationship with DAZL during germ cell development remains unknown, its 
expression pattern in gonads is studied across several species such as human, mouse 
and fish (de Jong et al., 2008b, Kanai et al., 1996, Navarro-Martin et al. , 2009). A 
study in human male suggests that SOX17 is expressed in the germ cells of fetal 
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testis, and in spermatogonia, secondary spermatocytes and spermatids (but not in 
primary spermatocytes) in adult testis (de Jong et al., 2008b).  In mouse testis, 
Sox17 mRNA has two isoforms and the functional one is also mainly expressed in 
spermatogonia but is low from early pachytene (Kanai et al., 1996). This is 
supported by our in vitro studies in which both the endogenous SOX17 mRNA level 
and the translation of a luciferase reporter with SOX17 3’-UTR are decreased in 
TCam-2 cells after DAZL transfection, and this is due to the direct binding between 
DAZL and SOX17 3’-UTR.  Similar binding also happens between mouse Dazl and 
Sox17 (Zeng et al., 2008).  Together, our results suggest SOX17 as a human DAZL 
target, and they reveal a novel repression function of human DAZL as well. 
SYCP3 is a component of the synaptonemal complex (SC) and is necessary for 
synapsis during meiosis (Yuan et al., 2000). Sycp3 has been identified as a definitive 
Dazl target in mouse (Reynolds et al., 2007). In humans, the mRNA expression of 
SYCP3 increases in human fetal ovary around the time of the entry of the first germ 
cells into meiosis (Houmard et al., 2009), which is coincident with the increased 
DAZL expression at the same period. Our study on TCam-2 cells shows that the 
human SYCP3 mRNA increases after DAZL transfection, and it is co-precipitated 
with DAZL protein. Furthermore, its protein is partly co-localised with DAZL in 
human fetal ovary (see Chapter 4). Therefore, SYCP3 is likely to be a conserved 
mRNA target of DAZL in mouse and human. 
We also investigated DNMT3L, which is significantly decreased in DAZL transfected 
TCam-2 cells, although we could not definitely demonstrate that DAZL directly 
binds to DNTML3L mRNA. The repression of expression of DNMT3L mRNA by 
DAZL in vitro is consistent with the patterns of expression seen in in vivo. A 
previous study suggested that Dazl could bind mouse Dnmt3l mRNA (Zeng et al., 
2008), however the human DNMT3L has an extremely short 3’-UTR (58bp) 
compared to that of the mouse (273bp), and therefore this protein-mRNA interaction 
might not be conserved between human and mouse. It is possible that DAZL 
represses DNMT3L expression, however our experiments has not provided enough 
evidence to prove whether this is through direct or indirect pathway yet. 
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Previous research indicates that CDC25A could be a common target of both DAZL 
and BOLL (Jiao et al., 2002, Lin et al., 2009). Our in vitro experiments using 
HEK293 cells however, indicate that DAZL, but not BOLL, could possibly promote 
the stability of CDC25A, as the mRNA level of CDC25A in HEK293 cells slightly 
increased after introducing DAZL, although this change was not significant and 
further evidence is needed.  
VASA (Mvh) is another DAZL mRNA target which has been demonstrated in mouse 
(Reynolds et al., 2005), and suggested to be a target in humans based on increased 
numbers of VASA-GFP+ve human XX ES cell when DAZL or BOLL is 
overexpressed (Kee et al., 2009). It is co-expressed with DAZL in human fetal ovary 
and increases at meiosis initiation in vivo as well, although a similar increase is also 
found in the human fetal testis suggesting this might not be a meiosis-specific effect 
(Anderson et al., 2007). However we had difficulty investigating this mRNA as it is 
not expressed in HEK293 cells and has very extremely low mRNA level in TCam-2 
cells, and no detectable protein expression. Slightly, but not significantly, increased 
VASA mRNA level was observed in DAZL transfected TCam-2 cells. As its protein 
expression increased in human ES cell when DAZL was overexpressed (Kee et al., 
2009) but no significant change of mRNA level was observed in our experiments, it 
is possible that the human DAZL only promote the VASA translation, rather than both 
translation and mRNA stability.  
Our study also indicates that DAZL may stabilise its targets in human. Previous 
research (Takeda et al., 2009) demonstrated that zebrafish Dazl could stabilise the 
mRNA by preventing miRNA-mediated deadenylation. However other research 
(Wiszniak et al., 2011) which reported a similar phenomenon suggested that other 
pathways such as interaction with other germ cell-specific RNA-binding proteins 
may also contribute to the stabilisation of target mRNAs. By ActD treatment 
(transcription blocking), our study indicated that the increase might be due to the 
protection of mRNA from degradation, rather than up-regulated transcription. Our 
results also indicate a repression function of DAZL on its target at both mRNA and 
protein level; for detailed discussion see Chapter 7. Although we know these effects 
are due to post-transactional regulation, it is still unclear whether this occurs due to 
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prevented/promoted deadenylation or polyadenylation, or through other pathways 
and this remains to be investigated. 
The work described in this chapter has some weaknesses, and improvements could 
be made if they were to be repeated/extended in future. The first problem is as 
discussed in previous chapter, which is the small sample size. Each experiment was 
repeated 3-5 times and thus it was not possible to test whether the data obtained were 
normally distributed or not. Because of the small sample size, we had to use only 
non-parametric methods for the data analysis. Another similar problem is the few 
transfection replicates of the DAZL/BOLL transfection experiments on HEK293 
cells. Although the experiments were repeated for several times, each time one 
transfection only contained one sample. This could not guarantee that every time the 
transfection was performed properly as there was no sample to compare with. 
Although fortunately it seemed that the data were not extremely dispersed in this 
study, more replicates for every experiment and each treatment should be performed 
in future work.  
The next problem was the selection of controls. Although ActD treatment was 
supposed to stop transcription, the level of CTNNB1 mRNA showed almost no 
change after 24h. This indicates that either the transcription of this mRNA was still 
ongoing, or it might be protected by other mechanisms. The former indicates that 
further optimization of the ActD treatment may be required, to ensure that 
transcriptional arrest is complete. The latter suggests that other parameters which 
may affect the DAZL targets also need to be considered. And in either way, the 
CTNNB1 might not be the ideal control and seeking a new control mRNA would be 
necessary for future work. 
It will also be necessary to use PCR controls in in future RIP experiments. Although 
the –RT reactions were performed to make sure the no unspecific reactions occurred 
in +RT samples, it was not clear whether the PCR was worked properly, especially 
when no bands appeared in the +RT RIP samples. Therefore, the PCR positive 
controls are necessary. These could be performed using samples which contained the 
target mRNA (for example, cDNA of human fetal ovary) and with the corresponding 
primers. 
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Finally, for the luciferase assay, it would be necessary to standardise the cell numbers 
used between each experiment. Currently no standardisation was performed. 
Although the methods (volume of cell suspension added to the wells) were optimised 
beforehand to make sure the ideal cell density was achieved after plating and the 
wells were observed under microscope, the cells were no longer counted in following 
experiments. To count the cells before each plating to make sure same numbers of 
cells were plated is a possible solution, or this could be corrected by isolating the 
mRNA and performing qRT-PCR to compare the levels of a housekeeping gene. It 
was also not ideal to use the pCMV6-Entry vector as a control for the pCMV-DAZL 
vector. The best control should be an empty vector with the pCMV promoter, 
however it was unavailable. Since the unexpected problem of using pCMV6 vectors 
in TCam-2 cells (see Section 3.2.5), this could not be solved during this study. But 
with hindsight, if performing the same experiments again, the vectors from a same 
series would be a much better choice.  
In conclusion, we have identified several putative human DAZL/BOLL targets, and 
have found that TEX14 and SOX17 are likely to be definitive mRNA targets of 
human DAZL. Regulation of TEX19 and TEX14 by BOLL was also observed, but 
needs further investigation. The expression levels of other DAZL targets including 
TEX19, DNMT3L, SYCP3 and potentially CDC25A, all changed after DAZL 
transfection in vitro, suggesting these too may be DAZL targets in humans. The 
increased expression of TEX19 and SYCP3 is coincident with increased DAZL 
expression in the human fetal ovary, and we demonstrated direct binding of DAZL to 
these mRNAs as well. We also found that DAZL may regulate the stability of its 
targets at post-transcription level, although the pathway remains unclear. Overall, our 
study not only identified potential DAZL/BOLL targets, but also co-related them 
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Chapter 6. Investigating the Expression of Putative DAZL 
Targets in Human Fetal Ovary 
6.1 Introduction 
In the previous chapter, several potential DAZL mRNA targets, namely TEX14, 
TEX19, CDC25A, SOX17, SYCP3 and DNMT3L were identified. However, the work 
in the previous chapter was all based on the in vitro study. This does not always 
represent what actually happens in vivo and therefore it still cannot be concluded that 
the mRNAs identified are real human DAZL targets.  
For RNA-binding protein, it is essential to be co-localised with its targets in the same 
cells to regulate them. Several methods can be used to answer this question, 
including establishment of the protein expression profile of these targets in human 
fetal ovary and co-localising them with DAZL.  
Due to the commercial availability of antibodies, this chapter will focus on the 
expression of SOX17 and DNMT3L protein. Among all the other targets, the 
co-localisation of DAZL and SYCP3 has already been confirmed in Chapter 4. 
TEX14 protein is widely expressed in intercellular bridges between germ cells 
(Greenbaum et al., 2007), therefore it is very likely to be co-expressed with DAZL.  
TEX19 expression in human is not very clear. In mouse, Kuntz et al. (2008) reported 
that in fetal ovary, Tex19.1 mRNA expression increases at meiosis, then transiently 
decreases at e15.5 but recovered at e16.5. Other research suggested that its 
expression may extend to birth in female (Celebi et al. , 2012). In male mouse 
however, its protein seems to decrease at meiosis (Ollinger et al., 2008). According 
to these studies, Tex19.1 expression seems to be associated with meiosis and is very 
likely to be co-expressed with mouse Dazl as well. 
CDC25A expression has been investigated in human. In female ovary, its mRNA is 
known to be expressed in GV stage oocytes and increases during the growth of 
oocyte (Assou et al. , 2006) but it is not clear at earlier stages. DAZL is found in 
human GV oocytes as well (Chen et al., 2011) so their co-expression is possible. In 
males, its protein is most abundant at pachytene, co-localised with BOLL (Lin et al., 
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2009, Luetjens et al., 2004) but is also found in spermatogonia (Lin et al., 2009) and 
possibly co-expressed with DAZL at this stage as well.  
Mouse Dnmt3l is believed to be present in growing oocytes of adults (Bourc'his et al., 
2001). Some studies claim that it is not expressed in germ cells of early stages in 
fetal ovary (reviewed by Schaefer et al., 2007), however this seems to be based on 
one study (La Salle et al. , 2004) which only investigated e13.5 and later. In testis, 
Dnmt3l cannot be found in non-dividing pro-spermatogonia or spermatogonia, but is 
highly expressed in differentiating spermatogonia at day 2 after birth (Bourc'his and 
Bestor, 2004) then soon becomes undetectable after day 6 (Bourc'his and Bestor, 
2004, La Salle et al., 2004). Notably, it also declines in e13.5 male germ cells when 
meiosis is induced by RA treatment (Ohta et al. , 2010). 
For Sox17, one of its functional variants in mouse is expressed in pre-meiotic cells 
(Kanai et al., 1996). In human, its expression pattern remains unknown in the ovary, 
but its protein is detected in testis in spermatogonia, secondary spermatocytes and 
spermatids (de Jong et al., 2008b).  
In previous work (MSc thesis, J He 2010), I have already tried to find out whether 
their expression changes in vivo, especially around the initiation of meiosis because 
DAZL is necessary for this process (Lin et al., 2008). qRT-PCR was applied to 
mRNA extracted from human fetal ovary to detect these targets during three stages 
which represent the periods of key events of development, i.e. before meiosis (8-9 
week), after meiosis initiation (14-16 week) and the beginning of follicle formation 
(17-20 week). Each group contained 5-6 individuals, and the samples were assayed 
in duplicate by qRT-PCR. Due to the small sample size, it was not possible to 
determine the normality. Data were then analysed by One-Way ANOVA, followed by 
Tukey's multiple comparisons test. 
At 14-16 week gestation, i.e. at meiosis initiation, both TEX19 and TEX14 increased 
significantly (p<0.005, n=5-6) compared to 8-9 week gestation. The increased 
expression of TEX14 is consistent with other research which indicated that TEX14 
sharply increased at 10-12 week and maintains this level afterwards, whilst in testis 
its level is relative stable (Houmard et al., 2009). Expression of both was slightly 
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higher at 17-20 week but not significantly so when compared to the 14-16 week 
gestation (Figure 6.1). The expression of SYCP3 mRNA has been previously 
investigated and found to increase when meiosis started, with high expression 
remaining at later gestations (Houmard et al., 2009). In contrast, DNMT3L mRNA 
showed a trend of slightly reduced expression during development but not 
significantly so. SOX17 declined to less than 50% of its level at 8-9 week gestation 
after meiosis initiation and this change was significant (p<0.05, n=5-6). This 
reduction seemed to be transient, because while expression at 17-20 week was lower 
than at 8-9 week gestation, this was not significant.  
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Figure 6. 1 The mRNA expression in human fetal ovary of putative DAZL targets.  
Almost no TEX19 is expressed before meiosis at 8-9 week gestation (4.93±1.36×10-5 relative to 
RPL32), then its level dramatically increases after the meiosis initiation (4.63±1.03×10-3 relative 
to RPL32) becoming higher during later development (8.06±1.66×10-3 relative to RPL32). The 
level of TEX14 is also significantly higher when meiosis starts (4.90±0.39×10-2 vs 
4.08±1.69×10-3, both relative to RPL32) and remains at a high level when the primordial follicles 
begin to form. DNMT3L shows a trend of declining expression through the three key stages of 
human ovary development but the change is not significant. At 14-16 week gestation, SOX17 
decreases to only 38% (1.93±0.27×10-3 relative to RPL32) of its level in 8-9 week gestation 
(5.03±1.13×10-3 relative to RPL32) and it soon recovers to about 60% (3.06±0.49×10-3 relative 
to RPL32) at 17-20 week. n=5-6, *p<0.05, **p<0.01, value=mean±s.e.m. 
MSc Thesis, J.He 2010 
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6.2 Results  
6.2.1 DNMT3L is expressed in less mature germ cells in human 
fetal ovary 
We next examined the protein expression of the potential DAZL targets in human 
fetal ovary. As there were no good commercial antibodies for other targets and 
SYCP3 expression had already been investigated in my previous studies (see Chapter 
4), we focused on the expression of DNMT3L and SOX17. In the following results, 
all the experiments were performed on at least 2 sections from 2 different individuals 
to make sure the results were robust. 
Although DNMT3L was not significantly enriched in DAZL RIP, its mRNA level 
decreased after the DAZL transfection (see Chapter 5). Because the sample size of 
the DAZL RIP was small (n=3), which could lead to a type II error (did not correctly 
reject the null hypothesis), the possibility remained that DNMT3L could directly bind 
with DAZL.  
Single immunofluorescence was first applied on human fetal ovaries at different 
gestations to show the expression pattern of DNMT3L (Figure 6.2). At 63 or 65 days 
(9-10 week) gestation, DNMT3L is widely expressed in the nuclei of germ cells. 
Later at 14 weeks gestation after meiosis started, DNMT3L was still germ cell 
specific but with fewer cells expressing it in their nucleus; most of these were less 
mature germ cells distributed around the edge of ovary (Figure 6.2B). Toward the 
central area, most germ cells were DNMT3L-ve with some still having positive 
staining. At 18 week gestation when germ cells began to form primordial follicles, 
the distribution of DNMT3L+ve cells was similar to that at 14 week gestation – some 
germ cells with DNMT3L staining around the peripheral area and no or few positive 
cells occurred in the central area.  
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Figure 6. 2 The protein expression of DNMT3L in human fetal ovary.  
A) At 63 and 65 day gestation, DNMT3L (green) was widely expressed in the nucleus of germ cells with round pattern (arrow). This pattern 
also existed in the ovaries at later stages of development (14 and 19 week gestation) but most cells were less mature and distributed around 
the edge of the ovary (arrows). Some more mature germ cells with bigger nucleus in the central area of the ovary were also DNMT3L+ve 
(arrowheads) but most were negative, suggesting that the protein level of DNMT3L decreased during germ cell development. B) Higher power 
image of the 14 week section. Arrow indicates the cell with abundant nuclear DNMT3L in the edge, and arrowhead points a more mature germ 
cell with staining in the central area. Counter stained with DAPI (blue), Scale bar=20μm 
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6.2.2 DNMT3L is partly co-expressed with DAZL in human fetal 
ovary 
After investigating the expression pattern of DNMT3L protein in human fetal ovary, 
the next question we raised was whether its protein translation could be regulated by 
DAZL in vivo. This included whether they co-express and whether any suggestion 
that DAZL was repressing DNMT3L could be detected in germ cells, as seen in the 
previous in vitro experiments.  
We applied dual-fluorescence immunohistochemistry for DAZL and DNMT3L in the 
human fetal ovary at these three key developmental stages (Figure 6.3). As 
previously shown, both DAZL and DNMT3L were specifically expressed in germ 
cells. In all the specimens investigated at different gestations, three kinds of germ 
cell type were identified – only DAZL+ve, only DNMT3L+ve and 
DAZL+veDNMT3L+ve co-expressing cells. At 65d (9-10 week) gestation, most 
DNMT3L+ve germ cells were also DAZL+ve, whilst some DAZL+ve cells, especially in 
the central area did not show DNMT3L expression (Figure 6.3A, upper panels). At 
14 week gestation, there were a lot of DNMT3L+ve cells identified which did not 
express DAZL, and most of positive ones were around the edge of the ovary. From 
the edge toward the central area, DAZL and DNMT3L showed an extensive 
co-expression pattern, however when the germ cells were more mature, had bigger 
nuclei and abundant DAZL staining, the DNMT3L staining seemed to be 
disappearing (Figure 6.3A, middle panels; Figure 6.3B, upper panel). At 16 week 
gestation, the expression and distribution pattern of DNMT3L and DAZL was similar 
to that at 14 week, however there were fewer germ cells co-expressing both proteins 
(Figure 6.3A, lower panels; Figure 6.3B, lower panel).  
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Figure 6. 3 The co-expression of DAZL and DNMT3L proteins in human fetal ovary. 
Both DAZL (green) and DNMT3L (red) were expressed in all the specimens we examined. A) At 65 day gestation, DNMT3L was partly co-expressed with 
DAZL (arrows) but some cells were DNMT3L single positive (arrowhead). At 14 and 16 week gestation, most DNMT3L+ve cells were in the peripheral area 
and did not express DAZL (arrowheads), whilst some more mature DNMT3L+ve cells were also DAZL+ve. But in some more mature cells with bigger 
nucleus, the DNMT3L almost disappeared (unfilled arrows). In 16 week, the DNMT3L/DAZL double positive cells were not so extensively distributed as the 
ones at 14 week. B) High power images for the 14 and 16 week gestation specimens. As in Figure 6.3A, arrows indicated DNMT3L/DAZL co-expression, 
arrowheads and unfilled arrows indicated DNMT3L and DAZL single positive cells, respectively.  Counter stained with DAPI (blue), Scale bar=20μm 
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6.2.3 Does DNMT3L re-express when DAZL expression 
decreases? 
Because the DAZL expression is transiently replaced by BOLL during germ cell 
development in the human fetal ovary (see Chapter 4), the repression effect on 
DNMT3L by DAZL could be relieved when the DAZL expression is reduced. 
Alternatively BOLL may also have a regulatory function on DNMT3L. 
To examine this hypothesis, we applied dual-fluorescence immunohistochemistry for 
DNMT3L and BOLL to see their co-expression pattern (Figure 6.4). The BOLL+ve 
germ cells represented the more mature germ cells with lower or no DAZL 
expression. As BOLL was not expressed before meiosis, only ovary sections at 14 
and 16 weeks gestation were used. Although the images of Figure 6.4 were taken 
from central area of the sections where mostly more mature germ cells were settled 
in, both specimens still contained DNMT3L single positive cells. In the section at 14 
week gestation (Figure 6.4, upper panels), although a lot of cells were BOLL+ve, only 
one cell was found had DNMT3L/BOLL co-expression. In contrast, the ovary at 16 
week gestation showed a higher ratio of co-expression with DNMT3L among the 
BOLL+ve cell group (Figure 6.4, lower panels, about 50% in this image).  
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Figure 6. 4 The DNMT3L and BOLL protein co-expression in human fetal ovary.  
At 14 week gestation, almost no BOLL+ve (green) germ cells were also expressing DNMT3L (red, 
asterisk). Although most BOLL+ve germ cells were distributed in the centre of the ovary, there were 
still some DNMT3L single positive germ cells in this area (arrowhead). Later at 16 week gestation 
however, more DNMT3L/BOLL double positive germ cells were seen (arrows), with some 
DNMT3L+ve cells were still BOLL-ve (arrowhead). Counter stained with DAPI (blue), Scale 
bar=20μm 
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6.2.4 SOX17 is partly co-expressed with DAZL in human fetal 
ovary 
As the level of SOX17 transcripts was also repressed by DAZL transfection in 
TCam-2 cells (see Section 5.2.4), we performed dual-fluorescence 
immunohistochemistry for SOX17 and DAZL on human fetal ovary at three different 
developmental stages to determine their expression pattern (Figure 6.5).  
At 65d (9-10 week) gestation when most germ cells were still undifferentiated, 
SOX17 was expressed in germ cells and many of these cells were also DAZL+ve 
(Figure 6.5A, upper panels). Later at 14 week gestation after meiosis initiation, 
SOX17 was also mostly expressed in the less mature germ cells across the edge but 
still partly co-expressed with DAZL (Figure 6.5A, middle panels; Figure 6.5B, upper 
panel). Similar images were also obtained from 16 week specimens (data not shown). 
Another image (Figure 6.5A, lower panels; Figure 6.5B, lower panel) shows a lot of 
peripheral cells that had both SOX17 and DAZL proteins (Figure 6.5B, arrows), but 
the more mature DAZL+ve germ cells distributed in the central area were still mostly 
SOX17-ve (Figure 6.5B, unfilled arrows). Since the section still showed the trend of 
decreasing SOX17 in maturing DAZL+ve germ cells, the unusual large number of 
SOX17 and DAZL positive cells here might not be a new cell type, but more mature 
germ cells at the transient period just before SOX17 protein began to decrease.  
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Figure 6. 5 SOX17 and DAZL protein co-localisation in human fetal ovary.  
A) At 65 day gestation, SOX17 (red) was expressed across the whole section of ovary and mostly co-expressed with DAZL (green, arrows), but some 
cells were still SOX17 single positive (arrowheads). After meiosis initiation at 14 week gestation, SOX17 was mostly expressed in the less mature 
DAZL-ve germ cells around the edge (arrowhead), with limited co-expression with DAZL (arrows). However, more mature DAZL+ve cells with larger nuclei 
did not express SOX17 (unfilled arrows). At 16 week gestation, the staining in some sections was similar to the 14 week gestation (data not shown), but 
in this section, although most SOX17+ve cells were still around the edge, almost no cells are SOX17 single positive (arrowhead), and most SOX17+ve cells 
were also DAZL+ve (arrows). However, the more mature DAZL+ve were still SOX17-ve (unfilled arrows). B) High power images for 14 and 16 week gestation 
sections. Arrowheads and unfilled arrows indicated SOX17 and DAZL single positive cells, respectively, whilst arrows pointed SOX17/DAZL double 
positive cells. Counter stained with DAPI (blue), Scale bar=20μm 
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DNMT3L and SOX17 were identified as potential human DAZL targets in Chapter 5. 
In this chapter, to explore whether the regulation also happens in vivo, the expression 
pattern of their protein and their co-localisation with DAZL was investigated in 
human fetal ovary. 
In human fetal ovary, the decreasing trend of mRNA level of SOX17 and DNMT3L 
was consistent with the repression by DAZL on their mRNA in in vitro experiments. 
For other targets, the increased mRNA level of TEX19 and TEX14 was also 
consistent with in vitro results, most likely by increasing their stabilization by DAZL. 
The expression pattern through the three stages of fetal ovarian development 
suggested that DNMT3L protein was mainly expressed in less mature germ cells and 
its level decreased during germ cell development, which was consistent with the 
dynamic change of its mRNA level in human fetal ovary. In second trimester, the 
DNMT3L was mainly expressed in early germ cells, especially in DAZL-ve cells but 
still partly co-expressed with DAZL. This was therefore evidence for the hypothesis 
that DAZL is repressing the translation of DNMT3L protein. Co-staining with BOLL 
suggested that DNMT3L did not immediately re-express when the level of DAZL 
protein decreased, but possibly appeared after a short delay whilst BOLL protein still 
existed, providing further evidence of a potential repression function of DAZL on 
DNMT3L in vivo. 
DNMT3L expression in human fetal ovary had not been investigated so far and most 
research has focused on its function in de novo methylation, which occurs in adults at 
ovulation  (reviewed by Schaefer et al., 2007). In mouse, it was believed that the 
Dnmt3l is absent in early germ cells in females, however the original research only 
investigated e13.5 and later (La Salle et al., 2004). Therefore, its germ cell 
expression before meiosis remains unknown in both human and mouse ovary. This 
research raises the possibility that human DNMT3L is actually expressed in 
pre-meiotic germ cells in the female and decreases later, which is conserved with its 
transient expression in mouse testis in differentiating spermatogonia (Bourc'his and 
Bestor, 2004). The loss of mouse Dnmt3l can cause failure of meiosis in testis, but is 
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lethal to female fetuses (Bourc'his and Bestor, 2004) thus its function in fetal ovary is 
still not very clear. However, the conservation of its transient expression between 
human female and mouse male may imply that it has the similar functions in human, 
i.e. involved in a genome scanning for de novo methylation before meiosis (Bourc'his 
and Bestor, 2004). 
The expression and function of SOX17, however, has not been so extensively 
investigated as DNMT3L. In human, its protein expresses in spermatogonia, 
secondary spermatocytes and spermatids (de Jong et al., 2008b) but the expression in 
female remains unclear. In this study, SOX17 was found to be expressed in early 
germ cells in human fetal ovary, potentially in pre-meiotic ones. The loss of SOX17 
protein expression in ovarian meiotic cells was consistent with its expression pattern 
in human testis (not detected in spermatocytes) as well as the level change of its 
mRNA. The co-staining of SOX17 and DAZL showed that SOX17 was reduced in 
DAZL+ve cells and therefore it could also be down-regulated by DAZL in vivo. 
Notably, unlike the results from DNMT3L co-staining which suggested continuing 
DNMT3L expression when DAZL was present, most DAZL+ve cells at early second 
trimester were already completely SOX17-ve, likely indicating a more rapid reduction 
of SOX17 protein in these cells. 
The function of SOX17 during early germ cell development remains unclear, 
although a recent study suggests that it is necessary for promoting the differentiation 
from iESC to PGC-like cells (Irie et al. , 2015). It is possible that SOX17 is not 
required for development after PGC differentiation and then it is repressed by DAZL 
at meiosis initiation. Indeed, the absence of SOX17 in human primary spermatocytes 
(de Jong et al., 2008b) may support this point of view, but further investigation is 
still needed. 
However, it is also necessary to point out that the co-localisation between DAZL and 
the translated protein of its mRNA targets does not directly confirm the regulation. 
Although not very likely, the protein of these targets can be translated in DAZL-ve 
cells and transported to DAZL+ve cells, leading to false positive results. Therefore the 
best way is to co-localise DAZL with the target mRNA, however this was not 
possible in this study (as discussed in Chapter 7). Another possible improvement is 
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that the expression level of target proteins can be semi-quantified and statistically 
analysed based on the immunohistochemistry images. The expression of both 
DNMT3L and SOX17 seemed to be gradually decreasing in DAZL+ve cells, but 
without the proper quantification, it cannot be concluded whether this is true. If it is, 
it can be strong evidence of the repression function of DAZL on these two targets.  
In summary, this chapter extended the in vitro study to in vivo investigation, further 
proved the findings in previous chapter. DNMT3L and SOX17 protein were both 
expressed in germ cells and decreased when DAZL expression was observed, 
supporting a novel repression function of DAZL on these two targets in human fetal 
ovary. The expression patterns of these two proteins were consistent with the changes 
in their mRNA levels and were conserved between species and/or sexes, providing 
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Chapter 7. General Discussion and Future Work 
7.1 Introduction 
In this study, we investigated the expression and potential targets of human DAZL 
and BOLL. In Chapter 4, we examined DAZL and BOLL expression patterns in 
human fetal ovary in first and second trimester, further related their expression 
timing with different stages of meiosis prophase I, and compared it with that of 
mouse fetal ovary. In Chapter 5 and 6, we identified several potential mRNA targets 
of human DAZL and BOLL using a range of methods, and co-localised the protein of 
two potential targets with DAZL in human fetal ovary.  
In Chapter 1, two hypotheses were proposed for this PhD project: 
3. DAZL and BOLL show different expression patterns during human oogenesis, 
and these expression patterns may reflect distinct roles for these proteins in 
regulating this process. 
4. DAZL plays a critical role in regulating human oogenesis by controlling the 
translation of mRNAs encoding key proteins involved in germ cell 
development. 
 
For the first hypothesis, this research found that DAZL and BOLL are both expressed 
in human fetal ovary prior to the arrest of meiosis I, however they are distributed in 
germ cells of different developmental stages – DAZL is expressed in germ cells 
before pachytene and also in primordial follicles, whilst BOLL expression is 
transient and mainly associated with pachytene. Interestingly, this distribution pattern 
is not conserved in the ovary between human and mouse.  
Corresponding to hypothesis 2, further research isolated several potential mRNA 
targets of human DAZL, including TEX19, TEX14, CDC25A, SOX17, SYCP3 and 
DNMT3L. Genetic manipulation of all these targets is associated with reproductive 
phenotypes, especially with disordered meiosis, and therefore provided support to the 
hypothesis that human DAZL is very likely to be essential for germ cell development 
as in mouse. It is also the first time repression function at translational level of 
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human DAZL has been reported. Unfortunately, due to the lack of a functional BOLL 
vector, the work on BOLL targets and function was limited. 
Most previous studies on DAZL and/or BOLL either focus on animal experiments, or 
simply relate human reproductive phenotypes with DAZL/BOLL expression 
deficiencies but lack any insight into the molecular mechanisms. An overall 
comparison of DAZL/BOLL expression and function between human and model 
animals is also limited. The research of this thesis therefore for the first time focused 
on DAZL and BOLL functions during human oogenesis at a molecular level, and 
contributed to our understanding of their different expression/functions between 
human and model animals. It provided some clues about that how meiosis prophase I, 
and potentially how the general process of germ cell development, is regulated in 
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7.2 Establishment of human DAZL and BOLL expression profile 
In hypothesis 1, we proposed that BOLL is likely to be expressed during early stages 
of meiosis prophase I in human fetal ovary, and aimed to find out the relationship 
between DAZL/BOLL expression and germ cell development. 
Using qRT-PCR, we found that both DAZL and BOLL mRNA levels increase around 
the time of the entry of meiosis in human fetal ovary, and they show different timing 
of protein expression which is very different from that of mouse (Figure 7.1). This 
suggests that the two proteins may associate with different stages of meiosis during 
oogenesis. This result is consistent with the previous speculation that DAZL and 
BOLL show distinct expression patterns during human fetal ovary development. 
However, it was unexpected that this expression pattern appears to be non-conserved 
with that in mouse fetal ovary. 
The possibility that BOLL plays a more important role for germ cell development in 
human than in mouse was discussed in Chapter 4. However, it is also worth 
considering that whether different BOLL expression patterns between these two 
species is caused by the compressed germ cell development period in mouse. Human 
has a much longer pregnancy period than mouse. In human, meiosis arrest and 
primordial follicle formation begins at approx. 18 week gestation (De Pol et al., 
1997), whilst it begins in neonatal mouse just after 20.5 days (about 3 weeks) 
development (Borum, 1961). This implies that the human early germ cell 
development could be much more similar to mouse than it appears to be, if it is also 
compressed in such a short period. Furthermore, in our study, the complete 
co-expression of mouse Dazl and Boll was observed at e15.5 (leptotene/zygotene) 
whereas Boll disappears at e18.5 (pachytene), thus we assumed that the Boll 
disappears just after e15.5. However, samples at the period between e15.5 and 18.5 
were not examined and it cannot be excluded that Boll expression actually extended 
to e16.5 or further.  
In human fetal ovary, Boll expression was mainly distributed in pachytene cells. This 
study already demonstrated that mouse Boll expresses at e15.5 and disappears after 
e18.5. In mouse, pachytene occurs from e15.5 to e19.5 (Borum, 1961). If the 
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minimal-co-expression of Dazl and Boll is similar that in human, then Boll single 
positive germ cells may exist and occur in mouse fetal ovary at e16.5 and/or e17.5. If 
that were to be the case, then it is possible that mouse Boll is equally importantly 
associated with the later stages of meiosis I as in human, although this is not 




Figure 7. 1 Comparison of human and mouse DAZL/BOLL expression patterns during 
meiosis.  
A) DAZL and BOLL show distinct spatio-temporal distributions during human fetal oogenesis. 
DAZL is expressed before and at meiosis initiation but down-regulated afterwards; BOLL is 
transiently expressed at later stages of meiosis with minimal co-expression with DAZL. DAZL is 
re-expressed in oocytes within primordial follicles. B) Expression of Dazl and Boll during meiosis 
from e13.5 to neonatal mouse ovary. Dazl expression persists during meiosis, whereas Boll is 
only transiently expressed around E15.5.  
adapted from He et al. (2013) 
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However, it is also worth pointing out that our study suggests in human fetal ovary, 
the BOLL expression persists to a very late stage of meiosis prophase I, very likely 
until late pachytene or early diplotene just before meiosis arrest. In contrast, in 
mouse ovary, Boll expression has already completely ceased at e18.5, at which time 
point most germ cells are still at late pachytene and some reach early diplotene 
(Borum, 1961). In addition, if mouse Boll expression extends beyond e15.5, the 
present data suggest it stops at e16.5 or e17.5, which is much earlier than in human. 
Therefore, with the limitation of this study, it is very difficult to affirm that the 
DAZL/BOLL expression pattern in fetal ovary is largely conserved between human 
and mouse, but it remains as an additional possibility to be considered. 
Whether the minimal co-expression pattern is conserved between human and mouse 
or not, the mechanism behind this phenomenon remains unknown. DAZL is known to 
self-promoting the production of its own protein (Chen et al., 2011; Maegawa et al., 
2002), and CPEB1 can also increase the translation of DAZL (Chen et al., 2011). 
CPEB1 is essential for both maintaining the number of germ cells and meiosis (Tay 
and Richter, 2001), the latter function is possibly partly achieved by indirectly 
regulating Sycp3 expression in mouse, by regulating the expression of Dazl 
(Reynolds et al., 2007). Interestingly, CPEB1 is also known as a translation repressor 
(de Moor and Richter, 1999), although it is not known to be involved in DAZL 
regulation. Therefore, a possible pathway of DAZL regulation, for both the 
translation activation and repression could be through CPEB1. And although no 
previous study has investigated the regulation of BOLL, both the DAZL and CPEB1 
recognition motif (UU2-5[C/G]UU2-5 for DAZL and UUUU[A/AA]U for CPEB1) can 
be found on its 3’-UTR, implies that it could be a target of both DAZL and CPEB1, 
and temporarily increased/repressed by these two protein. Finally, it is also worth 
noting that even in fish, dazl mRNA expression does not overlap with boll (Li et al., 
2011a; Xu et al., 2009; for detailed description see Section 1.4.3.2). Therefore, this 
expression pattern could be very critical to maintain normal germ cell development 
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7.3 The roles of DAZL and BOLL during germ cell development 
In hypothesis 2, we speculated that human DAZL and BOLL translationally regulate 
some mRNA targets which are important for the germ cell development, and some of 
the targets may be the homologue of those in model organisms, especially those in 
mouse. 
To further understand the predicted human DAZL and BOLL functions, we tried to 
find out their potential mRNA targets using both in vitro and in vivo methods. In 
Chapter 6, TEX14, SOX17, TEX19, SYCP3, DNMT3L and CDC25A were identified 
as putative DAZL and/or BOLL targets in human. Among these targets, the 
translation of TEX14 and SOX17 were confirmed to be directly regulated by DAZL 
through their 3’-UTR, whilst TEX19, SYCP3 and potentially DNMT3L showed 
mRNA-protein interaction with DAZL. Unfortunately, although there was some 
evidence that BOLL also had some effect on the regulation of TEX14 and TEX19, 
due to the lack of a functional BOLL vector in TCam-2 cells, further experiments 
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TEX19 ↑ ↑ (ns) unknown unknown unknown + ↑ unknown 












↑ unknown unknown unknown + ↑* + 




↑ (ns) unknown unknown unknown unknown ↑** +** 
 
** Previously investigated by Anderson et al. (2007) 
*  Previously investigated by Houmard et al. (2009) 
↑, increased; ↓, decreased; ↔, no change; +, positively detected; ns, not significant. 
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All the mRNA targets identified in this project are associated with different stages of 
germ cell development. These targets could be sorted by their functions – TEX14, 
TEX19, SYCP3 and CDC25A are related to germ cell development and/or meiosis, 
SOX17 and TEX19 are involved in pluripotency whilst DNMT3L is necessary during 
de novo methylation, especially for the establishment of maternal imprints. We also 
found that DAZL could regulate its mRNA targets at the post-transcriptional level, 
which has only previously been reported in zebrafish (Takeda et al., 2009, Wiszniak 
et al., 2011), and it also shows a novel repression function on its potential target 
SOX17, which has never been reported before in human. 
Therefore, part of the hypothesis was not fully tested - the targets of BOLL still 
remain unclear, though TEX14 and TEX19 were identified as potential targets. On the 
other hand however, part of the aims were robustly achieved. Several mRNA targets 
of human DAZL were identified as we expected, mostly the homologue of mouse. 
And through them, it is possible to associate DAZL with defects in human 
reproduction. An unexpected novel repression function of human DAZL was also 
discovered, which enlarges current understanding of its roles.  
Our study demonstrated that human DAZL function is tightly associated with 
meiosis. A potential common target of both DAZL and BOLL we identified is TEX19. 
Our study reveals that in human, its mRNA expression increases at the entry of 
meiosis, and this is consistent with mouse Tex19.1 in females, which increases at 
meiosis initiation as well, but shows a transient decrease at e15.5 and then recovers 
at e16.5 (Kuntz et al., 2008). The dynamic change of Tex19.1, as well as of human 
TEX19, does strongly imply that it is associated with meiosis. Previous studies 
already demonstrated that Tex19.1 plays an important role during germ cell 
differentiation, synapsis and recombination, by helping to stabilise the genome and 
reducing DNA damage (Ollinger et al., 2008, Tarabay et al., 2013). In our study, 
human TEX19 could be regulated by DAZL and potentially by BOLL; and if the 
function of human TEX19 is conserved with that of mouse Tex19.1, DAZL could act 
to indirectly promote germ cell derivation and stabilise the genome at recombination 
by regulating TEX19 protein expression. Both Tex19.1 and Tex14-deficient male 
mice show a phenotype of meiotic arrest at pachytene. Given that BOLL expression 
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appears to be the abundant DAZ family member in germ cells in the human fetal 
ovary at this stage, this suggests that BOLL may be involved in the regulation of 
TEX19. It is noteworthy that the dramatic decrease in Tex19.1 at e15.5 in mouse fetal 
ovary completely overlaps with the transient Boll expression, and therefore it is 
possible that mouse Boll may contribute to the repression of Tex19.1. This is 
supported by the reports of repression function of Dazl on Tex19.1 (Zeng et al., 
2009). 
It seems likely that DAZL is regulating/promoting the progress of 
synapsis/recombination, as another DAZL target we identified, SYCP3, is one of the 
very few confirmed mouse Dazl target (Reynolds et al., 2007) and is essential for 
synapsis. In our study, both DAZL and BOLL were co-localised with SYCP3 protein, 
but BOLL shows a higher co-localisation ratio. Sycp3 expression seems to be critical 
in male mouse at zygotene stage, and our study suggests that during human 
oogenesis it is the period at which DAZL is down-regulated and BOLL begins to be 
extensively expressed; therefore it is possible that the translation of SYCP3 is first 
promoted by DAZL, then maintained by BOLL to regulate synapsis. The regulation 
of SYCP3 by BOLL is supported by Kee et al. (2009), who demonstrated that both 
DAZL and BOLL could promote the correct assembly of SYCP3 on chromosomes. 
But some SYCP3 expression without the presence of either DAZL or BOLL was also 
found in human fetal ovary, which implies that DAZL or BOLL could up-regulate 
SYCP3 expression to a required threshold and help it to load on chromosomes, to 
maintain normal synapsis and the formation of chiasmata, but are perhaps not 
essential for late stages of SYCP3 expression. 
Beside the progression of meiosis, DAZL is also known to be necessary for entry 
into meiosis (Lin et al., 2008). Unfortunately we were not able to test if STRA8, 
which is also required for meiotic initiation, is regulated by human DAZL due to the 
limitations of the in vitro model used (no STRA8 expression in our cell lines) and the 
lack of an antibody to study it in vivo. Instead we investigated CDC25A, the human 
homologue of Drosophila twine. twine was originally identified as a target of fly bol 
(Maines and Wasserman, 1999) and is required for meiosis initiation in male, and 
meiosis maintenance in female (Alphey et al. , 1992, Courtot et al. , 1992). However, 
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in our study, BOLL seemed to have no effect on CDC25A mRNA expression, whilst 
DAZL slightly increased its expression level, but not significantly. This is consistent 
with (Lin et al., 2009)’s report, which demonstrated that human BOLL could bind to 
and promote the translation of CDC25A, but cannot stabilise it. This mRNA does not 
show significant change during human ovary development (see Figure 6.1), so it is 
difficult to conclude whether it is regulated by DAZL and/or BOLL in vivo. Human 
CDC25A protein is found in spermatogonia, but is most abundant in pachytene 
spermatocytes and spermatids (Lin et al., 2009). If it is a target of DAZL and BOLL, 
then the regulation of CDC25A may be divided into two stages – by DAZL in 
spermatogonia, then by BOLL at pachytene and later.  
To conclude, by regulating TEX19, SYCP3 and possibly CDC25A, DAZL and 
potentially BOLL act to maintain the normal progression of meiosis, especially 
synapsis and recombination. This also helps to explain the severe meiotic phenotypes 
in DAZL deficient mouse. And in human, the DAZL mRNA expression is much 
lower (albeit not statistically significantly) in azoospermia patients with maturation 
arrest, who have meiotic spermatocytes (Lin et al., 2001). If DAZL is involved in 
meiosis, then it is possible that insufficient DAZL expression caused this phenotype. 
However very limited information is available about the relevant human phenotypes 
(both male and female), thus it is difficult to made a detailed assessment of how the 
data presented here match with the known human information.  
The functions of TEX14 have been described in Section 1.2.3. It is an essential 
component of intercellular bridges. This connection allows germ cells to exchange 
cell organelles/components, contributes to synchronised development inside the cysts 
and helps some germ cells “nurse” others (Ruby et al., 1969, Zamboni and Gondos, 
1968). In our study, the mRNA level of TEX14 increased in early second trimester, 
implying that is likely to be co-expressed in germ cells with DAZL and is may be 
associated with meiosis. Indeed, another study suggests that Tex14 mRNA expression 
in mouse testis begins at the spermatogonia stage and peaks in pachytene, diplotene 
and in meiotically dividing spermatocytes (Wu et al., 2003), implying a possible 
requirement of this protein during meiosis. Our other experiments also strongly 
suggest that DAZL promotes the translation of TEX14 through direct binding of 
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3’-UTR, and therefore it might be an important pathway to regulate meiosis by 
DAZL. An interesting finding is that the female Tex14 deficient mouse is fertile but 
has reduced follicle numbers; if TEX14 function is conserved between human and 
mouse, and its expression is promoted by DAZL, then it may contribute to the 
phenotypes of premature ovarian failure/early menopause in human with DAZL 
SNPs (Tung et al., 2006b). 
Notably, the mRNA level of TEX14 also increased in BOLL-transfected HEK293 
cells, raising a possibility that it is a common target of both DAZL and BOLL; 
indeed, according to the pachytene arrest Tex14 phenotype in mouse and the strong 
BOLL expression around pachytene in human, it is very likely that BOLL is 
regulating human TEX14 during oogenesis.  
A novel repression function of DAZL was found regarding the regulation of SOX17. 
It is well known that during embryo development, disrupted interaction between 
OCT4 and SOX2 by SOX17 seems to be necessary for promoting the differentiation 
of endoderm (Stefanovic et al. , 2009), but the role of SOX17 during germ cell 
development remained unclear, until recently a study suggested that human SOX17 
is critical for the differentiation of iESCs to PGC-like cells by regulating BLIMP1, 
which is not conserved with this progression in mouse (Irie et al., 2015). It is also 
known that in human PGCs, SOX17 replaces SOX2, a factor which maintains 
pluripotency together with OCT4 (de Jong et al., 2008b). In mouse testis, a 
functional form of Sox17 variant (DNA-binding active) is mainly expressed in 
pre-meiotic germ cells (Kanai et al., 1996).  
In our study, qRT-PCR suggests that SOX17 expression significantly decreased when 
meiosis starts in human fetal ovary, and this is further demonstrated by double 
fluorescence immunohistochemistry which shows that SOX17 protein is decreases in 
in the nuclei of differentiating germ cells, and it is partly co-expressed in some germ 
cells with DAZL. SOX17 expression then slightly increases again at later stages, 
which is coincident with the re-expression of OCT4 in primordial follicles. Thus the 
pattern of low SOX17 expression in early meiotic germ cells appears to be conserved 
between human male and female gametogenesis. Together these data suggest that 
besides promoting the differentiation of PGC, SOX17 with its co-factor OCT4 in 
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germ cells may also act to maintain the pluripotent state of PGC or prevent apoptosis 
in germ cells. If this is true, then by down-regulating SOX17, DAZL is further 
driving both the germ cell fate and entry of meiosis. This is consistent with DAZL 
limiting pluripotency and promoting germ cell differentiation from both human and 
mouse ES cells (Chen et al., 2014, Haston et al., 2009, Kee et al., 2009). 
The final, and uncertain putative DAZL target we identified is DNMT3L. Despite it 
being down-regulated after DAZL transfection in TCam-2 cells, DNMT3L was only 
slightly enriched in DAZL pull-downs; therefore their direct interaction is not clear. 
DNMT3L functions to promote DNA methylation, and during germ cell development, 
it is necessary for the de novo methylation and establishment of maternal imprint 
(Bourc'his et al., 2001, Ooi et al. , 2007). During meiosis in mouse fetal ovary at 
e17.5, the methylation of several imprinted gene remains at a low level, in contrast to 
the higher methylation level in fetal testis (Li et al. , 2004), and this may be 
associated with repression of methylation factors. Indeed, the DNMT3L mRNA level 
slightly decreased through gestation in human fetal ovary, and this could be regulated 
by DAZL according to our immunohistochemistry analysis. However, this still needs 
to be confirmed. 
Overall, by analysing the functions of putative DAZL/BOLL mRNA targets we 
identified, it could be concluded that during germ cell development, the roles of 
DAZL and BOLL are largely involved in, but not limited to, meiosis. These data 
suggest that DAZL promotes germ cell differentiation and meiotic fate, and helps to 
stabilise the synaptonemal complex and genome by modulating the expression of its 
targets. BOLL is mainly involved in the later meiosis, possibly being necessary for 
meiosis progress beyond pachytene but before primordial follicle formation. 
Although there are several questions which remain to be answered, those potential 
targets we have identified contribute to our understanding of DAZL/BOLL function 
during human oogenesis. 
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7.4 Limitations and possible improvements to this project 
Despite this project extended the understanding of human DAZL/BOLL function and 
the progress of germ cell development, some improvement could still be made. 
The major limitations of this project were caused by the unexpected dysfunctional 
pCMV6 vectors in TCam-2 cells, which worked well in HEK293 cells. It is very 
difficult to give the reasons why pCMV6 did not express the protein in TCam-2 cells 
as no further experiments was performed. But since the transcription of these vectors 
in TCam-2 cells was shown (see Section 3.2.5), it is very likely that it is the stage of 
translation that was blocked. 
Due to this limitation, the first problem was that human BOLL function was not able 
to be as sufficiently investigated as DAZL, as planned in hypothesis 2. Furthermore, 
considerable expenditure of time in solving this problem made the project much 
more complicated than it would be. 
Misled by the positive transfection results in HEK293 cells, the cause of undetectable 
target protein levels in transient transfected TCam-2 cells was mistakenly thought as 
the low transfection ratio rather than the vectors themselves. To solve this, the effort 
of establishment of a stable transfected cell line was also in vain. To establish a stable 
transfected cell line, a single clone of transfected cells should be picked, which was 
not achieved in this project either. This was because no protein was detected in the 
polyclonal colonies and therefore this experiment was halted before the single clones 
could be made. 
Another subsequence was that although a replacement pCMV-DAZL vector was 
found, using pCMV6-Entry vector as a negative control was not a perfect 
combination. And if the pCMV-DAZL vector contains an antibiotic resistance maker, 
that would provide a potentially easier route to making a stable line with it rather 
than using the FACS system to separate the transfected/un-transfected cells.  
Therefore, a very critical improvement of this project could be made by the better 
selection and utilising of vectors. Another series of vectors containing empty, DAZL 
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and BOLL encoding sequences and antibiotic resistance loci, and most importantly, is 
translatable in TCam-2 cells would allow significant progress. 
Another problem was that, despite the direct interaction of DAZL and its potential 
mRNA targets being confirmed by the in vitro experiments, it is still unclear whether 
they really interact in vivo. This is a challenge if we want to find the real biological 
significance of the experimental data. 
One solutions would be to perform immunoprecipitation with human ovary tissue 
instead of the transfected cells. But more importantly, confirmation of the 
DAZL-targets co-expression is necessary. In this project, SYCP3 protein was 
co-localised with both DAZL and BOLL in human fetal ovary and thus provided 
essential precondition of the regulation, however the co-expression of other targets 
with DAZL/BOLL remains unknown. Part of the reason is the limited supply of 
commercial available antibodies against these targets.  
Alternatively, co-localisation of DAZL and its mRNA targets using fluorescent 
immunohistochemistry plus in situ hybridisation is also theoretically possible. This is 
even more advanced than the protein-protein co-localisation as it would aim to 
investigate the protein-mRNA interaction. Unfortunately, this technique is not easy to 
perform and may require a lot of time for optimisation, as well as the fetal ovarian 
tissue itself being in limited supply. Furthermore, most of the ovary tissues in our lab 
are fixed with Bouin’s fluid, which better maintains the morphology of human fetal 
ovary than other kinds of fixatives. However previous investigation already 
demonstrated that this fixation is not suitable for in situ hybridisation (McAllister 
and Rock, 1985). This makes it even more impossible to co-localise DAZL and its 
mRNA targets under the current experimental condition in our lab. Nonetheless, this 
step is still essential for finding out the in vivo targets of DAZL/BOLL and could be 
a future work. 
It is important to consider whether those findings which are statistically significant 
are also likely to have biological significance. For example, CDC25A, which is 
reported to be a BOLL-regulated mRNA target, only increased 1.09 fold after DAZL 
transfection and showed almost no change in BOLL transfected cells. However, it is 
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the only known BOLL target in human (Lin et al., 2009). Our finding is consistent 
with the fact that BOLL does not affect the CDC25A at mRNA level (Lin et al., 
2009), but leads to important questions as to whether some of the transcripts studied 
(such as VASA and TRF2) may still be human DAZL/BOLL targets despite not 
showing significant changes at mRNA level in response to DAZL/BOLL transfection 
in this study. Considering that the best-known regulating function of DAZL is on 
translation, rather than on target mRNA levels, it is possible that these targets are 
regulated by DAZL and/or BOLL but only at translational level. This could be 
investigated further by examining whether DAZL/BOLL affect the translation of 
these targets in a luciferase assay, which was not possible in this project in the time 
available.  
Furthermore, the magnitude of the changes seen in target mRNA also needs to be 
carefully assessed. TEX14 increased 2.6 fold in DAZL transfected HEK293 cells and 
the activity of its 3’-UTR conjugated luciferase increased 1.92 fold after DAZL 
transfection, and this consistency between mRNA and protein changes strongly 
indicates that regulation of TEX14 by DAZL may indeed have some significance in 
vivo. But in contrast, TEX19 only increased 1.68 fold in HEK293 cells, and it is 
unclear as to whether this represents a sufficiently large change in expression to 
affect cell function or development. Transfection can stress cells to produce a large 
amount of target protein, which is not what usually happens in vivo. There may also 
be confounding factors provided by proteins expressed in the host cell line. For 
example, although the changes in SOX17 mRNA levels (decreased to 57% of control) 
and luciferase activity (decreased to 68.8% of control) moved in the same direction 
in response to DAZL transfection, the absolute value of the SOX17-3’UTR reporter 
luciferase activity was extremely low when compare to that of the control vectors 
(2,000 vs 150,000). This may imply that the translation of SOX17 had already been 
largely repressed through its 3’-UTR in TCam-2 cells, by a factor other than DAZL. 
In both the case of TEX19 and SOX17, even if the regulation by DAZL is real, it is 
difficult to tell that whether this change will have any significance during germ cell 
development. Examining the expression of these factors in DAZL-deficient germ 
cells in vivo may provide insight into this. 
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As discussed in previous chapters, the small sample size was a major problem in this 
study. This was partly caused by the difficulty of obtaining human tissues, which 
made it difficult to analyse the distribution of data and I could only assume that they 
were normally distributed for further analysis. Therefore there was a risk of choosing 
improper methods. And if the standard deviation of distribution is higher than the 
difference of means, then even the data were statistically significant, it might still 
have no biological significance. But the small sample size made it very difficult to 
evaluate which one was true.  
In conclusion, this study provided some brand-new clues on the functions of human 
DAZL/BOLL during fetal oogenesis, although there are several flaws including 
selection of materials, chosen of methods, sample size and data analysis which made 
the results less convincing. Some of these defects were potentially avoidable and 
improvements should be made in future work.  
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7.5 Conclusions 
In this study, we found that human DAZL and BOLL are expressed at, and 
potentially associated with different stages of germ cell development in fetal ovary. 
Furthermore, a novel repression function of human DAZL is also reported. 
The major findings of this project are summarised in Figure 7.2. Although no 
definitive BOLL targets were found in this project, some of its novel putative targets 
were raised, as well as several almost definitive human DAZL targets being found. 
This investigation further revealed their roles in oogenesis and helps to explain their 
phenotypes in humans. BOLL is more strictly related with the later stages of meiosis 
prophase I but may also contribute to the interaction between germ cells. In contrast, 
functions of DAZL widely cover various aspects of germ cell development including 
early differentiation, epigenetic regulation, but still most importantly, with meiosis. 
And finally, by sharing some putative similar targets, DAZL may initially promote 
their expression whilst BOLL maintains it. Together, these findings contribute to the 
understanding of human oogenesis and possibly, the associated subfertility 
phenotypes. 
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Table 7. 2 Predicted roles of DAZL and BOLL during germ cell development in human fetal 
ovary 
DAZL is expressed in germ cells prior to and at early meiosis prophase I, whilst BOLL is 
associated with later stages, especially pachytene. However, DAZL is re-expressed in primordial 
follicles which do not express BOLL (not shown).  
According to the mRNA targets identified in this project, DAZL may contribute to the modulation 
of differentiation and methylation in early germ cells by a novel repressing function on both 
SOX17 and DNMT3L. Unfortunately its role together with retinoic acid/StRA8 during meiosis 
initiation is not proved in this study, but it is indeed essential for the development afterwards such 
as SC formation and recombination, by regulating SYCP3, TEX19 and CDC25A. And by 
promoting TEX14 expression, DAZL may also be involved in communication between germ cells 
in nests. No definitive targets of BOLL were identified. However, it potentially shares TEX14 and 
all meiotic-associated targets we identified with DAZL, and may help to maintain their expression 
when DAZL is transiently down-regulated in germ cells. 
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7.6 Future work 
Our study mainly investigated the expression pattern and potential mRNA targets of 
human DAZL and BOLL, especially focusing on their roles during oogenesis in fetal 
ovary. However, several questions extended from our research, and are yet to be 
answered. 
The investigation of BOLL is still far from sufficient; the BOLL targets we identified 
are only based on the BOLL-transfected HEK293 cells. To further investigate these 
targets, it is necessary to confirm the direct binding between BOLL and these targets, 
and how their translation are regulated; for this propose, it is also essential to identify 
the recognition motif of BOLL – although its ability to stimulating translation has 
been known for a long time, surprisingly no study has focused on this.  
Additionally, the 3’-UTR interaction was only confirmed between DAZL and 
TEX14/SOX17. Although the direct protein-mRNA interaction was proved possible 
for TEX19, SYCP3 and DNMT3L, whether they are regulated through the 3’-UTR is 
unknown and therefore similar luciferase assays are required. As mentioned in 
Section 7.4, RIP and/or co-localisation should be performed for both DAZL and 
BOLL targets as well using human tissue, to find out whether they can interact with 
their targets in vivo. Another task is to determine how DAZL regulates the expression 
of STRA8 and meiosis entry; the co-localisation of DAZL and STRA8 has never 
been investigated in human fetal ovary, neither are their interactions. 
Moreover, although several in vitro studies suggest that DAZL could promote germ 
cell differentiation from ES cells, its expression at PGC formation, or whether it 
regulates this process in vivo remains unknown so far. And for BOLL expression, we 
still do not know whether it is necessary for meiosis II in fertilised oocytes, which is 
similar to DAZL. The roles of DAZL in pre-implantation embryos are quite 
interesting as well, as its functions are potentially not restricted to germ cells. 
And finally, the novel repression functions of DAZL also need to be investigated in 
depth. Although there are several possible explanations, the underlying mechanism is 
still far from clear. This investigation could also extend to the other two members of 
the DAZ family, how they are regulated, and species other than human and mouse, to 
Investigating the Expression and Function of DAZL and BOLL during Human Oogenesis 
 
Chapter 7. General Discussion and Future Work 
237 
give an in-depth look of the evolution of this gene family which is central to fertility 
across a wide range of species.
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November 14, 2013 
As a result of mistakes in the typesetting process, there were errors in the Figure 4 legend in 
the PDF. A correct version of the legend is available below. 
 
Figure 4. BOLL displays greater co-localisation with the meiosis marker SYCP3 than 
DAZL. 
 
A) Triple immunofluorescence analysis of DAZL (green), BOLL (blue) and SYCP3 (red) in 14 
and 17 week ovary. All BOLL+ germ cells also express SYCP3 (arrowheads), but only a few 
DAZL+ germ cell express SYCP3 (arrows). Unfilled arrows indicate the SYCP3-positive cells 
that express neither DAZL nor BOLL. The asterisk indicates a germ cell nest containing 
BOLL+SYCP3+, DAZL+SYCP3+ and DAZL+SYCP- germ cells in close proximity. Scale bars: 
20µm. B) magnified image of germ cell nest marked with asterisk in A, showing neighboring 
germ cells expressing different combinations of DAZL, BOLL and SYCP3 expression; arrow 
denotes DAZL+SYCP3+ germ cell, arrowhead denotes BOLL+SYCP+ germ cell. C) 
Quantification of DAZL, BOLL and SYCP3 co-expression. ~69% of SYCP3+ cells also express 
BOLL+. This is significantly greater than the percentage of all the other co-expression patterns 
(n=3 14-17 week human fetal ovaries; ***p<0.001). 
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